TSS:Hg 195041.1

Basic information about the TSS

---

TSS ID: hg_195041.1 Species: human Chr: chrM		Start: 14440 End: 14443 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000361789.2 Distance: 304 GeneID: 4519 HGNC/MGI_ID: HGNC:7427 UniProt_ID: Q0ZFD6

Gene_name: mitochondrially encoded cytochrome b Gene_symbol: MT-CYB Gene_synonyms: COB CYTB UQCR3 Gene_source: HGNC:7427

TATA-Box annotation

---

Distance to TSS:	-6928
Nearest PromoterID:	NR_162149
Entrez ID:	113219467
Nearest Unigene:
Nearest Refseq:	NR_162149
Nearest Ensembl:
Gene Name:	mitochondrially encoded cytochrome b
Gene Alias:	-
Gene Description:	microRNA 12136
Gene Type:	ncRNA
CpG%:	0.01
GC%:	0.442786
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@MT-CYB p2@MT-CYB p3@MT-CYB p4@MT-CYB p5@MT-CYB p6@MT-CYB p7@MT-CYB p8@MT-CYB p9@MT-CYB p10@MT-CYB
Sample		p1@MT-CYB	p2@MT-CYB	p3@MT-CYB	p4@MT-CYB	p5@MT-CYB	p6@MT-CYB	p7@MT-CYB	p8@MT-CYB	p9@MT-CYB	p10@MT-CYB
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	42.27	180.39	103.83	63.12	12.08	8.77	10.71	24.74	8.96	5.06
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	46.94	250.47	130.29	99.34	11.53	18.82	18.61	31.16	20.43	8.70
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	69.06	287.23	129.25	113.23	18.33	20.45	16.40	40.70	23.34	10.61
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	30.77	166.54	85.04	119.13	11.64	7.07	7.69	21.21	12.68	3.95
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	38.02	218.89	103.93	124.86	9.67	13.50	12.15	42.07	19.35	5.40
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	44.58	266.88	135.67	153.69	13.95	15.89	16.09	44.58	24.42	9.11
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	54.69	366.48	202.20	165.16	18.08	22.88	16.12	53.38	21.79	9.37
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	33.91	182.15	93.50	94.47	9.93	10.17	8.72	31.49	14.53	4.84
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	28.00	159.86	88.69	97.88	9.83	10.90	9.19	39.32	12.18	5.98
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	35.94	225.47	113.61	191.28	17.97	6.96	15.07	37.68	21.45	6.96
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	35.57	329.86	157.25	257.50	20.62	13.74	19.40	40.02	25.06	6.47
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	36.59	154.90	88.63	141.07	10.57	6.50	8.94	37.81	8.94	4.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	53.03	152.00	117.67	37.40	11.44	8.06	9.67	1.45	3.22	3.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	37.44	122.99	102.09	39.84	10.22	6.62	7.67	2.10	1.95	2.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	28.32	105.61	79.04	28.54	6.59	5.71	7.68	2.42	1.32	3.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	64.13	166.74	122.22	52.31	13.58	11.32	9.31	4.53	3.02	3.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	49.80	152.01	112.48	43.03	10.92	6.12	9.83	1.97	0.22	2.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	137.51	318.05	226.09	94.91	24.89	14.34	14.76	5.91	4.64	5.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	63.98	186.07	120.49	36.25	17.59	10.66	7.46	2.67	2.67	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	46.19	98.54	80.34	27.08	7.37	5.27	6.62	2.41	1.81	1.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	70.97	154.23	132.05	38.36	12.70	8.42	9.09	3.07	2.67	2.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	65.25	128.78	101.50	29.86	10.88	6.73	8.63	2.93	2.42	2.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	54.55	125.38	103.02	31.15	9.44	6.33	5.56	1.29	3.10	2.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	78.87	168.65	128.13	39.07	13.59	8.25	9.95	3.15	3.88	3.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	73.53	120.48	97.78	35.09	10.58	5.42	8.26	3.61	4.13	3.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	60.77	143.06	120.59	47.48	10.44	6.96	6.33	2.22	0.32	2.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	109.89	271.98	167.04	70.33	19.78	18.13	9.89	2.75	5.49	3.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	37.25	207.23	158.90	47.62	16.03	11.32	12.26	2.36	3.06	5.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	60.25	126.31	95.94	29.72	5.81	6.62	6.46	2.26	2.75	1.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	45.42	91.39	72.93	24.61	6.88	5.61	5.07	2.71	0.90	1.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	51.71	104.04	78.09	23.03	6.91	6.91	3.14	1.67	2.72	2.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	50.02	114.30	91.44	33.80	8.40	6.84	5.67	4.69	1.95	1.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	121.34	297.76	218.20	83.99	24.69	21.52	12.45	7.81	6.75	3.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	47.34	160.16	129.97	41.89	11.71	7.59	10.39	2.14	0.99	2.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	43.94	103.78	92.93	28.42	8.23	5.24	6.36	2.06	1.12	1.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	48.48	112.48	94.66	33.15	7.09	5.75	4.79	3.83	2.11	1.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	55.18	128.35	97.08	38.63	10.22	9.20	6.13	2.86	2.45	2.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	33.85	69.51	50.37	20.95	5.04	3.43	3.63	0.81	1.01	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	46.19	123.71	101.56	24.58	9.18	8.91	5.40	2.97	2.43	1.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	41.53	92.42	70.34	24.97	6.48	4.08	3.12	1.68	1.68	2.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	46.35	103.04	83.05	29.17	9.41	6.12	7.53	3.76	2.12	2.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	47.29	123.12	105.40	36.01	7.61	6.59	7.03	3.37	2.78	2.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	31.21	82.04	62.85	24.04	7.59	4.22	7.59	1.48	1.48	1.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	48.95	152.10	113.11	46.68	8.92	9.09	8.22	2.10	3.15	1.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	34.93	98.98	69.87	28.71	8.63	6.42	5.62	5.02	3.01	2.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	44.67	160.06	113.53	40.71	12.80	9.31	11.17	2.09	2.09	3.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	26.39	104.36	89.01	30.95	8.16	6.24	5.04	4.08	2.16	3.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	38.15	127.57	96.27	38.75	8.64	8.05	3.87	7.75	2.68	1.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	36.62	111.55	82.82	28.72	9.34	7.18	7.18	2.87	1.20	2.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	31.34	108.38	80.47	28.91	5.66	9.50	6.27	2.63	3.03	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	89.56	154.94	95.10	39.15	15.58	14.35	7.17	4.71	2.46	3.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	95.18	263.96	166.78	65.16	20.90	18.90	12.90	4.23	3.11	5.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	461.74	8367.32	4575.44	1343.25	475.73	209.88	293.84	41.98	41.98	153.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	48.97	165.72	90.13	44.00	14.19	7.81	6.74	3.55	1.42	4.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	41.75	54.35	28.83	17.23	4.97	4.97	4.31	2.65	0.99	2.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	395.14	2700.54	1529.38	600.68	125.84	112.42	136.75	12.58	24.33	85.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	141.91	449.14	281.06	92.31	23.88	35.82	21.58	6.89	10.56	8.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	57.04	87.19	58.34	27.55	7.78	4.86	3.57	2.92	2.59	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	74.51	175.04	114.02	56.85	13.49	11.88	10.92	2.89	2.89	2.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	194.88	244.23	170.05	63.81	21.37	26.72	11.32	6.29	3.77	5.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	38.78	105.05	76.85	23.97	7.76	9.17	7.05	3.53	2.82	2.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	51.03	95.33	64.49	29.16	7.85	4.49	5.61	5.61	1.68	3.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	315.27	1149.63	733.25	398.07	74.84	156.04	69.26	39.81	54.14	31.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	135.57	325.50	222.21	92.42	20.05	29.56	18.69	9.51	8.83	8.83
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	113.40	199.50	151.74	74.73	27.29	13.00	9.42	22.74	6.50	3.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	63.90	155.48	107.20	44.37	12.78	7.10	8.87	2.84	1.77	1.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	274.79	8809.34	5657.38	1487.08	468.75	355.61	452.59	64.66	32.33	129.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	379.08	8529.28	4809.57	1050.36	402.77	315.90	418.57	55.28	39.49	197.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	38.03	115.54	71.66	38.03	11.21	11.70	4.39	1.46	2.93	1.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	39.67	59.50	52.56	13.88	5.95	4.46	2.48	2.98	2.98	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	26.74	57.70	38.47	13.60	6.10	2.81	2.35	1.88	1.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	67.23	115.58	78.82	34.77	8.94	8.94	5.30	2.32	1.99	3.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	35.88	77.64	49.80	18.87	5.26	4.95	3.40	3.71	0.93	2.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	30.27	99.37	71.54	25.07	10.40	6.11	3.97	5.81	1.53	2.75
Adipocyte - breast, donor1	11376-118A8	196.40	41.34	24.39	9.82	2.22	1.90	1.58	0.79	1.27	0.63
Adipocyte - breast, donor2	11327-117E4	55.19	238.07	189.14	8.82	24.38	12.03	11.71	1.28	4.49	3.53
Adipocyte - omental, donor1	11473-119C6	12.60	62.09	40.84	13.87	5.47	5.60	4.07	1.40	1.65	2.42
Adipocyte - omental, donor2	11474-119C7	124.83	53.07	38.12	15.70	2.99	4.48	1.49	1.49	0.00	0.75
Adipocyte - omental, donor3	11475-119C8	4.02	52.58	41.53	17.08	3.68	3.01	0.33	0.67	1.00	1.00
Adipocyte - perirenal, donor1	11476-119C9	82.94	38.28	23.61	16.59	0.64	1.28	0.64	0.64	1.91	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	145.13	15.39	13.19	5.50	0.00	3.30	1.10	2.20	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	123.75	57.81	36.58	12.65	4.97	1.81	2.71	0.90	0.00	2.26
Adipocyte - subcutaneous, donor3	11408-118E4	397.77	159.87	125.64	40.32	17.38	8.86	6.78	1.56	4.34	1.74
Adipocyte differentiation, day04, donor1	13019-139D4	98.57	27.97	21.32	6.85	1.37	1.37	0.98	0.00	0.59	0.78
Adipocyte differentiation, day04, donor2	13022-139D7	80.30	19.56	9.01	9.01	0.26	1.03	0.51	0.77	0.00	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	105.93	16.45	13.94	8.92	0.84	1.39	0.28	0.84	1.39	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	9.40	26.45	12.34	11.17	0.00	0.00	0.00	0.00	1.18	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	204.86	119.60	90.33	28.23	8.53	5.47	7.32	2.01	1.53	3.94
Adipocyte differentiation, day08, donor2	13023-139D8	128.78	35.83	27.43	17.75	2.26	1.29	1.29	0.32	0.65	1.29
Adipocyte differentiation, day08, donor3	13026-139E2	150.89	30.92	19.73	12.26	3.73	1.07	2.13	0.53	0.53	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	11.69	25.04	18.92	12.24	3.34	1.11	1.11	0.56	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	213.35	61.55	33.27	22.87	4.16	4.99	3.33	0.83	0.83	2.50
Adipocyte differentiation, day12, donor2	13024-139D9	137.89	29.39	29.89	13.31	2.51	1.00	0.75	0.25	0.25	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	162.97	30.76	20.29	13.74	2.95	1.96	1.31	0.00	0.33	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	15.53	27.71	17.05	12.79	2.44	2.44	1.22	0.91	0.30	0.91
Alveolar Epithelial Cells, donor1	11510-119G7	6.63	44.42	32.49	8.62	3.09	1.99	3.31	0.66	0.44	0.44
Alveolar Epithelial Cells, donor2	11590-120G6	2.51	46.26	44.82	13.27	3.23	1.79	1.08	1.43	1.43	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	9.58	75.47	55.11	4.79	7.19	2.40	3.59	1.20	4.79	2.40
Amniotic Epithelial Cells, donor1	11533-120A3	111.00	80.78	41.56	10.79	2.88	2.34	4.86	2.34	1.98	0.90
Amniotic Epithelial Cells, donor2	11613-122A2	128.86	45.18	36.82	10.04	5.02	1.67	1.67	1.67	0.00	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	9.86	58.14	38.83	11.09	4.11	2.67	2.05	3.49	0.82	1.44
Anulus Pulposus Cell, donor1	11248-116E6	7.09	15.91	10.87	3.78	0.92	0.69	0.57	0.46	0.34	0.46
Anulus Pulposus Cell, donor2	11463-119B5	3.43	18.61	11.02	4.65	0.98	0.73	0.24	2.45	0.24	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	33.70	68.29	47.18	16.17	4.49	2.70	4.04	3.15	0.90	1.35
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	26.92	140.66	93.77	29.96	6.95	3.47	6.51	1.30	2.17	3.47
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	79.19	77.05	51.37	23.54	2.14	2.14	6.42	2.14	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	35.27	97.45	69.65	12.26	6.28	2.39	3.89	2.69	2.09	2.09
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	34.15	94.85	69.56	15.18	5.06	1.26	5.06	10.12	0.00	5.06
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	26.40	51.49	37.62	13.86	3.96	0.66	1.98	0.66	0.66	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	23.39	64.33	36.06	9.75	4.55	2.60	1.95	0.65	0.97	1.95
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	25.24	113.11	62.14	21.36	8.74	6.31	2.91	3.88	1.94	4.37
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	36.82	40.98	27.91	11.28	1.78	0.59	0.59	1.78	0.00	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	29.00	61.39	43.69	12.05	4.14	2.26	2.26	2.64	1.13	1.51
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	29.03	100.87	44.27	13.06	5.08	2.90	4.35	0.00	0.73	3.63
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	73.97	38.87	32.60	11.28	5.02	0.00	1.25	0.00	6.27	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	8.40	14.33	14.00	5.27	0.99	0.82	0.66	0.66	0.49	1.65
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	28.66	65.51	54.59	12.28	5.46	2.73	2.73	6.82	1.36	4.09
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	17.34	13.42	8.29	9.05	1.66	0.30	0.45	0.45	0.15	0.75
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	26.25	70.19	54.11	12.32	4.29	2.68	2.14	0.54	2.14	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	21.16	36.84	22.48	10.58	3.78	2.08	2.27	3.40	0.57	0.76
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	16.57	73.50	39.56	17.37	4.54	2.41	1.60	0.80	0.27	2.41
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	26.34	91.69	42.92	13.66	5.85	0.98	5.85	0.00	2.93	4.88
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	18.24	29.03	25.71	9.29	1.66	1.16	1.66	1.33	0.50	1.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	27.62	19.21	19.21	4.80	3.60	0.00	1.20	0.00	0.00	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	7.08	81.42	24.78	10.62	0.00	0.00	0.00	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	16.81	88.68	65.35	16.81	7.89	4.29	2.57	1.20	2.06	2.23
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	20.97	12.58	16.78	4.19	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	30.10	72.33	48.06	14.08	3.88	1.46	1.94	2.43	1.94	2.91
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	14.80	35.67	26.18	10.25	3.42	1.52	0.76	0.38	0.38	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	50.88	42.40	32.71	14.54	6.06	0.00	2.42	0.00	2.42	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	22.23	42.18	25.08	9.69	1.71	1.14	1.14	2.28	0.57	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	17.10	58.36	41.47	12.19	3.85	2.35	2.57	2.35	1.07	1.07
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	10.58	45.68	31.23	15.74	3.87	2.06	2.06	1.03	0.26	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	23.46	60.53	42.23	12.67	6.57	2.35	2.82	1.41	1.88	3.75
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	28.62	75.89	48.55	15.11	6.75	3.54	2.57	1.29	1.61	1.61
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	14.98	22.83	22.83	9.99	0.71	0.71	0.00	0.00	2.85	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	32.76	69.02	36.27	15.21	1.75	2.92	3.51	3.51	1.75	2.34
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	13.55	66.24	41.85	17.76	4.82	2.11	2.11	2.71	0.90	1.81
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	49.90	47.52	30.89	19.01	5.94	1.19	0.00	3.56	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	38.65	64.08	44.75	12.21	1.53	2.54	4.07	0.51	1.02	2.03
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	46.35	82.01	67.49	17.83	5.60	4.58	2.55	5.86	0.51	1.53
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	19.06	10.80	12.07	3.18	0.00	0.64	0.00	0.00	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	26.32	59.12	45.31	10.79	4.75	3.88	2.16	0.43	0.43	1.29
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	21.80	30.69	25.40	9.10	2.96	1.69	1.06	0.85	0.64	1.27
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	15.08	35.96	23.20	8.99	2.03	1.16	0.58	0.29	0.29	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	27.40	124.71	49.13	16.06	5.67	0.00	1.89	1.89	1.89	2.83
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	18.65	41.19	30.01	10.34	4.41	1.53	1.86	0.51	0.68	0.85
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	39.38	81.07	44.01	23.16	2.32	2.32	0.00	0.00	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	10.56	99.29	27.46	14.79	2.11	0.00	2.11	0.00	0.00	4.23
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	12.65	39.45	30.45	10.29	3.65	0.64	1.72	0.21	1.07	0.64
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	12.03	25.87	17.45	6.02	1.80	0.60	0.00	1.20	1.20	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	16.04	59.05	35.72	7.29	2.92	2.92	0.73	7.29	1.46	2.92
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	17.93	37.93	29.42	10.57	2.53	2.07	0.92	0.92	0.46	1.15
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	71.41	137.72	127.51	28.05	5.10	2.55	2.55	0.00	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	18.30	14.24	8.39	10.17	0.51	0.00	0.25	1.02	0.25	1.02
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	19.41	81.96	47.69	17.75	5.37	4.54	3.10	4.75	1.86	1.86
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	15.30	66.40	46.21	19.28	4.90	3.06	1.53	0.31	0.92	1.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	23.42	78.39	38.72	15.77	6.69	2.39	3.35	3.82	1.43	1.91
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	21.07	88.47	50.33	15.97	5.54	5.32	3.55	2.88	1.33	3.10
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	27.46	30.52	24.41	9.15	0.00	3.05	0.00	0.00	3.05	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	21.60	38.77	27.69	9.42	2.77	0.55	0.55	0.55	0.00	2.22
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	15.09	56.14	38.92	16.15	4.50	4.24	2.65	0.79	2.12	1.06
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	13.81	42.89	31.62	10.54	1.82	2.91	2.54	0.36	0.00	0.73
Astrocyte - cerebellum, donor1	11500-119F6	2.09	69.02	44.83	7.61	4.30	2.21	1.84	3.68	1.60	0.49
Astrocyte - cerebellum, donor2	11580-120F5	3.25	58.54	41.42	10.27	3.94	2.74	1.20	3.59	1.54	0.34
Astrocyte - cerebellum, donor3	11661-122F5	7.97	49.08	31.46	11.33	3.15	1.89	2.52	2.52	1.89	1.05
Astrocyte - cerebral cortex, donor1	11235-116D2	101.44	43.57	30.68	12.90	2.44	1.74	2.44	1.39	0.35	1.05
Astrocyte - cerebral cortex, donor2	11316-117D2	233.28	81.21	54.36	23.13	8.25	4.21	3.24	0.32	0.81	0.81
Astrocyte - cerebral cortex, donor3	11392-118C6	22.52	39.08	38.19	14.17	4.62	3.58	1.34	0.45	0.30	0.60
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	466.20	263.55	247.15	66.52	28.90	23.74	12.27	7.11	5.28	4.82
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	533.32	264.60	258.96	69.03	31.82	18.67	11.90	9.15	5.14	5.89
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	495.70	236.13	228.62	58.49	31.07	17.75	9.90	6.15	5.46	3.53
Basophils, donor1	12241-129G9	53.09	12.29	8.11	3.66	0.52	0.52	0.00	0.00	0.52	0.26
Basophils, donor2	12242-129H1	8.66	17.32	7.58	8.30	1.44	0.00	2.16	0.00	0.36	0.72
Basophils, donor3	12243-129H2	70.56	17.20	13.82	8.67	1.91	0.73	2.50	0.15	0.15	0.44
Bronchial Epithelial Cell, donor1	11511-119G8	152.22	97.67	53.04	13.58	4.74	3.67	5.61	1.94	1.94	1.72
Bronchial Epithelial Cell, donor2	11591-120G7	1.37	101.50	67.21	10.97	4.57	3.20	0.46	5.03	2.29	0.91
Bronchial Epithelial Cell, donor3	11672-122G7	93.26	121.95	50.21	21.52	14.35	0.00	7.17	7.17	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	0.63	5.02	3.77	2.51	0.63	0.00	0.00	0.63	0.00	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	3.12	18.72	8.11	9.15	1.04	0.00	0.00	0.21	0.21	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	3.22	22.57	11.28	11.51	1.61	0.46	0.00	0.00	0.23	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	102.03	202.08	98.43	29.69	11.34	10.44	6.84	5.58	6.12	3.42
Burkitt's lymphoma cell line:DAUDI	10422-106C8	27.93	177.26	146.54	35.35	13.50	5.67	4.95	1.75	1.55	2.16
Burkitt's lymphoma cell line:RAJI	10476-106I8	48.68	351.92	287.17	78.95	27.72	13.04	11.88	7.45	5.12	5.12
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	13.43	9.59	17.91	4.16	0.96	0.00	0.00	1.28	0.32	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	227.52	31.03	10.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	19.16	35.50	27.05	19.16	2.82	1.69	1.13	0.56	1.13	1.13
CD14+ Monocytes, donor2	11305-117B9	381.59	224.58	166.30	66.26	16.15	12.62	8.54	3.34	7.24	3.90
CD14+ Monocytes, donor3	11381-118B4	290.45	219.32	140.06	65.20	14.49	14.71	10.76	10.54	11.42	4.61
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	8.49	36.80	30.29	12.74	3.11	0.57	0.57	0.57	0.28	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	67.85	34.12	23.88	14.40	3.41	0.76	0.76	0.76	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	57.86	44.38	30.90	18.41	3.29	1.97	4.60	0.33	0.99	0.99
CD14+ monocytes - mock treated, donor1	11863-125A9	11.85	122.58	82.97	26.74	9.54	6.50	4.77	1.01	3.04	2.02
CD14+ monocytes - mock treated, donor2	11873-125C1	9.66	77.85	41.64	20.82	4.53	2.72	3.62	1.21	0.30	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	5.21	84.81	37.43	22.74	3.79	3.32	3.55	1.18	1.90	1.42
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	10.88	151.50	66.12	35.49	7.37	8.87	8.04	2.68	4.52	2.85
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	9.11	182.17	71.76	42.23	11.04	7.73	7.18	1.38	3.31	3.86
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	7.93	92.97	54.79	17.85	3.97	5.21	3.22	0.25	1.24	1.74
CD14+ monocytes - treated with BCG, donor1	11860-125A6	13.90	120.81	66.18	33.48	7.05	4.70	3.52	0.59	2.94	1.76
CD14+ monocytes - treated with BCG, donor2	11870-125B7	13.53	111.99	54.84	24.04	5.70	4.27	4.99	0.18	3.56	1.25
CD14+ monocytes - treated with BCG, donor3	11880-125C8	5.44	40.48	19.59	9.14	2.39	2.18	1.52	0.44	1.09	0.87
CD14+ monocytes - treated with Candida, donor1	11868-125B5	10.30	75.39	52.21	29.97	3.75	2.58	3.28	1.17	3.04	0.47
CD14+ monocytes - treated with Candida, donor2	11878-125C6	12.67	129.89	63.36	20.07	7.92	3.17	3.70	0.53	2.11	1.58
CD14+ monocytes - treated with Candida, donor3	11888-125D7	7.77	86.53	39.94	26.62	4.44	4.44	3.33	3.33	3.33	2.22
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	18.89	165.56	105.46	36.44	14.87	8.63	7.88	0.45	1.64	1.78
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	8.18	84.21	50.49	17.56	7.38	5.59	3.39	0.60	2.20	1.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	8.33	31.85	19.57	10.41	1.25	1.87	1.67	0.83	1.04	0.62
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	17.39	100.21	64.97	22.19	7.09	3.66	2.75	0.00	2.97	0.92
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	7.01	69.44	31.67	19.23	1.36	2.04	3.17	1.36	1.58	1.36
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	7.42	97.33	49.32	22.26	7.86	5.24	1.75	1.31	3.06	1.75
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	7.53	62.67	27.97	26.63	2.15	2.42	0.81	0.54	2.96	2.42
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	19.54	196.97	111.31	32.28	11.51	10.99	11.17	0.87	4.01	2.79
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	3.79	132.14	58.49	28.19	5.05	7.57	6.31	0.42	1.68	3.37
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	24.43	286.41	155.42	58.79	17.45	14.33	12.31	1.10	4.96	3.67
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	8.10	140.55	55.66	44.03	5.64	7.40	7.75	1.76	3.17	2.82
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	10.97	133.37	65.81	37.29	9.21	7.90	3.07	0.88	2.19	0.88
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	24.94	212.21	119.97	43.59	14.30	12.38	7.32	1.39	7.15	3.14
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	26.76	400.67	186.95	88.09	21.93	19.33	14.50	2.60	5.95	8.18
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	9.27	43.33	29.31	13.15	2.37	1.72	1.94	0.43	0.86	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	80.67	216.62	89.27	72.07	14.74	9.01	4.91	8.60	12.28	2.05
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	6.26	59.11	25.50	12.98	2.09	1.85	1.85	1.16	1.85	1.39
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	9.51	48.25	21.11	17.17	2.55	2.32	2.78	3.25	0.46	1.16
CD14+CD16+ Monocytes, donor1	11789-124B7	117.70	40.32	22.89	12.86	2.62	2.18	0.65	2.62	2.62	0.65
CD14+CD16+ Monocytes, donor2	11801-124D1	7.62	74.84	46.43	22.41	5.77	2.54	3.00	1.15	1.39	1.15
CD14+CD16+ Monocytes, donor3	11912-125G4	12.56	22.31	19.71	11.48	1.08	1.30	0.65	0.22	0.65	1.08
CD14+CD16- Monocytes, donor1	11788-124B6	174.56	67.58	45.78	19.31	5.29	4.05	4.36	0.78	1.09	1.09
CD14+CD16- Monocytes, donor2	11799-124C8	9.08	44.71	30.04	12.75	2.45	3.14	1.22	0.87	2.10	1.22
CD14+CD16- Monocytes, donor3	11910-125G2	15.38	266.23	133.78	54.63	10.70	11.15	7.58	8.25	4.01	4.46
CD14-CD16+ Monocytes, donor1	11790-124B8	154.89	13.52	11.48	8.17	0.51	0.51	0.77	0.51	0.26	1.28
CD14-CD16+ Monocytes, donor2	11800-124C9	14.05	41.28	27.01	21.08	3.73	1.98	0.88	1.32	0.88	0.44
CD14-CD16+ Monocytes, donor3	11911-125G3	13.90	21.69	16.00	9.90	1.68	0.42	0.21	0.42	0.42	0.63
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	4.06	14.23	10.16	8.13	0.00	0.00	0.00	0.00	0.00	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	13.56	16.27	21.70	15.59	1.36	1.36	1.36	0.68	0.00	1.36
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	17.61	16.57	13.46	17.61	2.07	0.00	1.04	0.00	0.00	2.07
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	27.18	15.99	10.66	8.53	1.07	0.53	1.07	0.53	0.00	1.07
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	11.79	33.24	18.76	19.30	3.22	0.00	1.07	1.07	0.00	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	7.72	18.25	14.04	6.32	0.70	0.00	0.00	2.11	0.70	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	4.71	10.98	5.49	5.49	0.78	0.00	0.78	0.78	0.78	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	9.23	6.59	7.91	6.59	0.00	0.00	3.95	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	44.38	170.96	140.54	66.57	20.55	18.08	11.51	14.79	5.75	5.75
CD19+ B Cells, donor2	11624-122B4	520.13	216.18	129.13	51.51	16.68	17.41	10.88	21.76	5.08	4.35
CD19+ B Cells, donor3	11705-123B4	334.19	118.13	95.92	40.39	9.09	8.08	9.59	5.05	1.51	1.51
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	29.90	143.84	88.89	34.34	12.93	8.49	6.87	12.12	6.06	1.21
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	16.78	44.34	20.77	7.99	3.20	1.20	0.40	3.99	1.20	0.40
CD34+ Progenitors, donor1	11545-120B6	90.36	11.04	5.02	6.02	0.00	1.00	1.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	30.34	17.42	15.17	8.99	0.00	1.12	1.12	3.93	5.62	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	239.36	28.56	24.42	14.28	4.13	1.50	1.50	1.50	0.00	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	134.39	21.87	13.53	9.47	2.25	0.68	0.90	0.00	0.45	0.90
CD4+ T Cells, donor1	11225-116C1	221.38	132.47	94.98	39.99	7.14	5.36	3.57	3.93	3.21	1.79
CD4+ T Cells, donor2	11306-117C1	872.01	343.54	196.57	103.49	22.05	30.01	20.21	11.63	11.63	3.67
CD4+ T Cells, donor3	11382-118B5	397.71	291.88	205.26	77.47	21.04	9.76	7.32	1.22	4.88	3.05
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	111.28	63.55	36.75	15.82	4.34	2.55	2.04	0.77	0.00	1.53
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	15.27	52.78	42.00	19.54	5.84	3.14	1.35	4.72	0.67	1.35
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	14.37	38.23	20.12	15.24	3.16	0.86	1.72	2.01	1.15	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	198.64	39.35	17.07	15.17	2.37	0.00	0.47	1.90	0.00	0.95
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	22.47	35.12	35.12	22.47	4.21	2.11	1.40	0.70	0.00	1.40
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	23.07	49.44	6.59	16.48	3.30	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	78.04	42.78	23.99	8.96	2.02	1.88	1.59	1.73	1.45	0.72
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	35.93	109.30	84.39	25.08	14.23	8.81	4.41	2.37	2.03	0.51
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	38.53	81.41	56.74	24.18	9.35	3.71	2.26	0.97	1.13	0.81
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	231.77	39.45	31.83	26.90	3.14	2.24	0.90	0.45	0.45	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	19.57	34.59	16.42	14.67	2.45	0.70	0.35	1.40	0.00	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	14.08	149.15	81.84	22.88	6.60	7.92	6.16	5.28	4.84	2.20
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	137.45	110.47	66.20	13.91	5.48	3.79	1.69	0.84	2.53	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	30.33	84.98	63.99	26.18	9.56	3.53	3.53	3.12	1.45	0.62
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	21.38	45.11	33.08	14.70	4.01	2.34	0.33	2.67	1.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	308.65	165.06	102.79	43.78	11.69	7.34	8.43	2.72	1.63	4.89
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	21.44	70.75	41.80	20.90	8.58	2.68	4.29	3.75	1.07	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	14.35	125.53	75.32	19.73	10.76	8.97	5.38	1.79	1.79	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	124.98	54.70	37.27	13.72	3.52	1.67	1.85	0.56	0.74	0.74
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	12.56	56.54	38.34	16.46	4.33	0.43	2.82	5.63	0.87	1.73
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	9.67	27.74	18.49	8.83	2.94	0.63	1.05	2.31	0.84	0.42
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	197.19	25.28	20.73	11.12	4.55	1.52	1.52	0.00	0.00	1.01
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	14.30	27.73	17.76	19.50	2.60	2.60	3.03	0.00	0.87	0.87
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	22.66	206.58	116.80	44.89	13.51	12.64	6.97	11.33	2.61	4.79
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	7.92	32.17	22.76	18.31	1.48	1.48	0.49	0.00	0.00	0.99
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	11.08	20.31	13.85	16.62	0.92	0.00	0.92	0.92	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	8.37	9.77	4.19	4.19	0.00	0.00	1.40	2.79	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	0.55	21.05	11.08	5.82	0.83	0.28	0.00	0.28	0.28	1.11
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	1.96	52.76	31.16	10.55	2.45	1.47	1.23	1.47	1.23	1.96
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	6.16	20.02	20.02	12.32	3.08	0.00	3.08	1.54	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	6.09	25.43	14.32	11.46	2.15	0.36	0.00	0.72	0.00	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	4.15	15.23	8.31	4.15	1.38	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	29.14	87.09	72.03	23.90	7.20	4.58	2.29	0.98	2.29	1.31
CD8+ T Cells, donor2	11307-117C2	617.96	347.27	210.24	106.62	28.16	17.65	13.14	4.51	7.51	5.63
CD8+ T Cells, donor3	11383-118B6	447.16	349.19	240.37	109.08	27.27	18.94	14.64	2.52	10.10	4.29
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	118.82	410.38	236.27	86.71	26.84	17.20	28.90	2.98	8.49	10.78
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	168.23	643.20	329.27	117.90	35.95	25.40	43.14	7.91	13.66	16.06
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	126.95	637.19	326.39	129.14	49.79	23.53	35.02	8.75	13.95	12.31
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	110.48	343.44	197.24	64.25	19.81	18.91	20.41	7.51	7.21	13.51
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	169.91	360.69	222.70	55.44	18.24	17.04	19.20	4.08	4.08	8.88
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	102.32	204.87	129.38	41.84	14.10	8.87	11.14	1.59	2.50	5.46
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	91.04	272.91	142.76	52.80	16.51	17.38	16.95	4.35	6.08	9.13
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	75.28	260.57	135.55	49.75	13.69	9.74	13.42	4.21	6.58	5.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	88.18	256.79	157.59	49.72	17.12	15.24	16.89	2.35	7.04	5.39
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	150.33	460.97	239.09	80.30	34.11	18.41	22.04	6.94	9.96	15.09
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	135.67	377.66	235.60	70.59	24.11	15.98	20.04	4.07	6.39	5.81
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	83.66	189.43	117.23	37.83	9.86	9.06	8.53	3.46	5.06	6.13
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	65.22	34.58	30.64	14.01	1.31	3.94	2.63	0.44	2.19	1.31
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	54.65	43.27	30.51	12.30	3.64	2.73	3.19	0.91	3.64	1.82
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	73.84	54.45	45.50	25.36	2.98	1.49	4.48	5.97	4.48	1.49
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	85.00	180.44	113.81	39.26	12.61	7.56	8.64	6.48	5.76	5.04
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	86.60	286.57	181.26	50.06	18.99	10.07	13.24	3.45	6.04	8.34
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	74.95	170.64	109.60	39.60	10.84	6.36	6.36	1.89	4.24	2.83
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	87.78	302.01	180.00	54.82	14.89	14.26	19.65	3.49	7.29	9.51
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	80.27	252.51	143.02	49.52	20.91	12.30	10.76	4.92	4.61	8.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	83.35	181.45	120.22	41.36	14.43	8.34	9.94	4.49	5.13	4.81
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	94.85	250.13	144.57	53.16	15.68	12.24	9.18	3.06	6.88	7.65
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	103.26	238.83	130.84	53.60	11.82	13.40	7.49	5.12	7.09	6.31
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	126.32	304.08	155.82	74.13	15.13	8.32	16.64	6.05	9.08	4.54
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	110.81	293.08	158.99	77.89	16.86	13.65	18.47	9.64	16.86	6.42
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	132.19	326.63	211.23	92.32	25.18	9.79	20.28	9.79	20.28	6.29
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	112.20	336.59	269.47	93.16	19.03	12.02	19.03	16.03	16.03	13.02
Cardiac Myocyte, donor1	11525-119I4	31.07	109.66	74.94	31.07	1.83	9.14	9.14	3.66	7.31	1.83
Cardiac Myocyte, donor2	11605-120I3	157.12	34.59	19.76	5.93	2.47	1.48	0.00	0.49	1.98	0.49
Cardiac Myocyte, donor3	11686-122I3	28.52	6.52	4.63	1.26	0.95	0.74	0.42	0.21	0.21	0.21
Chondrocyte - de diff, donor1	11261-116G1	11.09	254.45	133.81	31.89	13.52	17.68	2.43	38.83	3.12	1.73
Chondrocyte - de diff, donor2	11338-117F6	9.60	24.88	9.60	9.95	1.78	1.42	0.71	0.36	0.36	0.71
Chondrocyte - de diff, donor3	11410-118E6	24.92	68.72	60.08	16.95	7.85	5.01	2.05	1.48	1.59	1.25
Chondrocyte - re diff, donor2	11339-117F7	6.27	40.29	28.65	8.95	2.69	0.90	1.79	0.00	0.00	2.69
Chondrocyte - re diff, donor3	11411-118E7	27.50	52.17	32.35	19.82	4.04	3.64	2.83	5.66	1.62	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	26.97	30.07	20.31	8.49	3.44	1.03	0.69	0.11	0.23	0.46
Ciliary Epithelial Cells, donor2	11323-117D9	58.36	67.34	44.68	21.38	5.56	5.13	1.92	0.21	1.92	1.28
Ciliary Epithelial Cells, donor3	11399-118D4	34.25	84.52	71.42	23.89	9.20	4.34	3.36	0.27	1.77	0.97
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	498.21	398.53	271.62	57.04	21.09	19.35	20.63	9.90	8.07	6.14
Corneal Epithelial Cells, donor1	11526-119I5	75.09	28.54	29.42	8.78	2.85	0.66	1.76	0.44	0.00	0.22
Corneal Epithelial Cells, donor2	11606-120I4	174.05	103.52	68.26	25.03	5.69	7.96	1.14	2.28	2.28	1.14
Corneal Epithelial Cells, donor3	11687-122I4	14.32	42.95	31.70	7.67	3.58	2.05	0.77	0.77	0.51	0.77
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	83.70	48.04	21.63	23.94	3.14	0.83	1.82	0.83	0.33	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	121.43	40.69	22.08	22.08	2.84	0.95	1.58	0.32	0.32	1.26
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	151.83	3.45	10.35	10.35	0.00	3.45	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	23.43	75.16	58.21	39.96	6.16	7.02	3.13	1.51	3.35	0.76
Dendritic Cells - plasmacytoid, donor1	11228-116C4	98.39	26.65	16.74	8.88	2.05	2.05	0.68	1.02	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	42.44	9.79	5.22	3.92	0.65	0.65	0.00	0.65	0.00	1.31
Dendritic Cells - plasmacytoid, donor3	11385-118B8	1.94	11.61	7.26	6.29	0.00	0.00	0.48	0.48	0.48	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	6.50	24.35	13.84	10.51	1.33	0.67	1.33	0.17	0.00	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	6.45	29.34	2.35	15.26	2.35	0.59	0.59	6.45	1.76	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	92.47	116.80	45.81	52.60	5.94	2.83	3.96	5.94	3.96	0.85
Endothelial Cells - Aortic, donor3	11412-118E8	6.68	38.14	9.83	19.27	2.36	1.97	1.18	1.18	1.57	0.79
Endothelial Cells - Artery, donor1	11264-116G4	75.92	24.14	13.09	5.24	2.91	1.16	0.87	1.16	0.58	0.29
Endothelial Cells - Artery, donor2	11341-117F9	11.76	49.41	98.58	9.65	2.59	2.35	2.12	0.00	0.47	1.18
Endothelial Cells - Artery, donor3	11413-118E9	4.21	10.69	6.31	4.56	1.23	0.00	0.18	0.18	0.00	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	119.69	21.06	21.06	7.76	2.66	0.66	1.11	0.22	0.22	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	18.26	40.16	31.64	9.43	6.39	3.04	2.13	0.61	0.91	1.52
Endothelial Cells - Lymphatic, donor3	11393-118C7	11.28	55.53	29.32	10.43	3.66	0.85	1.97	0.56	0.56	1.69
Endothelial Cells - Microvascular, donor1	11265-116G5	1.19	27.34	20.80	3.86	0.59	2.08	0.59	1.49	0.30	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	61.44	18.74	9.89	6.77	0.00	1.04	2.08	0.00	0.00	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	10.21	96.13	75.29	17.58	9.93	4.54	4.82	0.85	2.27	2.13
Endothelial Cells - Thoracic, donor1	11266-116G6	1.20	29.61	23.21	5.20	3.20	2.00	0.80	2.80	0.80	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	6.81	19.39	12.58	3.14	2.10	1.57	0.52	1.05	0.52	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	19.26	42.12	32.80	10.44	5.09	1.86	0.99	0.62	0.12	0.99
Endothelial Cells - Umbilical vein, donor2	11324-117E1	8.91	38.89	20.64	22.16	1.52	1.96	1.30	4.35	1.30	0.87
Endothelial Cells - Umbilical vein, donor3	11400-118D5	13.80	47.39	24.67	20.40	2.81	1.95	2.20	2.81	2.20	1.10
Endothelial Cells - Vein, donor1	11267-116G7	43.23	15.93	5.69	4.55	0.00	0.00	2.28	0.00	0.00	1.14
Endothelial Cells - Vein, donor2	11344-117G3	65.66	26.54	7.68	2.10	2.10	0.70	0.70	0.70	0.00	0.70
Endothelial Cells - Vein, donor3	11416-118F3	11.30	34.86	21.04	17.11	1.57	1.57	0.79	0.79	0.79	0.31
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	3.30	3.30	1.65	3.30	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	10.70	7.13	7.13	0.00	0.00	0.00	3.57	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	4.15	95.04	54.00	10.02	7.33	1.71	4.40	1.22	3.18	1.47
Esophageal Epithelial Cells, donor2	11587-120G3	2.08	118.57	52.00	8.32	0.00	0.00	0.00	4.16	2.08	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	32.54	32.54	16.27	32.54	16.27	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	20.12	59.52	46.39	18.47	6.57	3.28	2.46	2.46	0.41	1.64
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	25.95	62.52	37.66	23.65	3.39	3.28	3.07	1.53	2.85	2.19
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	1.19	2.82	0.76	1.08	0.00	0.00	0.33	0.33	0.11	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	21.10	47.91	43.78	11.64	5.09	1.33	1.33	1.21	0.12	0.73
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	6.41	50.77	30.98	10.92	4.64	3.68	1.64	1.64	0.82	0.68
Fibroblast - Aortic Adventitial, donor2	11326-117E3	16.98	87.12	64.02	14.45	7.49	2.53	3.16	0.74	0.42	1.48
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	14.23	364.41	215.27	66.14	19.50	20.82	8.43	10.01	6.32	6.85
Fibroblast - Aortic Adventitial, donor3	11401-118D6	33.22	136.87	110.62	26.58	16.28	7.97	6.31	2.99	4.65	1.33
Fibroblast - Cardiac, donor1	11268-116G8	7.71	16.78	11.34	12.25	0.91	1.81	0.91	2.72	0.45	0.91
Fibroblast - Cardiac, donor2	11345-117G4	6.06	26.53	10.61	9.85	2.27	0.00	0.76	0.00	0.00	0.76
Fibroblast - Cardiac, donor3	11417-118F4	13.25	41.79	36.43	6.78	3.63	0.95	2.37	0.47	0.32	0.63
Fibroblast - Cardiac, donor4	11452-119A3	5.46	12.12	9.09	3.64	0.00	1.52	0.61	0.00	0.30	0.30
Fibroblast - Cardiac, donor5	11456-119A7	66.62	19.54	14.72	7.99	2.54	1.52	0.76	0.89	0.76	0.63
Fibroblast - Cardiac, donor6	11460-119B2	3.94	21.37	15.01	4.85	1.36	0.61	1.36	1.97	1.06	0.30
Fibroblast - Choroid Plexus, donor1	11492-119E7	2.41	50.65	23.45	6.57	1.47	1.21	1.07	3.48	1.07	0.67
Fibroblast - Choroid Plexus, donor2	11572-120E6	12.51	20.71	12.51	5.61	2.59	1.29	0.43	0.00	0.00	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	26.37	196.28	109.86	35.16	19.04	14.65	7.32	1.46	4.39	4.39
Fibroblast - Conjunctival, donor1	11531-120A1	7.15	60.89	33.67	10.61	3.23	1.15	1.61	0.23	1.85	1.38
Fibroblast - Conjunctival, donor3	11692-122I9	12.21	73.10	49.19	13.74	4.41	6.78	2.71	5.43	0.34	1.02
Fibroblast - Dermal, donor1	11269-116G9	12.91	40.38	25.83	10.33	4.23	1.88	1.64	0.94	0.47	0.70
Fibroblast - Dermal, donor2	11346-117G5	5.19	38.68	15.09	29.72	1.89	2.36	0.47	1.42	0.94	2.36
Fibroblast - Dermal, donor3	11418-118F5	381.40	110.61	92.36	22.12	11.12	6.89	4.11	4.47	4.84	2.30
Fibroblast - Dermal, donor4	11450-119A1	52.00	13.57	14.70	5.09	1.92	0.79	0.45	0.23	0.23	0.57
Fibroblast - Dermal, donor5	11454-119A5	4.71	21.63	18.49	4.71	2.09	2.09	0.87	1.74	0.52	0.17
Fibroblast - Dermal, donor6	11458-119A9	3.09	22.58	17.87	6.50	1.46	0.81	0.49	3.90	0.49	0.16
Fibroblast - Gingival, donor1	11237-116D4	14.99	18.74	21.66	7.08	1.87	0.21	1.25	0.21	0.21	1.04
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	12.58	61.31	37.73	17.55	4.45	3.67	2.62	1.05	1.05	3.14
Fibroblast - Gingival, donor2	11318-117D4	38.09	71.16	65.50	12.91	9.36	3.16	2.64	0.53	0.53	1.98
Fibroblast - Gingival, donor3	11394-118C8	13.54	27.85	27.94	9.67	3.00	0.87	1.06	0.00	0.19	1.16
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	4.16	18.70	13.51	7.27	3.12	0.00	1.04	0.00	1.04	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	19.03	59.38	40.00	10.92	6.17	3.35	2.47	0.35	1.41	0.88
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	23.54	105.54	71.71	23.23	7.48	5.14	4.21	2.03	2.81	2.65
Fibroblast - Gingival, donor6 (control)	11922-125H5	22.99	85.19	66.53	19.20	7.84	4.46	3.25	2.03	0.81	1.62
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	3.18	23.29	7.76	15.17	1.41	0.35	1.41	1.06	1.06	1.06
Fibroblast - Gingival, donor7 (control)	11924-125H7	12.43	47.38	41.53	15.94	3.66	2.63	0.73	1.17	1.46	1.17
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	17.59	139.76	99.81	37.22	12.27	7.91	4.77	1.50	2.73	1.91
Fibroblast - Gingival, donor8 (control)	11926-125H9	10.42	64.39	50.57	19.09	6.14	3.29	2.74	0.77	1.32	1.21
Fibroblast - Gingival, donor9 (control)	11927-125I1	22.45	83.20	60.31	31.26	5.43	6.46	3.08	2.64	2.64	1.32
Fibroblast - Lung, donor1	11270-116H1	2.72	8.16	5.44	2.72	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	61.18	185.03	94.01	37.30	17.91	13.43	2.98	31.34	2.98	1.49
Fibroblast - Lung, donor3	11419-118F6	8.44	11.18	10.55	3.59	1.06	0.21	0.84	0.00	0.21	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	3.33	39.99	24.99	1.67	0.83	0.83	0.00	0.83	2.50	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	1.40	26.57	15.38	1.40	0.00	0.00	1.40	2.80	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	6.72	22.11	12.31	3.08	0.56	0.56	0.84	1.12	0.56	0.00
Fibroblast - Mammary, donor1	11540-120B1	6.90	25.17	30.85	5.28	2.44	0.81	0.41	0.41	0.00	0.41
Fibroblast - Mammary, donor2	11620-122A9	139.80	31.95	7.99	7.99	3.99	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	23.83	77.43	35.74	0.00	11.91	5.96	0.00	0.00	5.96	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	18.43	42.29	33.56	9.50	4.07	0.97	2.91	1.94	0.78	1.94
Fibroblast - Periodontal Ligament, donor2	11319-117D5	25.79	51.72	34.13	16.08	5.92	2.12	1.67	0.15	1.21	1.06
Fibroblast - Periodontal Ligament, donor3	11395-118C9	9.79	19.58	15.91	3.37	1.53	0.31	0.61	0.31	0.00	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	5.72	23.28	12.98	4.20	1.53	1.14	1.53	0.38	0.76	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	17.01	24.03	17.28	7.02	1.62	1.62	0.81	0.81	0.54	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	9.05	18.90	12.06	5.10	1.86	0.81	0.81	0.00	0.23	0.46
Fibroblast - Pulmonary Artery, donor1	11250-116E8	73.50	17.13	14.37	3.32	1.11	1.11	0.77	0.77	0.77	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	7.31	25.60	23.37	5.49	2.03	0.81	0.81	0.20	0.00	0.41
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	10.69	26.06	12.70	3.34	0.67	0.67	1.34	0.67	1.34	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	7.12	17.00	14.23	2.37	1.58	0.40	0.40	0.40	1.19	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	0.79	23.22	11.51	1.98	1.59	0.79	0.40	1.19	0.20	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	11.72	112.08	65.36	14.39	7.28	2.84	2.66	0.89	1.95	1.78
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	164.17	110.17	69.37	19.12	9.66	3.55	4.53	1.58	0.79	1.18
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	285.51	240.08	156.14	43.92	15.64	18.95	6.92	5.42	3.01	3.31
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	59.91	60.24	42.86	7.56	3.35	1.62	0.97	0.54	0.54	0.76
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	0.51	10.88	5.82	0.76	0.51	0.25	0.25	0.25	0.25	0.00
Fibroblast - skin normal, donor1	11553-120C5	5.91	69.73	49.55	12.96	4.76	2.63	3.61	1.31	0.66	0.66
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	40.90	484.43	334.45	94.24	43.31	31.68	29.27	13.03	6.62	10.03
Fibroblast - skin normal, donor2	11561-120D4	2.01	41.29	27.53	6.93	1.91	1.11	0.90	0.60	0.70	0.90
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	0.00	11.49	7.56	0.91	0.60	1.21	0.30	1.21	0.30	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	10.19	33.30	24.36	8.37	2.40	1.49	1.33	0.66	0.58	1.16
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	3.08	80.52	54.70	8.55	2.39	2.05	1.37	0.17	1.20	0.68
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	278.84	286.39	159.62	47.62	19.71	16.42	7.88	8.21	4.60	1.64
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	48.04	40.05	32.92	7.14	2.88	1.49	1.28	0.32	0.85	1.70
Fibroblast - skin walker warburg, donor1	11554-120C6	8.10	66.12	43.18	12.15	4.05	1.69	3.20	1.01	0.34	0.67
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	74.80	192.89	143.02	37.32	15.05	12.39	11.76	7.21	1.88	4.39
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	44.32	465.36	132.96	66.48	22.16	0.00	22.16	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	15.69	54.91	25.27	28.76	4.36	4.36	3.49	5.23	1.74	1.74
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	8.49	18.38	14.39	6.59	1.04	0.87	0.87	0.35	0.69	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	19.26	68.44	37.47	13.01	4.68	3.90	1.82	1.56	0.26	1.56
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	6.90	29.89	11.75	5.11	0.00	1.28	0.51	0.51	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	203.64	22.20	12.25	9.19	2.30	0.00	0.77	0.00	0.77	3.06
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	358.60	33.18	22.33	10.85	4.47	0.00	0.64	1.28	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	89.57	150.05	138.64	55.91	11.13	7.42	5.13	2.28	1.43	2.85
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	35.57	103.68	83.55	34.75	10.75	8.55	4.69	5.24	2.48	1.38
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	91.56	62.56	56.17	18.04	6.62	3.88	2.51	1.83	1.37	1.37
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	100.85	136.71	134.53	42.40	16.05	7.93	4.16	2.58	1.59	2.38
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	44.14	95.69	84.59	30.66	8.19	6.08	1.59	10.57	4.23	1.06
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	23.16	42.40	30.66	13.37	4.89	2.61	2.94	1.63	0.65	0.65
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	88.00	302.92	280.81	78.72	25.21	20.78	11.06	4.42	4.86	1.33
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	5.51	71.37	50.88	15.40	5.23	2.83	2.12	0.99	0.42	0.57
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	6.28	101.96	74.50	24.01	9.11	7.02	3.32	1.60	2.96	2.22
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	19.07	104.50	78.17	25.25	8.86	4.03	3.76	0.00	0.81	1.07
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	5.82	98.87	62.32	22.55	7.31	3.22	3.47	0.99	1.86	0.99
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	6.64	103.68	66.72	19.38	6.64	8.17	3.32	3.60	3.05	0.97
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	15.25	72.99	61.40	17.69	8.54	3.86	2.24	0.41	1.02	0.61
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	16.66	61.84	52.71	11.18	3.42	2.97	2.05	0.00	1.14	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	7.60	85.33	57.05	13.70	7.35	5.61	2.49	0.75	1.62	1.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	6.12	54.21	42.19	12.68	6.56	4.15	3.50	0.44	1.31	0.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	18.02	55.85	44.91	14.18	4.43	1.48	2.36	0.59	0.59	0.89
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	6.36	118.26	85.04	23.68	7.95	6.04	3.66	0.95	1.27	1.11
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	10.50	62.11	56.97	16.31	7.37	2.46	3.35	0.22	0.89	1.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	27.83	82.87	72.59	21.37	9.88	4.64	3.02	0.60	1.81	1.41
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	10.35	128.59	76.51	24.09	8.31	5.09	3.22	3.39	1.87	1.70
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	10.82	64.02	55.15	13.48	5.23	3.46	2.75	0.35	0.62	0.71
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	10.72	87.09	84.91	8.53	5.83	4.06	6.24	0.52	1.98	1.66
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	7.00	67.80	47.99	5.98	4.27	5.29	4.61	0.17	0.51	1.71
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	10.84	96.71	65.51	23.90	7.41	4.87	2.77	0.89	1.44	0.89
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	11.31	52.83	45.18	11.15	3.99	1.75	1.00	0.08	0.50	0.92
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	6.33	41.86	23.68	7.15	2.86	1.23	1.63	0.41	0.41	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	16.71	56.53	52.61	12.79	7.01	1.24	2.89	0.21	0.62	0.83
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	7.49	133.51	91.31	24.10	9.80	7.38	3.57	0.92	1.04	1.96
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	22.18	75.71	62.54	19.18	7.34	2.00	2.17	0.17	0.67	1.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	20.06	112.42	101.18	27.11	12.56	3.75	6.17	0.88	1.54	1.54
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	14.39	154.97	111.92	29.89	12.79	8.36	4.92	4.67	2.83	3.20
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	20.91	108.76	91.26	26.42	9.40	5.35	2.43	0.32	1.13	2.11
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	20.53	141.44	128.29	42.98	14.43	8.02	6.41	0.00	1.60	1.60
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	10.23	119.30	88.88	29.75	9.19	7.77	3.32	1.33	1.90	1.42
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	19.14	120.06	97.91	32.43	11.86	5.06	5.54	3.16	3.48	1.90
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	24.63	114.95	90.62	31.02	12.47	4.87	3.04	0.30	0.30	1.22
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	15.26	132.14	105.58	29.79	12.96	8.05	4.50	0.84	1.99	2.20
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	19.32	124.27	91.33	31.40	9.44	7.03	5.49	2.63	2.20	1.54
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	29.74	140.27	106.89	41.24	12.34	4.21	4.21	0.28	1.40	1.40
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	9.72	100.64	50.65	18.61	7.59	6.67	3.80	0.09	1.20	1.02
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	25.40	73.80	64.71	20.06	6.95	2.41	1.34	1.07	0.53	1.34
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	30.14	82.47	66.56	20.04	10.25	2.75	2.45	0.00	0.31	0.77
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	14.90	102.59	68.40	20.34	9.07	3.76	3.11	1.17	1.04	1.17
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	34.43	66.14	56.65	17.08	8.40	4.88	3.80	4.61	2.17	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	40.56	126.46	109.32	33.37	14.20	6.64	4.98	1.29	2.03	1.84
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	46.93	92.11	73.91	21.27	9.65	4.82	3.95	0.88	0.66	0.88
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	104.13	247.94	240.00	94.22	38.68	12.89	14.88	8.93	0.99	3.97
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	24.40	68.59	52.24	16.23	8.18	3.83	2.37	0.26	0.66	0.66
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	28.25	77.07	60.93	17.55	9.28	3.23	2.62	0.20	0.81	1.41
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	32.28	196.21	130.89	45.49	7.88	3.56	7.88	6.61	2.03	2.54
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	6.57	96.15	78.03	15.73	6.17	1.59	1.00	1.00	1.00	0.40
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	9.86	178.42	117.10	32.82	12.33	9.86	6.63	6.32	3.24	3.54
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	11.46	136.87	89.40	25.16	8.80	8.39	6.34	4.30	2.45	2.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	13.14	10.95	10.01	2.82	0.94	0.31	0.94	1.25	0.31	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	8.48	5.65	3.67	2.83	1.41	0.28	0.00	0.00	0.28	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	23.98	107.00	64.57	42.43	7.38	14.76	2.77	16.14	6.46	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	17.32	71.77	59.40	24.75	4.95	7.42	4.95	17.32	7.42	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	37.13	39.07	27.08	11.99	2.32	3.87	2.32	4.64	2.32	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	49.74	75.41	51.34	27.28	11.23	11.23	1.60	17.65	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	27.82	119.98	93.90	43.47	5.22	19.13	0.00	19.13	6.96	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	26.36	31.57	19.85	10.42	4.56	2.28	1.63	5.53	1.30	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	33.77	86.48	59.71	25.12	5.35	4.94	5.35	5.77	4.94	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	106.63	776.42	469.85	126.63	66.65	83.31	46.65	89.97	33.32	13.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	36.07	46.42	29.92	12.86	3.36	3.08	1.40	4.75	0.56	1.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	27.45	52.95	44.12	11.77	4.58	4.25	2.29	5.88	2.29	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	61.24	388.38	213.90	79.69	27.68	41.94	20.13	25.17	15.94	9.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	34.99	67.75	44.85	13.04	8.91	5.73	3.18	5.09	2.23	0.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	18.68	31.25	22.08	6.79	2.72	2.04	1.70	1.70	1.36	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	12.53	66.82	31.32	14.62	10.44	6.26	4.18	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	20.04	41.81	26.34	8.59	5.73	1.72	1.15	2.29	0.00	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	13.02	23.09	15.10	8.29	3.26	0.59	0.30	1.78	1.78	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	59.30	147.39	106.73	37.27	10.16	11.86	5.08	15.25	8.47	8.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	31.89	56.75	40.18	7.87	5.38	1.66	1.66	3.31	2.90	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	32.45	54.77	41.65	14.73	7.82	5.75	1.38	5.98	2.53	1.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	84.30	168.59	84.30	26.34	26.34	15.81	15.81	21.07	5.27	15.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	27.68	48.05	33.83	13.45	6.92	6.92	1.15	3.46	1.54	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	22.49	36.83	22.82	9.78	3.26	3.91	1.63	2.61	0.98	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	16.72	14.71	7.36	4.68	0.00	0.00	0.67	2.68	1.34	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	25.81	45.85	33.13	6.55	4.62	4.62	2.31	1.16	1.16	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	48.95	130.77	82.50	29.10	13.69	11.30	3.77	10.27	8.56	2.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	44.73	223.63	119.27	69.57	14.91	19.88	17.39	32.30	19.88	12.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	20.29	34.92	30.20	15.10	8.02	2.36	1.89	6.61	2.36	1.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	33.80	75.44	44.06	21.12	9.66	7.24	1.21	6.03	3.62	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	27.47	43.24	25.94	14.24	3.05	4.07	1.02	11.70	5.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	31.11	53.84	38.69	15.16	6.78	3.99	1.99	2.79	2.39	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	16.77	54.76	30.59	16.28	9.37	2.47	1.97	4.44	4.93	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	46.04	51.94	53.12	30.69	5.90	3.54	3.54	16.53	8.26	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	33.26	42.59	25.67	10.50	3.50	2.33	1.17	3.50	0.58	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	21.94	52.23	41.25	18.43	3.51	3.07	1.76	7.02	4.83	1.76
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	82.23	154.28	98.33	67.82	14.41	19.50	0.85	26.28	12.72	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	81.78	99.68	44.17	32.23	8.95	7.16	5.37	16.71	3.58	2.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	34.45	58.23	37.85	14.07	4.85	5.34	0.97	6.79	5.34	1.94
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	53.64	14.84	6.85	9.13	0.00	1.14	1.14	0.00	0.00	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	16.63	84.41	57.80	16.63	6.65	5.41	2.49	0.83	0.42	1.25
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	132.69	19.12	9.00	1.12	2.25	1.12	0.00	1.12	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	34.89	161.75	95.78	27.91	15.54	11.73	7.29	9.20	5.39	2.85
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	16.71	30.50	19.22	7.10	2.09	1.25	1.25	1.25	2.09	2.09
Hep-2 cells mock treated, biol_rep1	11898-125E8	12.53	41.31	26.46	6.61	3.02	1.28	1.28	0.93	0.70	1.04
Hep-2 cells mock treated, biol_rep2	11899-125E9	8.27	57.90	32.41	11.14	2.87	2.70	2.53	1.52	2.53	1.18
Hep-2 cells mock treated, biol_rep3	11900-125F1	5.23	42.54	22.30	9.10	2.96	1.59	1.37	1.59	1.59	0.68
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	12.79	50.72	38.48	10.60	4.48	2.62	1.86	3.06	0.98	1.09
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	7.31	33.10	23.21	9.24	2.15	0.21	1.07	0.43	0.21	0.43
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	9.90	43.27	34.01	11.41	1.94	1.72	1.08	1.94	0.65	0.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	13.82	49.57	41.60	12.20	4.11	1.25	1.12	0.75	0.62	0.50
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	6.52	35.34	26.93	8.75	2.23	0.69	0.86	0.86	0.34	0.69
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	7.37	35.24	30.76	10.89	2.24	0.32	0.32	0.64	0.64	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	3.92	25.74	22.38	5.60	1.12	1.68	0.00	0.56	0.00	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	5.19	25.53	20.77	6.49	2.16	0.43	1.73	1.30	0.43	0.87
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	5.29	150.70	111.04	29.08	23.79	18.51	5.29	2.64	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	4.94	59.26	37.74	14.46	2.47	3.88	3.88	1.76	0.00	1.06
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	139.49	98.08	59.57	17.44	8.72	3.63	3.63	0.73	3.63	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	5.94	27.80	17.13	5.42	1.75	1.57	0.87	0.70	0.00	1.40
Hepatocyte, donor1	11523-119I2	4406.60	899.48	595.62	516.93	64.16	71.43	19.37	6.05	27.84	8.47
Hepatocyte, donor2	11603-120I1	1883.19	359.83	215.47	142.21	34.47	30.17	12.93	28.01	15.08	4.31
Hepatocyte, donor3	11684-122I1	107.37	911.72	523.96	229.46	69.94	61.97	45.40	35.59	49.08	15.95
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	65.92	46.99	35.25	15.66	4.57	3.26	0.65	1.31	1.31	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	68.16	133.18	97.00	25.17	11.54	4.72	3.32	2.62	1.57	3.50
Iris Pigment Epithelial Cells, donor1	11530-119I9	14.68	129.39	91.24	22.36	11.11	8.64	7.41	14.13	4.53	3.57
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	0.00	0.00	0.00	0.00	3.18	0.00	0.00	0.00	3.18	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	6.68	6.68	0.00	6.68	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	24.92	9.69	1.38	2.77	1.38	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	5.01	7.51	2.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	11.87	11.87	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	7.69	20.50	12.81	5.13	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	4.57	4.57	0.00	4.57	0.00	0.00	0.00	0.00	0.00	4.57
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	11.37	3.25	9.75	6.50	0.00	0.00	1.62	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	5.00	6.67	10.00	5.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	7.26	7.26	18.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	7.94	5.29	2.65	2.65	1.32	1.32	1.32	0.00	0.00	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	5.54	1.11	2.22	1.11	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	15.71	15.71	0.00	0.00	0.00	0.00	0.00	0.00	5.24	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	5.67	4.41	3.15	0.63	0.00	0.00	0.63	0.00	0.00	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	3.09	3.09	1.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	43.90	0.00	14.63	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	8.40	2.58	5.17	1.94	0.00	0.00	0.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	8.05	6.44	3.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	11.95	0.00	0.00	0.00	0.00	0.00	11.95	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	6.52	3.26	4.89	2.44	0.81	0.81	0.00	0.00	0.00	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	2.94	0.84	0.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	14.37	14.37	0.00	0.00	0.00	0.00	0.00	14.37
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	5.63	7.23	8.04	2.41	0.00	1.61	0.00	2.41	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	4.62	0.00	1.85	2.77	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	30.16	15.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	2.36	4.25	0.47	1.89	0.47	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	2.72	2.72	0.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	14.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	7.53	5.38	4.30	1.08	0.00	0.00	0.00	0.00	1.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	6.35	2.54	1.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	16.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	4.46	6.38	8.93	0.64	0.64	0.64	0.00	0.64	0.64	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	7.29	3.65	3.65	3.65	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	6.43	17.85	12.85	2.86	0.00	0.00	1.43	0.00	0.00	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	13.27	3.32	3.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	20.85	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	8.95	9.88	13.27	2.78	0.62	0.00	0.31	1.23	1.23	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	3.51	5.27	1.76	1.76	0.00	1.76	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	0.00	3.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	4.87	7.65	4.87	2.78	0.00	0.00	0.00	0.70	0.00	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	4.43	13.28	11.07	0.00	2.21	2.21	2.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	9.73	9.73	3.24	0.00	3.24	0.00	0.00	3.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	15.69	20.93	13.08	4.36	0.87	1.74	0.87	0.00	0.87	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	9.00	15.75	15.75	4.50	0.00	0.00	2.25	0.00	0.00	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	6.97	17.42	10.45	6.97	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	12.80	20.27	16.00	4.27	0.00	0.00	0.00	1.07	1.07	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	4.16	16.63	5.54	6.93	1.39	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	0.00	14.25	8.55	5.70	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	9.20	8.28	4.60	6.44	0.92	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	12.10	12.10	6.05	3.03	0.00	0.00	0.00	0.00	0.00	3.03
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	18.63	6.21	6.21	6.21	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	6.34	13.75	10.57	5.29	1.06	0.00	1.06	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	90.90	55.08	33.54	8.08	3.59	0.82	1.14	0.33	0.41	0.90
Keratinocyte - epidermal, donor2	11349-117G8	1.17	14.64	6.44	2.34	1.17	1.17	0.00	0.00	0.00	0.59
Keratinocyte - epidermal, donor3	11421-118F8	11.74	124.19	80.27	18.55	8.52	6.72	5.21	3.31	3.12	1.89
Keratinocyte - oral, donor1	11251-116E9	8.97	73.79	53.58	9.42	4.09	1.02	2.16	0.45	0.91	0.91
Keratocytes, donor1	11527-119I6	4.81	48.48	30.26	7.22	4.13	0.34	0.69	0.69	1.03	0.00
Keratocytes, donor2	11607-120I5	8.20	39.84	14.06	5.86	4.69	0.00	0.00	1.17	1.17	0.00
Keratocytes, donor3	11688-122I5	6.13	37.35	25.89	7.51	2.37	3.56	1.19	0.79	1.19	1.19
Krukenberg tumor cell line:HSKTC	10687-109F3	0.00	76.93	21.98	24.18	2.20	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	19.42	55.02	36.68	17.26	4.31	2.16	3.24	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	12.69	85.11	65.05	14.65	7.73	7.84	5.19	4.84	0.12	1.27
Lens Epithelial Cells, donor3	11690-122I7	2.12	12.71	8.68	2.02	1.21	0.81	0.30	0.20	0.20	0.71
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	15.53	76.60	48.85	20.40	6.17	3.32	2.49	5.34	2.61	1.54
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	27.07	180.56	104.65	31.54	11.44	6.70	6.70	4.74	5.86	2.23
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	31.95	428.16	268.54	77.45	32.43	24.40	15.11	13.54	16.06	8.34
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	16.13	84.42	39.79	16.13	2.69	3.23	3.76	2.69	4.30	1.61
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	56.73	404.04	233.54	147.81	23.01	20.80	18.28	35.93	32.46	6.30
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	22.43	195.90	120.97	40.86	14.66	11.10	9.49	9.49	9.92	2.59
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	23.39	139.94	73.46	28.32	8.62	8.62	4.10	6.16	6.98	2.05
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	20.23	112.25	64.22	19.47	6.57	4.30	4.05	3.03	3.03	2.78
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	36.03	411.41	246.74	75.44	29.70	27.59	19.56	14.78	22.24	8.45
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	16.61	67.64	48.25	16.61	5.54	3.96	1.58	5.93	3.56	1.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	22.88	192.33	127.58	35.87	12.80	9.69	7.95	7.76	6.20	3.68
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	14.63	141.08	88.13	30.18	10.00	6.30	5.92	5.74	6.48	2.04
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	18.81	188.50	113.93	40.77	12.54	10.45	7.32	7.67	6.62	5.23
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	30.29	161.00	113.78	31.49	14.55	8.83	6.92	3.58	3.34	4.53
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	29.80	283.49	173.20	51.92	19.64	13.87	13.05	8.79	8.93	3.85
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	22.48	142.28	74.83	29.26	7.70	6.47	4.93	8.31	8.31	2.16
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	16.83	145.90	78.25	29.62	10.29	6.23	4.05	5.61	5.92	2.81
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	28.55	289.86	178.42	51.24	17.75	14.46	13.91	15.01	14.09	5.12
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	19.75	173.11	107.29	37.52	9.54	9.22	9.22	3.62	7.24	5.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	18.16	170.16	102.21	32.51	13.18	6.15	7.03	7.03	5.86	1.46
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	19.91	154.58	97.58	31.37	11.95	5.97	5.73	9.21	10.46	2.49
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	20.85	181.86	116.39	41.71	14.06	7.27	6.30	8.73	8.24	4.36
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	17.50	133.57	86.44	24.24	12.93	8.62	7.81	7.54	5.92	1.89
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	23.61	206.93	136.39	41.63	13.78	12.11	8.02	10.75	10.45	2.57
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	12.44	96.94	50.29	24.88	5.70	2.59	4.15	2.59	9.33	1.56
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	32.46	243.31	158.72	42.09	21.36	14.66	11.52	7.54	8.17	4.40
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	26.32	247.21	161.50	39.55	15.64	12.63	10.53	10.53	8.87	5.11
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	13.07	83.92	46.78	22.70	10.32	6.88	4.82	7.57	6.19	2.75
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	19.57	93.89	63.22	19.00	6.40	6.40	5.08	3.95	3.01	2.07
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	22.58	182.48	123.63	36.16	12.09	9.65	8.16	8.27	8.91	3.50
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	18.41	194.80	91.10	43.13	9.69	6.78	5.81	7.75	8.24	5.81
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	20.51	134.96	88.98	26.46	11.91	4.96	4.96	5.95	4.63	1.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	27.50	266.00	165.52	48.94	20.32	20.19	11.15	10.16	13.50	5.20
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	21.47	125.13	76.26	27.40	11.85	4.07	4.44	9.63	5.92	1.48
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	17.79	96.86	68.19	26.93	8.89	5.93	3.46	5.68	4.20	1.98
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	16.91	181.90	121.41	32.17	13.47	8.80	7.56	5.91	5.91	3.16
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	20.91	131.87	64.33	28.63	13.19	6.43	4.82	10.61	8.04	2.57
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	24.96	164.03	109.25	31.95	12.48	11.87	7.00	6.09	4.87	3.35
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	28.13	267.76	177.48	45.35	20.85	15.12	13.16	10.92	10.36	4.34
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	25.24	112.00	66.13	26.67	9.24	8.18	3.20	9.24	5.33	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	7.76	140.10	80.96	24.24	10.67	6.30	2.91	6.79	5.33	2.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	20.07	132.89	90.56	27.08	8.56	7.47	4.36	7.47	7.16	2.02
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	20.77	135.01	62.31	26.86	8.24	7.16	6.80	3.22	3.22	1.07
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	13.07	33.32	18.62	6.86	3.92	0.98	0.33	1.96	1.63	0.98
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	14.60	107.82	62.39	25.43	6.36	7.30	4.00	8.24	4.00	3.30
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	14.23	101.72	62.62	21.66	8.17	3.84	4.46	4.70	3.47	2.23
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	13.32	87.60	59.17	20.23	6.40	4.87	4.87	6.40	1.28	1.28
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	11.93	131.87	91.30	31.63	13.13	10.74	6.56	6.86	4.48	1.79
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	111.03	4.53	9.06	4.53	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	474.85	81.32	61.37	23.01	5.37	1.53	3.07	0.00	2.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	300.60	60.86	27.46	16.33	2.97	0.74	3.71	0.00	0.74	2.23
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	694.78	136.25	96.90	43.58	12.27	6.77	5.92	0.42	2.12	2.54
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	792.65	121.67	101.98	35.17	11.25	2.81	4.22	0.70	2.11	1.41
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	554.78	84.99	56.04	20.55	6.54	2.80	3.74	0.93	0.93	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	772.90	138.61	81.93	28.34	12.88	4.64	8.24	0.00	0.52	3.09
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	441.29	77.31	45.20	28.55	3.57	1.19	2.38	0.00	0.00	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	334.31	23.07	21.71	9.27	1.36	1.13	0.90	0.00	0.00	0.68
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	574.38	106.44	61.07	25.59	5.53	6.11	1.74	0.58	1.16	1.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	559.57	108.94	81.93	30.61	8.55	5.40	2.70	0.00	0.45	1.35
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	247.80	46.34	32.79	11.11	3.12	1.35	2.85	0.00	0.54	2.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	677.85	97.06	71.89	28.76	7.70	3.59	3.08	0.00	0.00	2.57
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	348.27	71.28	50.46	18.35	4.94	2.82	4.59	0.00	0.35	1.76
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	344.48	65.30	35.31	16.66	7.33	4.66	5.33	0.67	1.33	2.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	985.66	158.93	98.82	46.86	12.73	5.60	4.58	0.51	4.58	1.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	499.46	112.86	74.97	27.75	9.87	6.67	3.20	0.00	1.07	1.60
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	424.56	106.94	63.67	26.64	10.20	3.59	3.02	0.00	0.94	1.51
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	854.69	101.24	64.42	28.22	5.52	7.36	4.29	0.61	1.84	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	777.10	123.13	92.96	31.80	11.42	6.52	7.34	0.00	0.00	2.45
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	692.20	118.91	80.80	42.90	9.58	4.79	4.16	0.62	1.46	2.08
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	766.79	117.99	60.82	33.63	10.37	3.92	3.36	0.56	1.40	1.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	558.44	62.85	62.85	20.61	7.21	2.06	3.09	0.00	0.00	5.15
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	1034.06	154.44	100.45	49.06	11.32	7.55	2.32	0.00	2.03	0.87
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	469.02	73.84	44.84	21.52	6.28	3.59	2.99	0.60	1.79	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	461.97	79.12	50.35	19.92	3.87	2.77	3.87	0.00	0.55	1.66
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	862.51	141.75	101.45	37.47	13.43	4.95	5.30	0.35	1.41	1.41
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	611.81	120.96	71.91	29.13	7.38	4.43	2.95	0.37	2.21	1.84
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	409.85	67.93	39.14	11.51	3.45	0.00	1.15	2.30	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	778.63	133.16	73.68	36.46	9.21	2.30	5.76	2.69	1.92	2.69
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	988.46	116.62	68.50	26.61	11.32	3.40	5.10	0.57	2.83	1.13
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	383.16	64.82	56.61	13.13	4.92	1.64	2.46	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	739.73	116.13	68.23	26.21	7.23	3.16	4.97	0.90	1.36	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	638.43	98.39	56.02	28.73	10.05	7.90	0.72	0.00	0.00	1.44
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	507.89	70.21	59.01	21.66	4.48	3.73	2.24	0.75	0.75	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	887.74	131.92	92.16	26.38	11.89	4.09	2.23	1.11	2.23	2.23
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	358.38	70.21	38.77	19.81	3.88	3.45	1.72	0.00	0.86	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	378.48	41.96	39.39	17.13	2.57	1.71	1.71	0.00	0.00	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	712.00	124.94	84.96	26.65	7.33	5.33	6.00	6.33	4.33	3.66
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	760.17	95.93	58.52	14.48	6.03	3.62	1.21	0.00	1.21	1.81
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	429.44	46.93	30.57	8.53	7.82	1.42	3.55	0.00	1.42	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	657.53	97.27	61.53	27.84	7.56	4.47	6.19	0.34	1.03	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	726.22	81.59	53.67	22.01	4.29	2.15	2.68	0.00	0.54	1.61
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	523.20	72.05	49.83	12.79	12.79	2.02	2.69	0.67	0.00	1.35
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	1155.67	175.94	132.98	51.86	15.56	4.82	7.04	3.33	3.70	1.48
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	98.85	11.63	5.81	4.65	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	398.77	42.31	30.67	13.75	5.29	1.06	0.00	0.00	2.12	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	772.29	95.64	75.63	28.41	11.20	3.60	2.80	0.00	0.00	1.60
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	431.76	114.12	55.97	34.16	10.18	3.63	6.54	0.00	1.45	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	659.97	98.88	65.92	39.09	10.73	1.53	4.60	0.00	2.30	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	1243.06	140.58	98.16	39.96	16.77	5.92	2.47	0.00	0.49	3.45
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	624.78	100.68	68.69	18.82	7.53	0.94	3.76	0.94	0.00	1.88
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	623.00	85.98	61.34	19.61	3.52	5.53	5.03	0.00	0.50	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	726.41	120.77	82.91	38.75	9.46	3.60	5.41	0.00	1.80	2.25
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	721.14	104.99	48.19	22.37	12.05	13.77	5.16	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	735.71	72.59	59.68	20.49	6.23	2.23	0.00	0.00	0.89	1.78
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	738.26	144.68	87.98	40.28	11.34	2.74	2.74	2.74	2.74	3.13
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	495.46	71.25	37.60	18.47	3.96	1.98	0.66	0.00	1.32	1.32
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	512.70	77.32	60.71	24.39	5.71	4.15	2.59	2.59	1.04	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	1051.03	184.65	129.08	44.63	15.31	7.88	7.00	0.44	0.00	3.06
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	581.47	100.64	55.91	31.87	10.06	5.03	3.91	0.00	2.80	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	548.52	121.01	83.47	35.77	13.69	3.09	5.30	0.00	2.21	1.77
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	764.49	111.47	78.30	43.97	9.64	5.79	3.09	0.00	1.16	1.16
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	675.48	125.58	52.66	29.37	8.10	5.57	3.54	0.51	1.01	1.52
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	460.91	100.45	62.96	29.80	7.69	3.36	2.40	0.48	1.44	2.88
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	745.40	94.62	60.03	33.39	6.76	1.59	1.99	0.00	0.40	0.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	526.20	127.60	52.86	29.77	7.29	4.25	1.82	0.61	1.82	2.43
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	242.10	71.94	50.49	12.45	2.77	1.38	2.77	0.00	0.00	1.38
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	765.68	96.90	70.68	25.46	9.88	3.80	3.04	1.14	0.38	1.14
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	728.66	101.22	54.22	26.85	6.71	4.13	5.16	1.03	1.55	1.55
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	352.51	135.44	94.33	28.42	4.23	3.02	2.42	0.00	0.00	2.42
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	882.89	128.03	90.95	41.20	8.87	4.12	6.02	1.90	1.90	2.22
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	450.46	96.49	59.17	17.59	10.13	5.86	2.67	0.00	0.53	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	257.45	86.20	52.87	14.37	7.47	2.30	2.30	0.00	0.00	1.72
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	995.56	122.39	92.56	29.83	10.80	8.23	4.63	2.57	3.60	3.60
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	562.35	106.81	63.66	18.39	6.37	3.54	1.41	0.00	0.71	1.41
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	268.42	61.86	36.89	13.62	3.97	3.40	0.57	0.00	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	696.43	114.82	81.12	20.80	9.15	2.08	2.50	0.00	2.50	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	601.38	110.41	67.34	20.36	5.48	3.92	3.13	0.00	1.57	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	217.96	69.73	60.13	18.37	5.85	3.34	0.84	0.00	1.67	0.84
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	658.86	76.67	51.57	21.37	3.72	3.25	2.79	0.00	0.93	0.93
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	419.49	68.91	42.82	11.37	6.02	3.35	2.01	0.67	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	173.22	55.60	55.07	16.57	6.95	1.07	1.60	0.00	3.21	1.60
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	606.55	61.83	43.64	19.80	2.83	2.42	2.83	0.00	0.40	0.81
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	396.47	56.90	32.12	16.52	4.59	0.92	0.92	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	250.73	160.04	91.58	29.34	6.22	4.45	3.56	0.00	0.00	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	199.45	50.72	30.77	12.54	6.84	1.14	1.14	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	464.74	63.65	36.04	19.94	1.53	2.30	0.77	0.00	0.77	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	298.21	122.57	91.93	14.77	9.30	2.74	1.09	0.00	0.55	1.64
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	524.29	72.16	52.12	19.15	6.68	3.12	3.56	1.34	1.34	2.67
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	250.34	32.23	25.48	8.84	2.60	0.78	2.34	0.52	0.00	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	249.99	101.46	49.73	19.89	6.63	0.66	2.65	1.33	1.99	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	644.37	91.46	29.10	29.10	4.16	8.31	2.08	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	6.38	17.55	18.01	12.08	1.14	0.46	0.46	0.23	0.91	0.23
Macrophage - monocyte derived, donor2	11313-117C8	51.57	23.86	16.15	10.09	1.28	0.37	0.37	0.18	0.18	0.37
Macrophage - monocyte derived, donor3	11389-118C3	89.40	47.71	28.31	19.53	2.49	1.84	1.18	0.66	0.66	0.79
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	2.12	3.19	3.72	2.12	0.00	0.53	0.00	0.53	1.06	0.53
Mallassez-derived cells, donor2	11929-125I3	12.68	233.08	123.59	45.00	12.20	9.82	11.41	3.17	5.23	5.39
Mallassez-derived cells, donor3	11930-125I4	10.98	147.74	73.94	24.74	7.92	6.39	6.81	0.83	1.11	2.50
Mammary Epithelial Cell, donor1	11273-116H4	33.58	217.82	145.98	36.57	18.23	11.66	7.67	9.77	5.58	3.19
Mammary Epithelial Cell, donor2	11350-117G9	15.06	104.24	65.73	16.50	7.24	2.03	5.50	1.16	0.29	1.16
Mammary Epithelial Cell, donor3	11422-118F9	6.24	18.46	10.48	6.49	1.75	0.25	1.00	0.00	0.25	0.25
Mast cell - stimulated, donor1	11487-119E2	107.11	385.07	349.82	108.47	40.00	17.63	19.66	14.24	3.39	8.14
Mast cell, donor1	11563-120D6	18.92	230.56	165.13	53.10	19.90	12.54	11.46	2.27	2.05	3.24
Mast cell, donor2	11565-120D8	31.80	170.88	78.45	68.35	10.70	4.16	9.21	6.54	4.75	1.78
Mast cell, donor3	11566-120D9	167.04	47.73	25.66	21.16	4.28	2.70	2.03	2.25	2.25	0.68
Mast cell, donor4	11567-120E1	128.71	48.93	27.83	25.53	2.48	1.24	2.66	2.66	1.24	1.24
Mast cell, expanded and stimulated, donor5	11940-126A5	272.80	329.80	239.42	89.38	24.62	13.64	12.09	14.19	10.53	5.32
Mast cell, expanded and stimulated, donor8	11942-126A7	13.42	136.00	72.38	39.11	8.76	0.58	2.92	4.67	1.17	2.92
Mast cell, expanded, donor5	11939-126A4	158.66	54.15	37.63	22.94	4.82	1.49	2.52	1.26	1.15	0.69
Mast cell, expanded, donor8	11941-126A6	22.26	102.43	66.44	39.67	7.20	3.51	4.52	7.70	2.68	1.34
Melanocyte - dark, donor1	11502-119F8	68.85	34.53	29.25	6.87	3.98	1.39	1.09	2.09	0.30	0.30
Melanocyte - dark, donor2	11582-120F7	160.93	29.42	18.69	4.85	3.46	1.73	1.04	0.35	1.04	0.69
Melanocyte - dark, donor3	11663-122F7	161.98	123.95	88.45	17.68	10.00	4.71	6.23	3.04	2.75	2.10
Melanocyte - light, donor1	11274-116H5	336.86	75.46	57.59	27.27	4.00	2.82	4.47	0.24	0.47	1.18
Melanocyte - light, donor2	11351-117H1	237.50	64.15	26.62	27.30	3.41	1.36	1.36	0.68	0.00	0.68
Melanocyte - light, donor3	11423-118G1	140.49	28.62	17.34	7.81	3.47	3.47	1.73	0.00	2.60	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	13.43	46.54	34.99	8.43	3.12	1.25	1.04	0.83	1.04	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	196.60	56.75	36.04	11.56	2.15	0.81	0.81	0.54	0.54	1.61
Melanocyte, donor3 (MC+3)	12837-137B2	47.95	90.53	61.07	19.29	10.71	4.02	4.29	1.87	2.14	1.87
Meningeal Cells, donor1	11493-119E8	54.34	27.17	15.63	2.48	0.99	1.12	0.25	1.36	0.25	0.62
Meningeal Cells, donor2	11573-120E7	3.96	32.13	32.57	6.16	3.96	1.32	2.20	4.40	0.00	0.00
Meningeal Cells, donor3	11654-122E7	85.98	38.06	32.11	6.52	3.59	0.90	1.79	0.82	0.24	0.90
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	7.13	13.40	13.97	3.99	1.14	0.86	0.57	0.86	0.86	1.14
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	120.96	44.78	32.71	8.45	3.12	2.82	1.81	1.61	1.01	1.11
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	7.88	136.67	102.50	11.83	14.46	1.31	5.26	1.31	3.94	3.94
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	10.47	91.57	49.71	20.93	7.85	5.23	2.62	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	307.14	96.88	66.02	21.53	7.18	5.74	4.31	9.33	2.87	1.44
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	8.47	78.57	45.74	11.22	4.87	3.18	0.42	0.42	0.42	0.85
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	10.05	79.92	64.84	17.59	7.04	2.01	2.01	0.00	0.00	2.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	7.69	61.09	41.53	10.99	6.81	2.42	2.64	0.44	0.22	0.88
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	13.15	162.19	98.63	31.42	10.96	0.73	2.92	3.65	5.11	2.92
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	7.77	77.75	51.76	18.41	9.62	2.66	3.89	1.43	2.25	1.43
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	3.46	53.74	29.50	6.93	1.66	1.52	0.97	6.09	2.08	1.11
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	118.95	144.60	80.66	13.75	7.43	4.83	5.58	1.49	1.12	1.12
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	211.83	255.25	194.34	43.02	16.05	16.58	10.66	10.39	7.63	5.53
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	25.82	117.51	70.33	10.09	2.97	2.67	4.15	1.78	1.78	2.67
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	23.36	100.43	67.73	9.34	4.67	11.68	9.34	7.01	4.67	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	12.17	115.91	75.57	24.34	6.40	5.12	5.12	1.92	3.20	1.92
Mesenchymal stem cells - adipose, donor0	11217-116B2	95.35	18.79	15.60	5.32	2.13	1.06	1.06	1.77	0.00	1.06
Mesenchymal stem cells - hepatic, donor0	11218-116B3	90.69	44.72	35.03	7.82	2.19	2.81	2.50	3.44	1.88	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	27.58	23.22	12.34	4.35	2.90	3.63	0.73	5.08	0.73	0.73
Mesothelial Cells, donor1	11247-116E5	192.25	55.95	52.50	9.02	5.30	2.39	2.12	1.33	1.33	1.06
Mesothelial Cells, donor2	12156-128G5	3.00	15.01	13.01	6.51	1.00	0.00	0.00	0.00	0.50	1.50
Mesothelial Cells, donor3	11402-118D7	251.48	292.60	259.50	51.38	31.29	12.57	12.43	0.94	3.47	3.04
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	4.05	13.50	12.15	9.45	0.00	0.00	0.00	0.00	1.35	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	9.36	63.05	35.22	36.69	4.93	3.45	3.20	0.99	1.97	0.74
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	95.11	187.86	81.86	104.53	5.30	3.83	5.01	1.47	5.30	2.36
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	3.46	0.00	0.00	6.91	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	6.20	35.64	18.60	22.63	1.86	0.93	1.86	0.31	0.62	0.93
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	140.43	279.83	160.76	109.32	13.28	7.68	6.43	1.45	3.94	3.11
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	2.32	13.90	2.32	6.95	0.00	0.00	0.00	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	14.26	63.07	40.54	28.78	4.00	2.00	2.75	0.00	0.75	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	108.46	105.20	41.43	77.74	3.72	1.40	3.26	0.00	1.86	1.86
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	19.47	0.00	0.00	0.00	19.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	14.43	45.52	31.30	19.10	3.25	2.24	2.03	1.02	1.22	0.61
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	115.62	293.80	127.50	167.49	11.09	5.54	9.90	0.79	6.34	2.77
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	8.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	19.47	107.08	50.44	23.01	7.08	0.00	4.42	5.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	199.85	313.45	194.53	98.78	20.52	9.50	12.54	0.76	3.42	4.18
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	6.58	21.05	6.58	10.53	0.00	0.00	1.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	9.97	94.02	59.00	23.56	6.15	5.73	4.24	0.85	3.40	1.27
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	34.07	49.72	19.34	27.62	1.84	0.00	1.84	0.00	1.84	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	11.62	64.68	36.06	32.19	3.87	3.87	2.98	0.30	2.09	1.79
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	8.38	48.62	11.74	45.27	0.00	0.00	1.68	0.00	0.00	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	11.54	70.50	41.65	25.34	5.77	3.51	2.01	0.25	1.25	1.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	169.69	330.60	183.00	102.43	22.34	7.37	10.70	0.95	3.80	6.18
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	2.76	3.87	1.66	2.21	0.00	0.00	0.00	0.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	11.28	55.49	40.29	23.25	3.91	2.76	2.30	0.69	0.92	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	100.12	149.76	90.45	54.48	12.20	5.47	5.68	0.21	2.73	2.94
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	36.49	37.91	21.20	25.89	2.24	1.02	1.83	0.00	0.82	1.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	15.02	42.69	32.40	13.52	1.93	1.72	3.00	0.64	0.64	1.07
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	126.71	73.36	42.24	32.01	4.67	2.22	2.00	0.22	2.00	2.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	10.32	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	10.07	52.13	24.97	21.68	3.07	3.29	2.85	0.88	1.31	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	67.93	64.89	21.80	43.09	2.03	1.52	1.01	0.51	0.51	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	4.97	8.28	4.97	8.28	0.00	0.00	0.00	1.66	1.66	1.66
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	9.78	34.79	21.74	22.83	3.81	1.63	1.63	0.82	0.82	0.54
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	87.05	90.58	47.35	46.47	2.94	2.65	4.12	0.29	1.18	0.88
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	2.18	37.07	4.36	23.99	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	17.30	31.72	20.18	10.09	1.92	1.44	1.92	0.00	0.00	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	184.91	200.51	102.46	91.65	8.00	7.20	6.80	1.20	3.20	2.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	4.11	10.97	1.37	5.48	1.37	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	13.52	69.08	36.04	21.52	3.00	2.50	2.50	0.00	0.50	1.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	134.74	80.84	26.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	2.04	6.12	4.08	14.27	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	10.51	35.03	16.20	14.45	0.88	2.19	0.44	0.44	0.88	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	2.21	18.76	3.31	24.28	0.00	0.00	0.00	0.00	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	3.84	17.29	8.33	16.01	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	11.16	46.61	30.49	17.60	3.22	2.98	1.24	0.50	0.99	1.24
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	6.96	22.27	15.31	21.57	2.78	0.00	0.70	0.00	0.00	1.39
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	2.21	6.63	2.21	4.42	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	10.60	52.65	38.97	17.44	5.81	1.71	2.39	0.00	0.68	0.68
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	7.00	28.01	8.31	31.07	0.44	0.00	0.88	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	1.78	17.04	4.97	8.17	0.36	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	7.57	58.92	41.52	17.39	3.65	1.96	2.24	0.28	1.40	1.96
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	7.48	40.32	9.56	24.11	0.83	2.08	0.83	1.66	1.25	0.83
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	2.33	13.40	4.66	12.24	0.00	0.00	0.58	0.58	0.58	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	6.94	74.21	28.66	23.53	3.02	3.92	2.71	0.00	1.21	0.90
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	23.37	103.51	42.57	42.16	3.76	5.01	6.26	1.25	2.09	1.67
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	0.00	29.55	14.78	14.78	0.92	0.92	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	15.94	48.94	21.63	31.30	1.71	2.28	1.71	0.00	0.00	1.14
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	7.46	23.08	10.23	9.40	1.80	0.97	0.55	0.14	0.55	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	4.66	48.20	31.10	15.55	3.11	2.59	1.30	0.52	0.78	0.78
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	9.87	30.89	12.01	17.59	3.43	0.43	0.00	0.43	0.86	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	3.18	6.35	1.27	5.72	0.00	0.00	0.00	0.00	0.00	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	1.60	33.09	17.88	22.69	1.33	1.33	0.53	1.33	0.80	0.80
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	15.86	90.40	39.21	32.03	5.39	5.09	4.19	0.90	1.80	1.50
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	8.48	23.02	10.31	12.57	0.85	1.13	1.13	0.42	0.71	0.57
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	1.27	23.25	16.56	8.60	1.59	0.96	0.00	0.00	0.64	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	12.83	46.22	26.76	25.87	2.43	2.65	1.33	0.00	0.66	0.66
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	2.65	13.27	5.31	5.31	0.00	0.38	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	2.84	28.98	18.18	11.36	1.42	0.57	0.57	0.57	0.28	0.85
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	20.65	108.89	60.71	38.84	7.62	4.67	4.42	0.25	0.98	2.46
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	3.26	8.47	2.61	6.52	0.00	0.65	0.00	0.00	0.00	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	1.76	13.82	7.35	9.41	0.88	0.88	0.29	0.29	0.59	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	17.30	69.77	35.75	30.85	3.46	1.44	3.46	0.58	0.58	2.31
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	17.72	25.14	16.90	12.78	2.06	0.41	0.41	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	1.79	26.50	4.76	14.29	1.49	1.49	0.89	1.19	0.89	0.60
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	56.50	60.27	30.14	18.83	0.00	0.00	0.00	3.77	3.77	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	8.91	32.08	28.52	16.04	5.35	0.00	0.00	0.00	0.00	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	191.23	218.50	146.54	62.10	18.73	13.14	12.16	3.94	1.97	5.91
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	27.35	110.45	57.86	32.61	15.78	4.21	5.26	1.05	1.05	2.10
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	11.27	37.36	15.22	22.93	1.58	1.98	2.37	1.98	2.37	0.59
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	5.59	19.56	13.97	4.66	0.93	0.93	1.86	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	99.14	178.38	116.04	60.46	15.40	12.02	9.76	2.25	3.38	4.51
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	4.79	25.84	18.11	8.52	2.40	1.60	0.80	0.53	0.80	0.80
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	5.99	21.83	10.18	11.99	1.47	0.23	0.79	0.34	0.45	0.57
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	10.31	122.30	84.72	28.73	8.10	6.63	5.89	1.47	1.47	2.21
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	193.84	162.69	101.50	45.80	13.92	5.86	8.43	1.83	2.20	3.30
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	74.67	586.46	345.34	202.23	38.89	34.22	29.56	4.67	9.33	18.67
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	6.95	46.50	19.77	24.05	1.60	0.53	2.14	0.53	1.07	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	11.59	81.14	77.28	30.91	7.73	11.59	0.00	7.73	3.86	3.86
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	365.60	320.15	230.27	98.97	27.27	13.13	14.14	5.05	8.08	8.08
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	15.60	207.87	116.37	69.57	14.76	11.81	6.32	1.26	3.37	2.11
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	8.17	59.93	19.07	23.15	1.36	2.72	5.45	1.36	0.00	2.72
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	17.17	47.05	30.52	24.80	2.54	0.64	0.64	1.27	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	145.77	70.46	31.58	22.68	5.67	4.05	2.43	0.00	1.62	1.62
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	34.74	282.45	161.62	89.12	21.15	19.64	16.61	3.02	1.51	7.55
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	45.68	57.10	11.42	62.81	0.00	0.00	5.71	57.10	22.84	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	61.99	538.30	159.86	208.80	16.31	16.31	19.57	140.29	16.31	9.79
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	213.86	147.33	57.03	57.03	9.50	14.26	14.26	57.03	42.77	4.75
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	37.65	263.53	75.29	163.14	12.55	37.65	0.00	62.75	25.10	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	162.65	80.14	54.29	15.73	5.17	1.72	3.02	0.65	0.22	2.37
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	215.32	131.70	86.23	26.13	10.45	5.23	4.18	0.52	0.52	1.05
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	21.36	48.73	39.38	16.69	5.34	4.67	2.00	1.33	2.00	3.34
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	18.78	18.36	14.61	7.51	0.83	1.25	0.83	1.67	0.42	0.83
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	191.47	40.50	33.66	18.25	1.71	3.99	3.80	2.09	1.14	2.09
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	0.00	102.13	30.32	31.92	4.79	0.00	3.19	4.79	1.60	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	100.63	10.20	13.60	8.84	0.68	0.68	0.68	2.04	0.68	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	1025.40	1008.87	532.92	174.58	40.43	67.99	73.51	49.62	40.43	31.24
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	19.67	26.37	13.81	5.02	2.09	1.26	2.09	6.70	0.00	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	20.69	20.69	14.64	5.35	2.09	1.39	0.23	2.56	1.16	0.70
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	113.50	19.46	17.29	6.49	2.16	0.81	1.08	4.59	2.97	0.81
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	10.72	48.14	37.00	28.17	4.20	1.68	2.31	0.42	1.05	0.63
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	2238.08	2906.16	2360.56	679.22	211.56	189.29	77.94	100.21	167.02	77.94
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	151.88	63.04	53.11	16.38	8.44	2.48	4.96	3.47	0.99	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	61.44	76.60	58.74	20.84	7.85	6.50	4.60	9.74	4.60	2.44
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	26.07	42.39	29.92	10.65	3.17	2.04	3.17	5.44	1.36	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	94.55	27.76	25.64	10.12	2.61	1.63	0.49	3.27	1.96	0.65
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	15.49	36.09	29.16	11.66	2.55	2.00	0.55	4.56	0.91	1.09
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	214.30	53.04	46.68	22.28	6.90	2.12	2.65	7.43	2.12	1.06
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	93.05	12.01	18.61	6.60	1.80	3.60	1.20	3.00	0.60	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	110.27	171.96	121.43	47.59	14.77	7.55	6.24	9.19	4.59	3.61
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	18.86	26.51	23.74	7.32	2.76	1.63	1.30	6.18	0.65	0.49
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	13.23	65.44	49.56	23.46	5.64	2.65	2.29	0.88	1.06	1.59
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	152.60	37.27	29.54	13.36	3.52	2.11	2.11	9.14	7.03	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	198.59	38.62	23.90	19.31	2.30	1.38	4.60	6.44	0.46	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	20.89	31.81	20.89	11.57	2.25	3.21	2.25	7.71	0.64	1.29
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	166.58	186.24	164.51	44.15	10.69	19.66	11.73	27.59	11.04	7.24
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	1757.27	773.70	505.69	242.73	42.98	40.46	45.51	58.15	65.74	22.76
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	7.35	44.78	28.29	24.51	2.90	1.56	0.67	3.56	1.56	2.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	302.73	69.44	50.38	40.22	4.23	4.23	2.96	8.89	2.54	1.69
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	180.86	36.31	26.82	8.54	2.14	3.09	1.19	2.37	0.95	0.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	18.03	27.90	16.74	4.72	1.29	1.72	1.72	6.44	0.86	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	397.22	3087.49	2247.91	650.00	225.69	108.33	144.44	45.14	81.25	63.19
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	105.30	15.66	10.33	6.33	0.67	1.00	0.00	3.33	1.00	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	7.66	34.27	17.13	23.44	1.80	0.90	0.45	4.51	2.71	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	190.07	48.81	36.51	13.89	2.38	2.38	1.19	3.57	0.79	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	144.87	42.72	23.22	13.00	5.57	0.00	0.93	4.64	4.64	1.86
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	29.51	23.08	15.51	9.08	2.27	0.38	1.14	14.00	0.38	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	22.81	33.57	28.03	13.69	1.63	0.33	2.28	5.21	1.30	0.98
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	80.18	11.77	9.15	6.97	3.05	0.00	0.87	0.87	0.87	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	14.47	67.39	33.47	25.33	3.17	2.26	0.45	1.81	1.81	0.90
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	199.31	40.57	23.81	14.11	2.65	0.00	0.88	8.82	2.65	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	171.53	63.16	31.25	25.93	2.66	1.99	0.66	9.31	3.99	1.33
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	18.85	31.25	18.35	7.44	5.46	3.47	1.49	1.49	0.99	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	19.52	21.82	13.40	6.89	1.15	0.77	2.68	2.30	0.77	0.77
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	184.79	70.77	49.00	29.03	4.54	3.93	3.02	7.86	1.81	1.81
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	18.57	79.13	53.49	22.99	5.97	5.08	2.65	8.84	2.65	1.55
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	187.03	56.92	37.95	13.55	2.03	2.03	2.03	1.36	0.68	2.03
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	1338.70	1558.41	807.31	306.57	86.86	51.10	56.20	25.55	30.66	30.66
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	17.68	21.34	11.58	6.10	0.61	3.05	1.83	1.22	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	23.92	26.75	19.51	11.65	2.83	0.31	0.94	4.72	0.94	1.26
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	156.17	25.12	24.51	16.34	1.51	1.82	2.12	8.47	3.93	1.82
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	46.68	63.29	53.01	22.15	7.91	5.54	7.12	11.08	6.33	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	1882.98	454.59	462.53	261.87	41.94	29.47	34.01	35.14	48.75	18.14
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	1578.06	1527.48	940.77	895.25	141.62	136.56	91.04	96.10	242.78	60.69
Myoblast, donor1	11241-116D8	26.46	40.75	31.06	11.43	3.11	1.49	0.87	1.12	0.75	1.24
Myoblast, donor2	11322-117D8	28.19	69.62	48.91	20.52	6.90	4.99	3.84	4.03	1.73	1.15
Myoblast, donor3	11398-118D3	152.02	37.00	24.22	7.40	3.03	1.35	1.35	0.34	0.50	0.50
NK T cell leukemia cell line:KHYG-1	10777-110G3	52.54	159.80	143.45	50.20	13.72	11.97	9.92	2.19	4.09	3.36
Natural Killer Cells, donor1	11230-116C6	21.83	131.00	93.49	27.06	9.53	4.00	3.69	4.00	4.61	2.77
Natural Killer Cells, donor2	11311-117C6	342.87	287.08	170.98	66.95	19.00	21.11	15.38	7.24	9.65	5.43
Natural Killer Cells, donor3	11387-118C1	366.27	352.28	244.42	80.98	32.21	29.26	18.04	10.31	12.70	5.71
Neural stem cells, donor1	11275-116H6	837.30	225.02	161.87	49.72	21.05	26.49	10.53	13.07	8.71	2.90
Neural stem cells, donor2	11352-117H2	34.66	129.02	51.99	42.36	5.78	7.70	9.63	42.36	13.48	5.78
Neurons, donor1	11494-119E9	51.21	94.45	79.65	37.55	10.24	18.21	2.28	22.76	5.69	2.28
Neurons, donor2	11574-120E8	133.86	49.76	37.87	12.99	4.18	2.42	1.32	1.10	0.44	1.98
Neurons, donor3	11655-122E8	92.08	134.84	115.93	52.62	21.38	18.09	4.93	27.95	5.76	3.29
Neutrophils, donor1	11233-116C9	192.10	44.54	29.70	20.42	4.64	0.93	0.00	2.78	1.86	0.00
Neutrophils, donor2	11314-117C9	420.34	78.27	69.57	55.08	11.60	2.90	0.00	0.00	5.80	0.00
Neutrophils, donor3	11390-118C4	32.37	23.21	14.05	4.28	1.83	0.00	0.00	0.00	0.61	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	5.82	38.47	30.16	4.87	3.68	0.95	2.02	0.83	0.47	1.42
Nucleus Pulposus Cell, donor2	11409-118E5	7.16	45.58	37.44	7.81	6.51	3.26	0.98	0.65	1.30	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	2.01	15.64	6.62	2.21	1.60	0.20	0.80	1.60	0.60	0.20
Olfactory epithelial cells, donor1	11933-125I7	29.87	88.51	53.68	19.41	4.40	4.96	3.03	6.61	2.34	1.93
Olfactory epithelial cells, donor2	11934-125I8	168.92	89.16	73.39	21.86	10.57	5.07	2.75	12.30	2.17	2.03
Olfactory epithelial cells, donor3	11935-125I9	37.46	95.00	69.35	16.34	10.67	4.65	4.20	6.47	2.61	2.27
Olfactory epithelial cells, donor4	11936-126A1	47.53	68.76	55.61	20.36	8.08	1.66	2.43	0.49	1.17	0.68
Oligodendrocyte - precursors, donor1	11496-119F2	11.43	155.27	87.26	23.47	9.03	13.84	6.62	10.23	3.01	3.01
Osteoblast - differentiated, donor1	11276-116H7	49.35	7.66	5.32	4.25	0.85	0.00	0.00	0.21	0.21	0.43
Osteoblast - differentiated, donor2	11353-117H3	2.29	4.57	1.14	1.14	0.00	0.00	0.00	1.14	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	21.72	13.66	9.31	3.72	3.72	1.86	0.00	0.62	0.00	0.00
Osteoblast, donor1	11277-116H8	13.09	24.43	10.16	17.59	1.76	0.78	1.37	7.43	6.25	0.59
Osteoblast, donor2	11354-117H4	17.56	109.56	71.64	21.07	9.83	3.51	3.51	6.32	2.11	2.11
Osteoblast, donor3	11426-118G4	116.59	33.95	10.66	13.51	1.96	1.07	1.07	0.53	0.89	0.89
Pancreatic stromal cells, donor1	11249-116E7	24.51	52.56	47.68	13.22	6.15	1.94	1.68	0.84	0.34	0.93
Pericytes, donor1	11491-119E6	4.01	78.78	49.96	5.67	2.67	3.12	2.34	3.00	0.78	1.34
Pericytes, donor2	11571-120E5	36.90	37.35	30.79	7.24	0.45	1.58	0.91	0.68	0.91	1.13
Pericytes, donor3	11652-122E5	229.29	97.05	68.16	19.33	10.17	4.07	4.27	4.88	2.44	2.03
Perineurial Cells, donor1	11499-119F5	8.14	55.49	43.85	9.15	5.65	2.49	2.94	3.28	1.02	0.90
Perineurial Cells, donor2	11579-120F4	64.96	23.37	15.37	3.13	2.67	0.74	0.64	2.02	0.28	0.46
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	197.30	123.35	82.87	30.60	8.29	7.97	4.14	5.42	6.06	1.27
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	16.41	71.50	33.79	23.26	6.37	3.92	1.22	5.63	5.88	1.22
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	232.30	69.88	50.60	23.42	7.12	6.60	2.46	4.66	3.75	1.29
Placental Epithelial Cells, donor1	11278-116H9	9.09	0.48	0.24	0.96	0.24	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	63.21	9.98	16.63	1.11	0.00	1.11	0.00	0.00	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	9.62	7.85	5.89	2.36	0.39	0.00	0.39	0.20	0.20	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	49.37	129.11	88.29	9.49	9.18	7.28	7.59	3.80	2.53	3.16
Preadipocyte - breast, donor1	11467-119B9	150.07	28.14	16.88	6.19	3.75	1.88	2.25	0.56	0.56	1.13
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	0.13	2.22	2.74	0.52	0.26	0.00	0.26	0.13	0.00	0.26
Preadipocyte - breast, donor2	11328-117E5	24.99	67.32	52.68	2.93	6.53	3.83	2.25	0.23	0.90	1.35
Preadipocyte - omental, donor1	11468-119C1	13.96	71.39	42.09	13.32	4.37	4.16	3.41	1.49	1.81	1.28
Preadipocyte - omental, donor2	11329-117E6	193.36	77.69	47.14	16.15	7.42	3.93	0.87	0.44	1.75	1.31
Preadipocyte - omental, donor3	11403-118D8	40.97	123.62	91.25	24.64	9.31	7.59	5.01	2.15	1.72	2.15
Preadipocyte - perirenal, donor1	11469-119C2	27.56	16.73	14.76	9.84	0.98	0.98	0.98	0.98	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	74.94	4.91	5.22	2.46	0.31	0.92	0.31	0.00	0.00	0.92
Preadipocyte - subcutaneous, donor2	11356-117H6	456.86	193.55	131.04	33.82	20.72	12.22	5.84	3.90	4.07	3.90
Preadipocyte - subcutaneous, donor3	11428-118G6	20.43	49.89	35.76	8.34	3.58	3.41	1.70	1.87	1.36	1.02
Preadipocyte - visceral, donor1	11280-116I2	22.91	133.01	93.05	31.20	12.67	5.22	4.38	2.79	1.68	1.96
Preadipocyte - visceral, donor2	11357-117H7	28.99	97.10	58.44	19.33	11.50	5.52	0.92	1.38	0.92	1.84
Preadipocyte - visceral, donor3	11429-118G7	7.52	38.24	27.59	7.21	2.19	1.36	0.52	0.21	0.31	0.63
Prostate Epithelial Cells (polarized), donor1	11253-116F2	24.29	86.74	67.88	16.59	6.49	5.13	3.62	6.03	1.36	1.36
Prostate Epithelial Cells, donor2	11331-117E8	223.57	69.33	48.34	10.02	7.18	3.93	2.98	0.81	0.68	1.08
Prostate Epithelial Cells, donor3	11404-118D9	20.76	252.73	146.91	35.40	14.45	8.27	7.78	0.73	2.08	3.92
Prostate Stromal Cells, donor1	11254-116F3	156.39	43.28	34.06	10.36	4.10	1.71	1.37	1.14	0.68	0.57
Prostate Stromal Cells, donor2	11332-117E9	23.67	166.75	137.70	33.89	18.83	8.07	5.38	0.18	1.79	3.94
Prostate Stromal Cells, donor3	11405-118E1	14.60	48.49	53.39	8.76	5.32	3.23	1.88	0.31	1.15	0.94
Renal Cortical Epithelial Cells, donor1	11516-119H4	6.57	51.83	33.94	8.03	4.38	0.00	1.82	0.36	0.73	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	6.79	61.06	42.35	10.54	2.56	2.50	2.56	0.90	1.59	1.25
Renal Epithelial Cells, donor1	11517-119H5	10.14	99.42	50.22	13.19	6.59	1.52	5.07	1.52	2.03	2.03
Renal Epithelial Cells, donor2	11597-120H4	26.32	160.76	93.18	24.90	12.80	4.27	7.11	4.98	5.69	4.27
Renal Epithelial Cells, donor3	11678-122H4	10.27	131.06	78.34	19.16	7.73	4.98	4.45	3.28	3.18	2.01
Renal Glomerular Endothelial Cells, donor1	11514-119H2	4.09	38.81	34.72	13.62	3.40	5.45	0.00	6.81	2.04	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	59.03	80.59	54.58	15.36	4.18	4.04	2.16	5.12	1.75	0.81
Renal Glomerular Endothelial Cells, donor3	11675-122H1	13.32	93.24	60.61	16.87	7.10	5.11	6.22	2.89	3.55	1.78
Renal Glomerular Endothelial Cells, donor4	11783-124B1	19.30	32.61	28.61	7.99	2.00	0.00	2.00	0.67	1.33	1.33
Renal Mesangial Cells, donor1	11518-119H6	7.48	40.28	34.55	5.72	3.30	0.22	1.32	0.22	0.22	0.22
Renal Mesangial Cells, donor2	11598-120H5	13.79	114.74	16.93	23.83	5.02	4.39	3.13	1.25	1.25	3.13
Renal Mesangial Cells, donor3	11679-122H5	17.75	84.33	56.59	18.59	7.49	3.88	3.88	3.88	2.77	0.55
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	10.47	79.99	55.30	16.91	6.44	0.54	2.42	0.00	0.27	1.07
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	11.39	91.09	60.30	21.93	7.17	2.53	0.84	0.00	2.53	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	23.14	144.06	108.77	26.81	11.76	3.86	6.56	4.63	2.70	3.09
Retinal Pigment Epithelial Cells, donor0	11215-116A9	5.70	47.19	31.89	8.30	4.41	3.89	1.56	1.30	0.26	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	19.04	102.90	62.53	19.61	9.10	2.84	1.99	0.28	1.14	0.57
Retinal Pigment Epithelial Cells, donor2	11608-120I6	15.44	75.13	55.57	17.50	3.09	1.03	0.00	2.06	2.06	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	3.76	26.09	13.80	3.01	2.26	0.75	1.00	0.00	0.75	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	109.31	198.85	147.80	47.04	15.23	10.29	9.49	6.15	2.54	3.88
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	155.45	307.33	129.54	161.71	16.97	15.19	15.19	54.50	21.44	5.36
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	245.47	962.60	676.41	269.68	83.11	75.95	42.38	39.08	17.61	21.46
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	122.97	1000.01	483.19	463.46	50.46	44.08	42.92	74.83	24.94	27.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	0.91	60.85	33.81	21.97	1.56	1.43	0.52	0.00	0.78	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	23.93	171.20	101.59	52.23	11.12	7.05	8.14	4.57	5.86	3.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	20.30	125.82	78.08	29.11	9.37	7.14	5.13	5.69	3.57	1.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	12.78	186.81	145.25	33.99	14.14	11.91	5.71	2.60	3.72	3.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	26.81	177.15	122.02	34.61	13.75	7.58	7.81	3.38	3.15	3.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	45.76	312.49	205.01	70.50	30.05	30.51	13.17	22.88	12.71	7.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	4.11	158.95	73.25	54.35	7.80	7.26	3.83	4.38	2.46	1.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	20.57	98.78	81.69	36.91	6.96	3.93	3.93	0.30	0.91	2.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	10.03	22.94	16.49	9.86	1.43	1.79	1.08	3.05	1.97	1.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	10.76	166.70	108.88	39.88	9.32	12.19	4.45	3.73	2.44	3.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	23.93	92.83	67.39	30.16	7.30	4.94	2.47	1.93	1.50	0.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	39.39	174.36	125.68	35.18	11.06	14.83	8.85	17.48	9.51	3.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	2.68	87.75	33.26	45.69	1.72	4.40	1.72	0.96	0.76	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	15.47	81.61	50.03	38.10	4.47	3.82	3.82	2.70	2.61	1.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	42.28	510.17	344.43	101.28	45.10	20.11	13.53	13.72	8.27	8.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	3.18	85.73	43.53	53.88	3.18	3.45	1.33	0.93	1.06	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	21.22	107.95	83.91	39.13	8.18	4.09	2.43	0.39	1.27	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	95.67	449.90	274.60	99.87	38.96	42.97	13.18	36.66	21.58	6.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	4.70	88.00	52.12	37.38	3.10	3.52	1.39	0.43	1.28	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	43.73	122.21	89.70	42.33	7.29	5.05	5.05	1.12	0.28	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	26.83	111.25	66.65	30.25	8.89	8.20	4.79	7.18	7.86	2.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	4.19	64.73	32.45	36.28	1.82	1.28	2.01	0.18	1.09	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	27.35	147.89	126.92	41.20	12.02	7.24	6.87	1.10	1.96	2.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	29.01	115.92	79.25	25.66	7.52	10.75	4.43	7.92	4.16	2.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	5.66	139.64	83.03	25.95	5.90	7.08	3.54	1.18	0.47	1.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	25.40	135.32	109.72	32.34	14.68	6.15	3.17	0.79	1.79	2.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	24.32	143.11	88.16	37.18	8.89	10.76	7.25	10.29	3.74	3.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	6.22	136.65	72.78	35.04	9.12	8.92	2.90	2.49	2.90	3.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	10.84	73.88	41.59	25.00	4.65	3.10	1.11	0.66	1.55	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	24.44	102.35	63.29	31.54	8.36	6.89	3.55	9.19	6.68	3.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	4.98	168.23	107.26	42.93	10.09	8.48	4.44	3.10	2.02	2.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	6.47	46.15	25.03	28.27	2.38	0.17	1.87	0.34	0.51	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	36.05	245.23	145.37	63.04	17.93	17.93	8.68	12.53	10.99	5.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	5.67	158.18	91.64	28.89	8.42	7.39	3.27	0.34	1.38	2.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	11.66	57.34	33.19	36.35	2.06	2.19	1.65	0.41	1.65	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	25.94	131.83	89.47	38.09	8.21	13.30	5.58	7.55	2.79	2.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	4.09	123.22	63.74	54.37	6.48	7.50	3.24	4.77	2.22	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	46.01	207.29	161.57	41.28	17.46	11.39	11.24	9.91	8.29	4.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	23.72	65.04	55.18	26.12	7.20	3.73	5.33	1.33	0.80	1.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	7.05	131.77	74.53	36.23	4.01	7.19	3.87	4.70	2.77	0.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	40.72	145.48	109.53	28.33	13.81	12.86	8.57	10.95	7.62	3.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	36.88	184.21	141.08	73.36	18.94	14.91	6.85	10.88	8.67	2.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	5.37	122.80	83.44	22.32	6.59	6.87	3.77	0.94	1.13	1.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	129.61	644.57	425.52	124.72	58.69	69.52	23.06	39.83	30.39	11.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	53.49	159.27	94.59	57.12	16.32	14.20	7.25	10.58	11.18	2.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	6.00	146.25	100.36	24.35	9.30	6.85	2.08	0.98	0.98	1.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	26.20	114.40	77.00	41.34	11.21	6.40	4.37	10.04	4.22	2.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	50.50	90.05	45.63	33.46	7.91	6.08	3.04	16.43	3.65	1.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	5.12	108.50	65.40	26.22	6.03	9.04	2.11	4.82	3.01	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	145.67	547.15	368.46	143.63	50.67	46.14	18.10	33.70	22.39	11.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	73.09	257.31	180.02	69.79	33.55	18.57	6.29	5.09	4.19	5.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	5.08	293.77	134.25	51.48	13.46	9.68	4.84	15.23	8.97	3.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	23.69	60.40	44.61	14.51	5.76	8.75	4.70	0.85	1.28	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	53.49	253.01	98.56	114.79	18.03	28.85	16.23	13.82	10.22	4.81
Schwann Cells, donor1	11498-119F4	3.57	74.66	44.38	9.59	3.57	2.44	2.26	3.76	1.13	0.75
Schwann Cells, donor2	11578-120F3	13.61	34.02	23.82	6.80	0.00	6.80	3.40	3.40	6.80	0.00
Schwann Cells, donor3	11659-122F3	11.17	77.55	40.31	17.09	5.92	7.23	2.85	1.97	0.22	1.97
Sebocyte, donor1	11220-116B5	26.84	29.03	35.61	7.67	3.83	1.10	1.64	0.00	0.55	0.00
Sebocyte, donor2	11301-117B5	55.61	68.01	60.20	17.00	5.97	1.38	0.92	0.00	0.92	2.30
Sebocyte, donor3	11378-118B1	21.02	48.64	21.85	7.83	1.65	1.44	2.06	0.00	0.21	1.65
Sertoli Cells, donor1	11255-116F4	19.88	48.04	46.38	6.63	11.60	1.66	1.66	1.66	1.66	0.00
Sertoli Cells, donor2	11333-117F1	36.72	175.11	90.38	33.89	16.95	5.65	5.65	0.00	0.00	5.65
Skeletal Muscle Cells, donor1	11281-116I3	5.72	26.22	18.30	4.93	2.02	1.41	0.62	0.18	0.26	0.53
Skeletal Muscle Cells, donor2	11358-117H8	80.96	8.67	6.51	5.78	0.00	0.00	0.72	0.00	0.00	1.45
Skeletal Muscle Cells, donor3	11430-118G8	40.13	4.18	5.02	0.84	0.84	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	6.60	28.91	21.21	7.54	2.36	1.41	0.79	1.10	0.16	0.47
Skeletal Muscle Cells, donor5	11455-119A6	7.73	36.12	29.43	8.92	2.97	2.97	0.89	1.04	0.89	0.74
Skeletal Muscle Cells, donor6	11459-119B1	4.92	36.32	30.16	10.16	3.08	2.00	1.08	2.46	1.08	0.31
Skeletal Muscle Satellite Cells, donor1	11240-116D7	22.43	85.43	66.03	17.64	7.43	2.90	2.27	2.02	1.13	1.39
Skeletal Muscle Satellite Cells, donor2	11321-117D7	33.39	70.77	184.50	29.82	10.56	5.14	4.00	1.28	1.57	1.71
Skeletal Muscle Satellite Cells, donor3	11397-118D2	26.39	39.78	35.81	11.61	4.96	2.48	1.29	0.10	0.60	0.60
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	9.69	51.23	41.96	9.94	4.97	2.11	2.53	1.43	1.10	1.01
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	4.34	14.48	2.17	5.79	0.72	0.72	0.72	0.00	0.00	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	1.24	8.81	3.16	5.37	0.41	0.14	0.14	0.41	0.28	0.00
Skin - palm, donor1	10286-104F7	83.27	612.43	185.34	303.53	34.92	32.23	10.74	37.61	34.92	10.74
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	75.97	158.43	55.21	23.50	3.75	5.77	5.91	11.24	9.08	3.46
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	48.26	113.69	13.09	18.81	1.64	6.54	0.82	14.72	5.73	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	25.58	18.18	7.53	3.12	0.91	0.39	0.52	1.17	0.52	0.65
Small Airway Epithelial Cells, donor1	11256-116F5	14.73	56.30	33.78	12.51	3.34	1.81	0.70	0.70	0.97	0.83
Small Airway Epithelial Cells, donor2	11334-117F2	113.93	51.34	29.82	12.94	3.94	2.11	1.27	0.28	0.70	0.42
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	193.90	187.98	83.10	35.31	7.19	11.42	5.29	11.00	5.50	4.02
Small Airway Epithelial Cells, donor3	11406-118E2	200.12	73.53	47.89	20.61	3.82	3.15	2.70	0.52	1.65	1.50
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	0.62	4.01	1.85	0.00	0.00	0.00	0.62	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	10.23	413.09	261.24	41.80	19.79	21.79	7.34	4.89	4.89	6.23
Smooth Muscle Cells - Aortic, donor0	11210-116A4	5.88	8.23	7.05	6.47	1.18	0.59	0.59	0.00	1.18	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	4.42	16.35	7.73	7.07	1.33	0.44	0.66	1.77	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	25.60	5.12	9.45	2.76	1.18	0.00	0.39	0.39	0.00	0.79
Smooth Muscle Cells - Aortic, donor3	11432-118H1	6.18	11.59	8.50	3.09	1.55	1.55	0.00	2.32	0.00	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	14.01	88.07	52.04	26.02	3.00	2.00	1.00	4.00	3.00	3.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	0.93	3.33	6.39	1.06	0.40	0.00	0.13	0.00	0.13	0.27
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	77.14	217.89	147.84	43.89	20.61	20.84	7.09	17.95	7.31	3.10
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	6.15	1.02	0.51	0.38	0.00	0.00	0.00	0.00	0.13	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	88.56	9.44	12.37	4.23	0.33	0.65	0.65	0.00	0.00	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	12.40	20.08	19.20	7.09	2.66	0.59	0.59	0.30	0.00	1.18
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	161.16	24.34	21.64	9.40	2.56	1.14	0.57	0.57	0.28	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	78.08	47.18	35.95	5.37	3.74	0.81	2.11	1.46	0.98	0.81
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	91.03	18.27	8.52	5.78	1.22	2.13	1.22	1.83	0.61	0.61
Smooth Muscle Cells - Carotid, donor1	11285-116I7	43.69	4.55	4.80	2.02	0.25	0.25	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	61.21	24.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	1.43	2.38	1.43	0.00	0.48	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	17.11	22.42	16.52	7.96	1.47	0.44	0.74	0.15	0.15	0.44
Smooth Muscle Cells - Colonic, donor2	11320-117D6	21.52	30.99	21.74	6.89	3.44	0.43	1.08	0.43	0.86	0.65
Smooth Muscle Cells - Colonic, donor3	11396-118D1	15.01	20.47	20.05	6.51	2.20	1.47	0.94	0.31	0.84	0.52
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	15.93	4.18	2.94	1.24	0.62	0.46	0.15	0.31	0.15	0.77
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	11.86	26.95	11.86	11.86	0.00	3.23	1.08	1.08	2.16	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	2.09	6.87	2.99	1.79	0.90	0.00	0.00	0.00	0.00	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	8.88	75.45	40.97	10.92	4.44	2.73	2.39	2.05	0.34	0.68
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	20.73	152.82	118.11	23.87	11.47	6.75	7.46	5.26	4.00	2.75
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	28.18	163.14	144.62	31.10	19.63	10.47	7.75	8.15	2.01	3.02
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	104.67	76.23	51.88	11.15	7.28	4.55	3.19	1.14	1.37	0.91
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	0.60	7.25	4.23	3.62	0.00	0.00	0.00	0.00	0.00	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	26.49	206.11	161.07	44.51	19.87	16.96	11.66	20.66	7.42	4.50
Smooth Muscle Cells - Prostate, donor1	11257-116F6	3.06	62.19	44.74	8.92	3.06	0.93	0.53	2.40	0.67	0.80
Smooth Muscle Cells - Prostate, donor2	11335-117F3	262.21	173.55	133.36	30.30	21.04	10.02	6.76	1.00	2.00	2.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	148.65	18.01	15.22	3.30	1.01	1.01	0.76	0.25	0.00	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	10.25	18.39	8.29	5.88	1.66	0.90	0.45	0.60	0.45	0.75
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	140.28	20.25	26.26	15.00	3.00	0.75	2.25	0.00	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	42.64	29.72	10.34	23.26	0.00	2.58	0.00	0.00	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	6.98	13.95	8.37	4.65	0.93	0.00	0.00	0.00	0.47	0.93
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	10.60	20.70	17.17	7.57	1.51	0.50	0.50	0.00	0.00	1.51
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	0.63	10.34	2.51	1.57	0.31	0.63	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	10.62	52.51	32.45	8.26	3.24	1.77	0.59	2.36	0.59	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	3.67	7.08	6.83	1.92	0.33	0.33	0.25	0.33	0.17	0.25
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	7.94	14.48	11.68	5.14	1.40	0.93	0.47	0.00	0.47	1.40
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	4.32	7.92	5.47	1.87	0.43	0.29	0.14	0.00	0.00	0.58
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	16.32	30.85	17.85	9.43	2.04	1.02	0.51	1.78	0.76	1.02
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	3.01	13.91	6.21	6.58	0.19	0.38	0.19	0.56	0.56	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	2.24	34.66	25.43	5.17	1.96	1.12	0.70	0.70	0.42	0.84
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	2.68	8.97	8.71	1.68	0.92	0.34	0.50	0.00	0.00	0.17
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	1.43	59.05	47.14	7.62	3.33	2.38	3.33	0.00	1.43	0.95
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	6.12	10.03	6.85	3.67	0.49	0.49	0.49	0.00	0.00	0.49
Smooth Muscle Cells - Uterine, donor1	11258-116F7	110.25	87.27	54.80	13.04	5.52	3.98	1.55	3.31	1.99	0.88
Smooth Muscle Cells - Uterine, donor3	11466-119B8	177.89	12.29	12.29	4.97	0.88	1.46	0.88	0.29	0.29	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	30.13	111.37	75.22	27.40	11.66	8.55	6.03	0.39	1.75	2.14
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	44.16	154.18	105.25	35.17	13.75	9.52	9.78	1.32	1.85	4.76
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	475.72	183.00	133.16	42.40	15.62	8.18	9.67	1.86	1.86	6.70
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	82.65	258.00	167.09	54.62	21.92	12.22	15.81	3.95	1.80	5.75
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	254.66	62.74	36.91	18.17	3.97	3.12	3.69	2.56	0.57	3.97
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	245.38	100.04	78.38	27.18	7.88	7.88	4.33	1.58	0.39	3.15
Smooth muscle cells - airway, control, donor1	11966-126D4	541.93	130.28	107.42	30.73	11.68	9.40	8.63	2.54	1.52	3.81
Smooth muscle cells - airway, control, donor2	11967-126D5	82.66	204.05	137.37	53.91	23.96	5.59	10.78	3.19	2.40	5.99
Smooth muscle cells - airway, control, donor3	11968-126D6	445.18	85.27	50.16	28.01	6.27	8.78	2.93	1.67	1.25	2.93
Smooth muscle cells - airway, control, donor4	11969-126D7	234.68	53.17	32.09	12.38	5.04	2.29	3.21	0.00	0.00	2.75
Synoviocyte, donor1	11291-117A4	224.71	108.40	73.22	22.89	9.43	8.58	3.70	8.25	2.19	0.84
Synoviocyte, donor2	11368-117I9	55.15	81.97	73.92	19.11	7.04	8.55	3.52	9.05	4.36	1.34
Synoviocyte, donor3	11440-118H9	329.75	187.44	135.16	35.08	14.30	16.31	3.80	8.71	8.71	2.68
Trabecular Meshwork Cells, donor1	11532-120A2	9.65	43.24	26.09	5.00	1.07	1.43	0.36	0.36	0.36	0.71
Trabecular Meshwork Cells, donor2	11612-122A1	107.03	19.82	13.87	3.96	0.00	0.00	0.00	1.98	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	11.81	16.21	12.27	5.33	1.85	0.00	0.93	0.46	0.69	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	5.09	22.22	7.10	8.60	0.79	0.50	0.29	1.43	1.86	0.65
Tracheal Epithelial Cells, donor2	11369-118A1	11.60	14.30	7.34	3.48	1.16	0.77	0.00	0.00	0.77	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	28.06	8.02	2.86	1.72	0.00	0.00	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	107.28	205.82	146.40	47.36	17.22	9.35	8.73	7.01	5.41	3.81
Urethra, donor2	10319-105A4	109.70	1645.56	489.17	960.36	61.15	80.93	35.97	59.35	134.88	16.19
Urothelial Cells, donor1	11520-119H8	175.07	79.70	46.76	11.95	4.78	2.39	1.59	1.86	1.06	2.13
Urothelial Cells, donor2	11600-120H7	18.43	77.71	47.27	11.22	6.01	3.61	3.20	2.00	1.60	1.20
Urothelial Cells, donor3	11681-122H7	239.75	76.78	38.51	12.61	3.21	1.38	2.06	2.29	1.15	2.29
Urothelial cells, donor0	11216-116B1	143.77	82.47	50.82	11.37	6.46	1.11	2.45	1.34	2.67	1.78
Whole blood (ribopure), donor090309, donation1	12179-129A1	0.89	27.58	14.24	10.68	3.56	0.89	1.78	0.00	0.00	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	1.43	20.01	10.01	2.86	0.00	0.00	0.00	1.43	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	23.27	39.02	30.12	16.43	4.79	2.05	5.48	3.42	3.42	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	4.82	27.20	16.53	8.61	2.75	0.69	1.38	7.23	1.03	1.03
Whole blood (ribopure), donor090325, donation2	12177-128I8	3.49	36.60	14.53	2.32	1.16	1.16	1.74	4.65	0.58	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	2.08	27.07	9.37	5.21	0.00	1.04	0.00	1.04	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	0.92	31.20	19.27	9.18	6.42	0.00	1.84	4.59	1.84	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	11.87	40.17	20.08	11.87	3.65	1.83	1.83	0.91	2.74	1.83
Wilms' tumor cell line:G-401	10809-111A8	29.85	97.33	74.76	22.58	7.90	4.81	3.21	3.21	1.97	1.36
Wilms' tumor cell line:HFWT	10597-108E3	7.04	137.29	49.28	71.28	2.64	0.88	2.64	0.88	0.88	2.64
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	31.00	124.58	105.02	30.45	14.52	8.38	7.82	1.40	0.00	3.35
achilles tendon, donor2	10292-104G4	33.06	570.36	154.99	301.71	24.80	18.60	12.40	31.00	43.40	12.40
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	104.02	467.08	349.29	100.45	26.77	23.46	11.73	4.33	3.06	5.61
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	35.29	230.32	174.36	44.35	19.73	13.23	10.22	13.47	5.57	4.18
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	28.96	72.06	61.49	15.19	6.41	2.61	2.49	1.19	0.71	0.71
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	72.93	158.37	130.61	38.37	12.25	8.16	5.17	6.80	1.90	2.72
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	35.98	656.33	403.64	101.19	42.16	29.23	22.77	30.92	8.43	10.68
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	13.32	27.70	18.40	8.25	1.90	0.63	0.42	2.54	0.42	0.63
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	47.36	571.10	360.95	111.88	42.47	27.77	20.14	4.08	6.81	10.62
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	22.47	265.71	165.68	70.50	12.78	9.25	8.81	0.88	6.17	2.20
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	33.89	746.89	455.73	143.33	51.04	1.63	26.54	4.90	7.76	13.88
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	101.73	293.55	218.61	93.19	21.36	20.97	17.47	3.88	6.60	4.66
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	25.39	378.67	288.51	79.86	29.62	15.09	10.49	1.29	1.10	6.81
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	257.43	1014.13	635.78	175.52	50.71	74.11	58.51	74.11	39.01	27.30
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	40.20	306.51	230.76	59.95	20.68	17.20	12.78	4.88	2.32	5.34
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	310.42	341.49	253.21	65.50	20.71	13.72	10.10	3.62	2.59	3.62
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	597.05	705.18	463.79	129.17	52.31	27.76	25.43	6.43	10.23	11.40
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	14.41	126.41	72.50	54.84	7.90	3.72	5.58	1.86	7.44	1.39
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	10.28	280.89	110.63	92.94	12.34	5.76	3.70	2.47	8.23	4.11
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	3.38	52.18	14.12	17.50	1.53	0.61	2.76	8.59	1.23	1.84
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	18.78	171.54	151.48	38.83	16.64	0.00	11.52	2.56	2.99	3.84
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	20.32	105.55	84.62	21.23	8.49	0.00	4.85	2.12	1.21	1.21
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	15.41	125.17	110.24	29.37	10.11	0.24	4.57	1.93	2.41	1.20
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	209.15	220.73	162.82	59.69	18.04	6.24	7.35	3.34	5.12	1.34
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	26.02	158.10	99.40	32.02	7.67	0.00	5.00	6.00	5.00	3.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	13.01	183.96	143.08	154.23	0.00	11.15	7.43	7.43	3.72	3.72
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	27.87	147.27	140.49	53.49	14.69	10.17	6.03	3.39	4.90	3.01
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	30.53	132.58	80.68	35.33	5.23	2.62	4.36	0.00	1.31	1.31
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	1.87	133.09	69.36	95.60	5.62	7.50	9.37	3.75	5.62	1.87
adenocarcinoma cell line:IM95m	10796-110I4	29.91	101.03	70.41	31.56	5.42	4.95	5.42	2.83	2.83	2.12
adipose tissue, adult, pool1	10010-101C1	338.00	175.44	126.73	41.57	12.25	5.58	8.07	0.93	1.55	1.86
adipose, donor1	10184-103D4	86.79	172.99	122.56	78.58	17.01	10.56	4.69	7.62	1.76	2.35
adipose, donor2	10185-103D5	16.22	35.69	19.06	12.98	2.03	2.03	1.22	0.81	0.81	0.00
adipose, donor3	10186-103D6	115.18	59.63	68.07	17.43	5.99	5.17	3.54	1.91	1.91	0.82
adipose, donor4	10187-103D7	452.44	109.21	146.48	32.94	8.67	9.53	6.07	0.87	2.60	2.60
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	119.94	70.55	67.39	25.25	6.63	6.63	5.68	9.78	3.47	0.95
adrenal gland, adult, pool1	10081-102A9	196.43	207.35	134.59	47.29	10.91	7.28	14.55	7.28	7.28	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	16.28	155.95	140.21	54.56	15.21	4.94	4.94	0.93	1.47	1.87
alveolar cell carcinoma cell line:SW 1573	10708-109H6	41.80	127.91	101.47	33.23	13.22	8.93	4.64	6.07	2.14	1.07
amniotic membrane cells, donor1	12235-129G3	10.90	35.47	24.11	15.53	1.85	1.85	2.55	1.16	0.23	0.70
amniotic membrane cells, donor2	12236-129G4	12.17	25.02	12.17	7.44	1.01	1.01	1.01	0.34	0.34	1.35
amniotic membrane cells, donor3	12237-129G5	8.54	84.55	59.51	19.44	4.42	3.83	3.54	4.12	2.36	2.06
amygdala - adult, donor10196	10167-103B5	841.92	1160.90	817.01	324.91	79.45	90.12	64.03	59.29	39.13	30.83
amygdala, adult, donor10252	10151-102I7	313.07	853.65	704.62	285.90	79.28	86.58	47.85	76.44	61.03	16.83
amygdala, newborn, donor10223	10360-105E9	97.80	232.39	138.47	121.04	12.91	10.65	6.78	11.94	17.11	1.61
anaplastic carcinoma cell line:8305C	10428-106D5	9.93	68.89	61.88	13.88	6.24	2.16	2.42	1.02	1.02	1.15
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	29.56	183.12	144.95	48.32	15.44	9.93	8.60	4.63	3.97	4.63
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	2006.56	387.15	343.72	106.56	37.08	23.38	23.05	3.67	9.02	5.68
aorta, adult, pool1	10052-101G7	90.42	291.26	213.78	88.26	23.93	17.26	12.55	18.04	8.83	5.69
appendix, adult	10189-103D9	13.20	43.86	24.06	23.29	3.10	3.88	1.16	1.94	0.78	1.55
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	75.67	289.25	202.23	73.95	28.20	12.04	10.66	2.41	5.16	7.91
artery, adult	10190-103E1	108.70	236.41	172.55	77.45	23.10	16.30	5.43	6.79	13.59	5.43
astrocytoma cell line:TM-31	10425-106D2	12.02	40.27	37.67	9.42	1.88	1.88	1.30	0.14	0.58	0.58
b cell line:RPMI1788	10427-106D4	23.35	126.40	125.50	27.51	11.15	5.35	5.95	2.08	1.49	2.08
basal cell carcinoma cell line:TE 354.T	10702-109G9	212.80	39.67	32.46	8.88	2.50	2.50	1.66	1.39	0.28	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	19.45	81.47	73.93	13.79	5.46	3.37	3.77	1.19	0.40	0.89
bile duct carcinoma cell line:TFK-1	10496-107C1	13.73	53.39	35.65	16.74	4.02	1.34	1.67	0.84	2.01	0.67
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	229.29	60.96	53.13	24.05	7.27	3.91	2.24	2.24	1.68	1.12
bladder, adult, pool1	10011-101C2	13.04	89.63	62.58	30.64	5.43	2.61	2.82	0.33	1.20	1.30
blood, adult, pool1	10053-101G8	15.50	110.73	70.87	37.65	8.86	8.86	4.43	6.64	2.21	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	6.85	39.39	17.98	10.28	0.86	0.86	0.00	1.71	0.00	0.86
bone marrow, adult	10192-103E3	208.52	1630.38	852.31	369.80	123.49	157.91	39.14	66.13	42.51	20.24
brain, adult, donor1	10084-102B3	639.64	643.74	499.21	140.43	48.18	60.48	33.83	58.43	24.60	11.28
brain, adult, pool1	10012-101C3	358.57	188.08	190.42	66.93	20.94	5.79	12.36	1.22	3.34	2.23
brain, fetal, pool1	10085-102B4	181.66	192.34	173.64	72.13	29.39	10.69	13.36	37.40	8.01	8.01
breast carcinoma cell line:MCF7	10482-107A5	310.54	192.27	89.86	70.70	11.23	10.90	6.61	0.99	3.30	6.28
breast carcinoma cell line:MDA-MB-453	10419-106C5	291.46	164.64	148.91	43.31	14.85	5.12	5.87	1.50	2.37	3.00
breast, adult, donor1	10080-102A8	9.47	58.72	51.77	29.04	5.68	4.42	1.89	1.89	3.79	1.26
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	70.76	161.47	150.16	41.92	13.97	10.29	6.22	2.92	4.57	2.29
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	43.60	168.83	130.49	42.98	16.70	8.35	7.11	4.02	4.33	3.71
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	122.25	220.55	195.69	57.32	24.86	9.67	9.67	4.60	5.30	3.68
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	81.83	267.02	197.54	60.76	23.24	14.53	12.59	2.42	7.02	4.12
carcinoid cell line:NCI-H1770	10703-109H1	236.49	173.49	102.97	71.94	14.58	8.93	4.70	3.29	4.70	2.82
carcinoid cell line:NCI-H727	10735-110B6	245.34	89.91	68.80	33.14	6.13	3.83	4.70	0.44	0.77	2.08
carcinoid cell line:SK-PN-DW	10719-109I8	31.06	189.19	135.00	49.75	16.48	9.82	6.65	1.90	2.22	0.95
carcinosarcoma cell line:JHUCS-1	10642-109A3	42.59	304.51	184.46	51.37	16.50	25.02	8.78	26.09	12.51	5.06
caudate nucleus - adult, donor10196	10177-103C6	849.68	488.16	429.44	226.81	39.14	48.36	31.09	28.78	26.48	9.21
caudate nucleus, adult, donor10252	10164-103B2	380.00	837.30	710.47	335.82	81.66	93.20	42.33	94.04	86.84	20.25
caudate nucleus, adult, donor10258	10379-105H1	296.49	1159.20	1027.00	388.18	103.92	87.11	64.19	52.73	39.74	26.74
caudate nucleus, newborn, donor10223	10354-105E3	106.94	162.61	114.63	100.35	15.75	9.16	5.13	10.99	11.35	1.46
cerebellum - adult, donor10196	10173-103C2	804.06	585.57	425.34	233.06	49.53	52.44	20.39	37.87	14.57	11.65
cerebellum, adult, donor10252	10166-103B4	360.41	729.78	663.59	275.00	70.67	70.03	38.00	113.80	75.58	15.59
cerebellum, adult, pool1	10083-102B2	245.26	561.23	389.10	147.98	52.09	55.19	30.70	42.43	14.49	12.42
cerebellum, newborn, donor10223	10357-105E6	137.00	378.61	240.78	220.86	26.57	30.72	18.27	56.46	44.01	12.45
cerebral meninges, adult	10188-103D8	39.33	162.88	110.94	58.75	10.84	6.56	9.08	0.00	1.76	3.03
cerebrospinal fluid, donor2	10294-104G6	81.86	710.42	244.85	420.99	21.20	20.46	18.27	7.31	32.89	5.85
cervical cancer cell line:D98-AH2	10552-107I3	28.04	177.14	127.68	34.36	14.81	8.77	6.33	4.60	3.59	3.16
cervical cancer cell line:ME-180	10553-107I4	267.30	87.00	71.76	19.39	7.95	1.66	3.65	3.65	2.65	1.49
cervix, adult, pool1	10013-101C4	59.32	90.92	68.56	36.54	7.14	2.83	2.94	0.21	0.84	2.83
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	24.38	49.60	41.38	10.59	3.07	1.25	2.65	1.81	0.70	0.98
chondrosarcoma cell line:SW 1353	10700-109G7	27.43	37.88	26.13	20.90	3.92	1.31	3.92	0.00	0.00	3.92
choriocarcinoma cell line:BeWo	10423-106C9	695.08	110.85	99.05	24.36	10.94	4.23	4.60	0.75	0.50	1.74
choriocarcinoma cell line:SCH	10785-110H2	33.39	153.89	124.94	35.85	10.72	7.64	9.49	1.72	2.34	2.46
choriocarcinoma cell line:T3M-3	10618-108G6	29.65	117.64	79.22	42.22	9.96	5.93	2.13	10.67	7.12	4.74
chorionic membrane cells, donor1	12238-129G6	19.09	20.23	18.23	11.40	1.71	0.85	0.28	0.28	0.57	0.00
chorionic membrane cells, donor2	12239-129G7	14.02	46.93	31.62	14.12	3.88	2.39	2.88	1.79	0.40	0.80
chorionic membrane cells, donor3	12240-129G8	13.74	125.28	112.64	41.76	8.24	6.04	2.75	2.20	1.65	2.75
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	52.51	49.48	35.34	12.12	10.10	1.01	0.00	2.02	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	19.40	58.78	49.95	15.37	5.38	5.19	3.27	0.38	0.96	0.58
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	44.56	58.71	48.78	27.03	5.91	8.03	2.96	1.48	1.48	1.27
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	16.69	104.00	59.83	35.95	8.73	6.93	2.57	2.31	1.54	1.28
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	20.56	107.39	59.02	46.68	6.05	5.56	4.35	2.90	2.90	0.97
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	22.60	98.34	62.51	42.55	10.59	4.28	1.83	0.00	0.41	1.63
chronic myelogenous leukemia cell line:K562	10454-106G4	53.59	89.81	57.12	22.67	6.77	4.42	2.36	0.59	0.88	1.18
chronic myelogenous leukemia cell line:KU812	10409-106B4	28.67	120.41	107.64	33.36	9.12	1.56	5.99	1.30	0.26	2.61
clear cell carcinoma cell line:JHOC-5	10638-108I8	40.69	187.44	141.49	58.52	17.14	8.23	8.91	0.00	2.51	2.06
clear cell carcinoma cell line:TEN	10636-108I6	17.70	132.21	98.38	41.12	11.62	4.68	4.86	3.12	1.04	1.74
colon carcinoma cell line:CACO-2	10513-107D9	25.81	81.45	65.16	21.60	6.96	3.66	3.48	0.92	1.65	1.28
colon carcinoma cell line:COLO-320	10420-106C6	34.21	247.05	219.69	46.75	24.71	7.98	9.88	4.18	2.66	5.32
colon, adult, donor1	10082-102B1	49.98	386.76	248.72	108.29	41.65	21.42	20.23	30.94	11.90	9.52
colon, adult, pool1	10014-101C5	128.67	77.90	50.64	29.26	5.05	2.59	3.76	0.00	0.71	1.65
colon, fetal, donor1	10070-101I7	18.54	147.08	82.81	121.13	4.94	1.85	1.85	0.00	3.09	1.85
common myeloid progenitor CMP, donor1	12130-128D6	4.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	625.92	25.04	0.00	25.04	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	64.59	195.89	147.03	63.31	17.42	10.62	6.80	5.10	3.82	3.40
cord blood derived cell line:COBL-a 24h infection	10453-106G3	29.13	96.60	69.88	25.81	9.36	3.92	4.08	0.75	2.26	1.81
cord blood derived cell line:COBL-a untreated	10449-106F8	38.36	128.74	100.12	25.52	10.29	4.51	4.94	0.00	1.27	1.97
corpus callosum, adult, pool1	10042-101F6	198.02	383.32	298.41	86.02	33.39	14.26	15.59	10.06	6.08	6.74
cruciate ligament, donor2	10295-104G7	44.58	637.84	246.38	371.20	32.42	22.69	12.16	24.31	37.28	7.29
diaphragm, fetal, donor1	10069-101I6	58.59	328.25	208.67	199.84	25.68	21.67	12.04	46.55	17.66	8.83
diencephalon, adult	10193-103E4	26.64	265.43	167.27	110.63	25.92	6.48	9.36	0.72	4.80	4.32
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	72.56	717.31	539.13	160.73	69.11	47.07	31.23	14.70	13.78	12.40
ductal cell carcinoma cell line:KLM-1	10438-106E6	40.77	86.68	60.26	24.62	5.39	2.56	2.05	4.87	1.03	1.54
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	31.78	115.79	91.72	32.26	10.35	6.98	2.89	3.61	2.17	2.17
ductus deferens, adult	10196-103E7	44.35	165.45	124.58	42.36	13.95	9.47	6.48	6.48	4.49	2.49
duodenum, fetal, donor1, tech_rep1	10071-101I8	38.89	394.62	276.52	126.74	28.80	36.01	21.60	86.41	15.84	2.88
duodenum, fetal, donor1, tech_rep2	10071-101I8	38.25	595.88	268.51	131.68	31.63	42.67	25.01	50.02	19.86	10.30
dura mater, adult, donor1	10041-101F5	217.78	186.56	132.80	41.05	15.61	7.52	7.43	7.76	3.96	3.06
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	5.11	81.50	30.87	103.04	4.00	1.78	2.44	7.77	1.33	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	17.05	74.23	49.87	27.51	4.16	4.44	2.01	2.29	1.29	0.43
embryonic pancreas cell line:1B2C6	10604-108F1	6.17	90.64	43.78	36.38	3.70	1.85	3.70	1.23	3.08	1.85
embryonic pancreas cell line:1C3D3	10605-108F2	26.34	51.76	33.30	18.16	3.03	4.24	1.21	0.91	1.51	1.21
embryonic pancreas cell line:1C3IKEI	10606-108F3	3.70	62.98	31.49	23.46	4.01	2.78	2.16	0.00	0.31	0.00
embryonic pancreas cell line:2C6	10603-108E9	2.63	27.58	24.96	13.13	0.00	0.00	0.00	1.31	2.63	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	42.57	171.96	145.47	46.59	10.39	5.36	6.70	1.34	0.67	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	62.16	228.18	170.36	43.50	16.31	9.97	6.89	7.97	3.26	1.99
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	38.76	151.16	112.73	35.06	13.19	6.11	5.47	0.48	2.41	2.41
epidermoid carcinoma cell line:A431	10426-106D3	23.57	78.48	70.81	16.34	5.34	3.11	2.45	0.89	0.78	1.89
epidermoid carcinoma cell line:Ca Ski	10431-106D8	196.54	89.86	75.89	18.15	8.03	2.64	4.18	1.87	0.55	0.55
epididymis, adult	10197-103E8	22.40	100.89	65.10	27.42	8.37	7.12	4.19	1.26	3.98	1.47
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	18.81	116.03	96.51	27.14	7.10	6.03	2.48	3.02	1.60	2.84
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	18.48	132.13	115.22	48.76	11.80	5.51	6.29	0.39	0.79	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	62.12	201.03	165.12	58.45	24.24	14.68	7.08	7.73	4.19	3.67
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	47.24	216.13	201.17	61.02	25.20	19.68	11.52	3.25	4.92	5.12
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	63.63	182.83	145.75	51.87	20.84	15.57	8.07	7.73	4.71	3.70
esophagus, adult, pool1	10015-101C6	18.37	68.80	51.60	21.02	5.42	0.74	3.19	0.00	0.42	1.38
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	6.89	98.56	86.91	27.68	8.64	3.76	2.63	2.00	2.13	2.13
eye - muscle inferior rectus, donor1	10272-104E2	9262.30	6896.02	2373.53	4034.75	294.58	212.48	152.12	43.46	260.77	111.07
eye - muscle lateral, donor2	10298-104H1	147.29	2838.57	736.47	1498.19	103.11	88.38	56.81	10.52	105.21	44.19
eye - muscle medial, donor2	10299-104H2	108.64	3628.27	1195.04	2473.41	92.27	59.53	72.92	49.11	63.99	83.34
eye - muscle superior, donor2	10297-104G9	151.34	3368.41	1074.27	2088.92	124.97	68.79	75.67	33.25	75.67	64.20
eye - vitreous humor, donor1	10268-104D7	52.47	179.26	78.70	87.44	7.29	7.29	5.83	20.40	2.91	2.91
eye, fetal, donor1	10054-101G9	20.34	217.88	160.17	46.27	24.66	14.75	11.95	12.20	6.10	3.81
fibrosarcoma cell line:HT-1080	10758-110E2	223.88	87.83	70.91	28.34	7.95	5.13	4.62	4.10	2.82	1.41
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	39.41	80.72	57.22	23.27	7.60	3.56	3.56	5.46	5.94	2.37
frontal lobe, adult, pool1	10040-101F4	388.62	393.50	311.96	88.10	39.78	16.33	17.26	11.82	9.01	5.91
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	86.47	455.48	358.50	116.80	39.33	17.11	11.41	12.01	5.70	3.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	14.45	85.22	70.41	16.37	5.39	2.74	3.47	0.82	1.28	1.83
gall bladder, adult	10198-103E9	20.76	77.98	52.15	41.53	4.35	2.41	2.66	0.48	2.17	0.72
gamma delta positive T cells, donor1	11937-126A2	23.08	35.97	29.53	16.11	2.68	0.54	2.15	0.00	1.07	0.54
gamma delta positive T cells, donor2	11938-126A3	45.19	54.53	35.48	19.42	4.11	1.12	1.87	1.87	0.00	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	42.24	215.86	137.08	52.80	24.71	13.94	10.35	0.00	2.32	2.53
gastric adenocarcinoma cell line:MKN45	10612-108F9	36.56	118.18	81.43	28.82	12.19	8.32	6.19	1.93	2.71	2.51
gastric cancer cell line:AZ521	10549-107H9	29.51	171.83	108.87	30.50	11.15	6.89	7.38	9.02	3.93	3.28
gastric cancer cell line:GSS	10560-108A2	25.63	149.18	118.98	42.10	11.90	0.92	7.32	2.75	2.75	4.58
gastrointestinal carcinoma cell line:ECC12	10615-108G3	57.57	382.89	231.66	74.71	30.16	32.67	16.68	28.33	14.16	7.54
giant cell carcinoma cell line:LU65	10487-107B1	12.74	54.96	34.77	14.69	3.44	1.38	1.26	1.26	0.92	0.46
giant cell carcinoma cell line:Lu99B	10433-106E1	11.48	41.43	43.67	10.50	4.34	1.40	2.38	0.28	0.28	0.56
glassy cell carcinoma cell line:HOKUG	10688-109F4	98.27	159.88	107.00	48.39	9.23	5.49	5.74	12.22	14.47	2.74
glioblastoma cell line:A172, tech_rep1	10444-106F3	262.40	88.03	61.64	19.84	4.75	2.85	2.96	1.27	1.06	1.27
glioblastoma cell line:A172, tech_rep2	10444-106F3	283.12	110.81	67.55	35.95	7.30	4.21	3.09	2.53	2.11	1.40
glioblastoma cell line:T98G	10485-107A8	260.59	134.55	114.02	29.47	12.25	3.75	4.41	0.99	1.10	1.10
glioma cell line:GI-1	10413-106B8	28.70	74.68	68.83	13.18	6.15	3.51	2.64	4.39	0.88	1.17
globus pallidus - adult, donor10196	10175-103C4	529.92	400.90	235.44	148.70	25.51	32.80	24.05	26.97	26.97	11.66
globus pallidus, adult, donor10252	10161-103A8	413.74	838.22	761.33	437.66	79.57	82.99	39.30	171.60	122.78	28.07
globus pallidus, adult, donor10258	10367-105F7	124.60	1228.18	918.74	464.16	101.32	50.66	26.01	46.55	58.88	19.17
globus pallidus, newborn, donor10223	10364-105F4	72.48	118.31	74.61	64.48	11.72	5.86	6.93	5.33	8.53	3.20
granulocyte macrophage progenitor, donor1	12131-128D7	0.00	2.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	601.06	21.86	0.00	21.86	0.00	0.00	10.93	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	52.27	0.00	15.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	3.20	64.32	39.36	25.28	3.84	3.84	2.24	0.64	1.28	0.96
hIPS +CCl2, biol_rep1	14383-156B9	162.07	180.89	78.51	36.27	7.35	11.94	7.80	11.94	3.67	9.64
hIPS +CCl2, biol_rep2	14384-156C1	178.79	230.00	75.45	46.64	10.52	19.66	6.86	10.52	7.77	8.69
hIPS +CCl2, biol_rep3	14385-156C2	134.62	168.11	48.31	22.54	1.93	11.59	3.86	9.02	2.58	5.15
hIPS, biol_rep1	14380-156B6	24.43	56.05	8.62	25.87	1.44	1.44	0.00	0.00	0.00	1.44
hIPS, biol_rep2	14381-156B7	101.51	110.42	21.95	39.78	4.80	10.97	1.37	12.35	4.12	0.69
hIPS, biol_rep3	14382-156B8	40.83	957.81	441.39	203.04	46.35	38.62	34.21	12.14	9.93	17.66
hairy cell leukemia cell line:Mo	10712-109I1	473.54	518.08	370.96	80.17	45.69	30.75	20.11	10.34	12.36	9.77
heart - mitral valve, adult	10205-103F7	139.92	567.44	449.35	185.96	49.03	35.58	24.81	22.72	28.70	9.87
heart - pulmonic valve, adult	10206-103F8	422.54	2323.73	1586.37	715.14	199.77	173.36	84.72	117.66	112.96	44.97
heart - tricuspid valve, adult	10207-103F9	424.65	1691.93	1013.32	605.33	104.08	114.90	64.95	95.75	75.77	38.30
heart, adult, diseased post-infarction, donor1	10050-101G5	857.85	467.90	350.16	148.96	37.55	27.75	18.77	9.18	14.69	9.39
heart, adult, diseased, donor1	10051-101G6	2276.93	1122.07	727.32	298.93	77.93	58.76	36.62	16.61	29.38	15.33
heart, adult, pool1	10016-101C7	41.63	136.84	66.69	86.70	6.21	2.76	7.36	0.00	1.84	3.22
heart, fetal, pool1	10046-101G1	498.72	546.05	419.96	122.81	46.62	22.59	25.05	14.17	13.25	9.24
hepatic mesenchymal tumor cell line:LI90	10778-110G4	18.20	42.58	34.86	12.96	3.70	3.09	1.85	0.00	0.31	1.23
hepatoblastoma cell line:HuH-6	10633-108I3	3.57	90.38	40.43	60.65	3.57	0.00	2.38	9.51	9.51	2.38
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	44.64	285.41	233.92	77.02	31.05	24.86	11.82	18.45	8.73	5.08
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	55.59	241.66	199.30	65.06	21.85	23.55	12.14	17.48	5.70	3.88
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	44.77	280.42	265.57	75.79	34.46	26.68	13.44	17.58	6.67	5.76
hepatoma cell line:Li-7	10484-107A7	15.57	67.62	60.39	15.68	6.34	2.22	1.89	1.67	1.33	0.89
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	17.29	104.12	93.77	22.41	8.94	7.64	4.32	1.21	1.91	1.21
hippocampus - adult, donor10196	10169-103B7	848.86	1014.46	746.65	288.63	59.62	57.73	55.83	45.42	33.12	18.93
hippocampus, adult, donor10252	10153-102I9	474.12	1035.60	980.09	407.18	107.56	107.36	56.33	115.32	94.50	21.43
hippocampus, adult, donor10258	10374-105G5	12.45	1255.83	272.38	287.32	22.91	39.84	21.91	11.45	14.44	28.88
hippocampus, newborn, donor10223	10363-105F3	83.54	167.07	85.30	119.84	9.16	9.16	7.05	9.87	13.04	2.82
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	161.13	142.21	114.74	48.22	10.99	4.27	5.49	4.88	2.44	3.66
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	52.62	109.37	89.34	38.68	12.17	4.91	2.36	1.18	2.16	0.98
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	71.60	107.91	82.52	25.90	12.44	4.32	5.33	1.52	0.51	2.03
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	36.65	39.47	23.68	12.41	7.33	3.38	1.13	3.38	1.69	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	20.66	45.45	43.38	19.88	5.94	2.32	1.03	1.29	1.55	1.55
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	25.05	44.03	30.37	9.87	5.31	4.93	1.90	4.18	0.38	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	19.85	26.86	19.27	6.13	3.80	2.63	1.75	1.75	0.29	1.17
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	12.93	50.19	34.25	15.51	4.74	3.45	2.80	1.72	1.08	1.08
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	17.52	18.35	12.51	4.17	0.83	2.09	0.42	2.09	0.42	1.67
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	15.15	21.78	17.52	6.87	2.60	1.18	0.47	1.66	0.47	0.47
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	23.79	61.72	49.66	16.88	6.43	2.73	2.09	2.25	0.96	0.96
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	17.51	12.79	8.08	8.75	0.00	0.00	1.35	1.35	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	82.47	119.08	117.83	36.62	14.55	5.01	2.97	0.16	1.88	2.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	46.18	155.74	124.79	49.13	11.79	4.42	5.40	9.83	2.46	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	205.97	185.90	139.64	52.37	13.96	8.73	3.49	5.24	1.75	2.62
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	32.07	65.67	44.86	28.45	6.87	2.86	2.48	1.53	0.76	0.95
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	20.06	91.14	52.76	29.65	7.85	6.11	2.62	21.37	3.49	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	51.98	62.47	45.48	28.99	6.00	2.50	1.50	9.00	1.50	2.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	6.97	37.87	25.62	11.12	3.01	2.07	0.75	2.83	0.94	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	4.55	15.46	11.82	6.37	1.82	0.00	0.45	2.27	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	12.22	26.94	14.41	10.65	1.88	2.51	2.19	3.13	1.57	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	25.15	38.21	35.44	11.92	3.76	2.12	0.65	2.29	1.14	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	13.64	31.93	31.64	10.45	4.06	2.03	1.45	1.74	0.58	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	29.59	37.07	23.02	9.27	4.78	2.09	1.20	2.69	1.20	0.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	396.46	77.41	103.27	30.11	9.42	3.51	2.96	1.29	0.55	1.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	324.37	52.21	65.90	12.84	6.85	3.14	2.00	1.14	0.86	2.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	789.67	55.12	70.64	18.37	7.35	2.86	6.12	2.45	0.41	1.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	158.79	24.65	32.74	8.45	3.17	2.11	1.76	1.41	0.00	0.70
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	135.56	31.36	39.91	11.72	5.38	0.95	1.58	3.48	0.63	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	253.60	17.25	18.46	7.57	3.93	1.51	2.12	2.42	0.61	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	49.64	8.27	12.41	6.21	0.00	2.07	0.52	2.59	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	54.46	11.95	12.62	3.32	1.33	0.00	1.33	0.00	1.33	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	65.93	6.67	8.72	3.59	0.77	1.28	0.51	0.51	1.03	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	112.23	14.57	15.85	3.07	1.02	0.77	0.51	1.28	0.26	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	93.90	13.63	12.12	5.30	1.51	2.27	0.00	1.51	0.00	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	179.45	17.47	14.79	7.06	1.01	0.67	2.02	1.34	0.34	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	405.73	47.58	76.32	26.57	7.97	3.14	2.42	1.69	1.21	1.93
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	715.28	65.51	78.88	24.07	10.70	3.57	4.46	7.58	1.34	0.89
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	528.79	46.83	58.54	20.49	8.78	1.95	2.44	0.49	0.49	0.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	161.06	36.37	39.12	20.17	7.33	2.14	2.44	4.28	2.14	0.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	2169.91	198.45	243.99	104.10	9.76	22.77	16.27	65.06	9.76	9.76
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	350.14	30.12	33.76	11.91	1.99	3.64	3.64	10.26	0.99	0.99
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	71.70	15.87	18.06	7.11	2.74	2.74	1.64	1.64	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	95.18	12.30	15.20	9.05	2.17	1.81	1.45	0.72	0.36	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	96.80	8.54	9.25	2.85	0.36	2.14	0.71	0.71	0.36	0.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	159.91	29.83	28.64	9.55	0.00	1.19	2.39	1.19	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	94.53	20.86	21.13	5.96	2.17	1.22	1.63	3.25	0.41	0.41
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	181.84	21.01	26.94	9.43	4.04	1.89	1.35	1.35	1.08	0.81
immature langerhans cells, donor1	11904-125F5	16.95	110.66	64.41	35.84	7.26	4.12	4.12	4.84	1.94	3.63
immature langerhans cells, donor2	11905-125F6	606.77	73.67	46.74	34.85	4.75	5.54	3.96	4.75	5.54	2.38
insula, adult, pool1	10039-101F3	319.86	451.50	333.11	107.69	43.15	19.31	17.89	14.38	9.08	7.10
keratoacanthoma cell line:HKA-1	10791-110H8	66.33	83.89	60.80	30.56	4.88	5.85	3.90	4.23	2.28	2.60
kidney, adult, pool1	10017-101C8	64.78	255.02	200.05	97.32	22.73	6.41	9.81	0.40	4.21	5.11
kidney, fetal, pool1	10045-101F9	252.10	158.73	113.18	32.82	13.02	5.73	6.15	4.46	2.62	3.54
large cell lung carcinoma cell line:IA-LM	10509-107D5	10.65	92.60	70.58	23.29	7.10	2.56	2.70	0.00	0.43	1.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	28.34	61.24	41.61	14.10	6.08	3.32	2.49	0.83	0.83	1.80
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	16.51	36.52	21.47	12.11	2.57	0.73	1.28	1.10	1.10	0.92
left atrium, adult, donor1	10079-102A7	51.22	390.11	401.01	143.84	57.75	22.88	14.71	2.18	15.26	5.99
left ventricle, adult, donor1	10078-102A6	80.40	323.11	288.22	139.56	34.38	17.70	17.19	8.09	13.65	6.57
leiomyoblastoma cell line:G-402	10721-110A1	151.31	90.02	62.38	25.99	6.84	5.20	4.10	2.19	1.92	2.19
leiomyoma cell line:10964C	10569-108B2	403.08	67.18	42.03	16.53	5.03	2.16	3.59	0.36	0.36	0.72
leiomyoma cell line:15242A	10570-108B3	25.54	78.26	46.20	21.74	5.43	2.17	1.09	0.00	4.35	1.09
leiomyoma cell line:15425	10571-108B4	346.26	92.03	68.72	19.67	8.01	2.67	3.40	0.97	0.97	1.94
leiomyosarcoma cell line:Hs 5.T	10722-110A2	241.28	6.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	16.73	26.14	14.64	14.64	3.14	0.00	1.05	0.00	1.05	2.09
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	67.77	215.46	186.65	54.54	20.66	10.15	10.86	2.24	5.31	3.54
liposarcoma cell line:KMLS-1	10782-110G8	23.28	72.48	58.89	20.46	8.75	3.59	3.91	2.19	1.09	1.56
liposarcoma cell line:SW 872	10726-110A6	227.35	60.92	52.27	18.15	5.73	3.90	4.39	0.85	0.85	1.95
liver, adult, pool1	10018-101C9	353.29	200.79	147.48	61.42	14.42	6.48	8.27	0.00	1.62	3.08
liver, fetal, pool1	10086-102B5	130.76	104.42	77.14	34.81	6.58	12.23	5.64	11.29	12.23	0.00
locus coeruleus - adult, donor10196	10182-103D2	1183.07	761.06	604.59	299.82	72.33	38.06	33.39	43.46	39.52	12.40
locus coeruleus, adult, donor10252	10165-103B3	388.85	633.38	567.68	289.74	57.76	79.91	26.76	108.15	116.08	15.50
locus coeruleus, adult, donor10258	10375-105G6	174.08	466.09	354.37	183.95	34.99	25.96	17.77	33.01	22.01	10.44
locus coeruleus, newborn, donor10223	10362-105F2	128.71	587.60	391.60	306.63	59.31	28.60	33.65	25.24	29.44	8.83
lung adenocarcinoma cell line:A549	10499-107C4	115.01	25.60	33.08	15.09	2.49	0.97	0.97	1.11	0.42	0.55
lung adenocarcinoma cell line:PC-14	10408-106B3	19.30	91.00	66.87	26.89	5.52	0.00	1.38	1.38	0.69	1.38
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	232.39	63.27	55.10	20.70	5.40	3.43	2.90	2.50	0.79	1.71
lung, adult, pool1	10019-101D1	73.95	42.29	32.37	17.96	3.90	0.35	2.48	0.12	0.59	0.71
lung, fetal, donor1	10068-101I5	2.00	200.07	107.60	27.40	5.99	5.99	5.42	1.71	3.14	0.86
lung, right lower lobe, adult, donor1	10075-102A3	30.70	339.54	255.68	191.08	31.16	27.49	11.91	9.16	17.41	5.04
lymph node, adult, donor1	10077-102A5	20.83	200.71	160.00	71.00	17.99	14.67	4.73	0.95	3.79	3.79
lymphangiectasia cell line:DS-1	10727-110A7	179.07	85.26	81.97	30.47	8.55	5.04	3.07	5.48	3.51	1.75
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	14.64	137.34	99.01	27.77	9.81	8.00	4.68	3.17	2.11	1.96
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	21.24	41.63	29.73	16.99	3.40	0.85	0.85	1.70	0.00	0.85
mature adipocyte, donor1	12231-129F8	194.91	20.87	7.55	7.99	0.00	1.33	0.89	0.00	0.00	0.44
mature adipocyte, donor2	12232-129F9	190.93	22.00	14.53	9.13	1.45	1.04	0.83	1.04	0.83	1.25
mature adipocyte, donor3	12233-129G1	146.27	18.02	11.38	6.64	1.19	0.95	0.24	0.71	0.47	1.19
mature adipocyte, donor4	12234-129G2	15.79	19.74	13.95	7.37	2.90	0.26	1.32	0.00	0.00	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	25.26	53.13	67.90	26.21	6.91	1.91	3.57	3.57	0.95	2.86
medial frontal gyrus - adult, donor10196	10170-103B8	914.83	1026.51	839.25	346.31	72.19	81.22	46.25	67.68	57.53	24.82
medial frontal gyrus, adult, donor10252	10150-102I6	411.21	801.46	718.15	343.17	76.87	75.03	39.17	144.92	97.84	17.10
medial frontal gyrus, adult, donor10258	10368-105F8	70.21	595.03	491.14	235.72	46.38	50.51	22.87	13.34	20.01	13.03
medial frontal gyrus, newborn, donor10223	10352-105E1	262.72	319.87	226.04	159.51	16.21	21.75	11.52	46.49	30.71	6.82
medial temporal gyrus - adult, donor10196	10183-103D3	1402.49	638.22	657.12	229.84	90.11	50.79	26.16	50.63	28.69	13.50
medial temporal gyrus, adult, donor10252	10156-103A3	450.77	1182.09	1066.64	570.46	110.99	124.79	56.45	210.95	140.49	25.89
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	30.82	945.79	448.82	331.32	36.60	63.57	21.19	25.04	17.34	17.34
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	502.38	34175.96	27329.28	5554.85	2339.64	1090.87	1722.43	129.18	244.01	732.03
medial temporal gyrus, newborn, donor10223	10353-105E2	117.37	174.80	129.22	104.81	10.05	10.77	3.23	23.33	11.13	2.15
medulla oblongata - adult, donor10196	10174-103C3	745.03	563.31	433.52	211.57	38.94	56.46	27.26	36.99	33.10	19.47
medulla oblongata, adult, donor10252	10155-103A2	228.80	531.13	481.59	227.56	54.49	55.26	23.22	84.68	62.70	13.62
medulla oblongata, adult, pool1	10038-101F2	398.26	441.60	331.41	87.59	40.90	15.26	20.57	8.90	7.92	6.53
medulla oblongata, newborn, donor10223	10361-105F1	70.48	182.27	114.22	94.78	11.11	7.64	5.55	6.94	6.94	5.21
medulloblastoma cell line:D283 Med	10838-111E1	487.55	329.46	355.81	84.36	41.63	34.10	17.05	8.64	9.96	5.98
medulloblastoma cell line:ONS-76	10759-110E3	18.10	75.08	59.91	21.64	6.85	4.04	4.89	3.91	4.89	1.71
melanoma cell line:COLO 679	10514-107E1	21.85	77.05	60.23	20.41	8.05	2.73	2.59	0.72	1.15	0.86
melanoma cell line:G-361	10465-106H6	1048.93	357.24	296.17	79.81	30.13	10.86	13.84	12.49	3.26	5.97
meningioma cell line:HKBMM	10691-109F7	10.49	27.68	25.33	7.06	2.35	0.90	1.09	0.18	0.00	0.54
merkel cell carcinoma cell line:MKL-1	10843-111E6	1008.04	244.96	158.61	47.58	22.03	10.57	7.05	5.29	1.76	2.64
merkel cell carcinoma cell line:MS-1	10844-111E7	642.36	113.02	117.17	5.70	11.41	5.96	6.74	2.85	3.11	1.56
mesenchymal precursor cell - adipose, donor1	11747-123G1	12.58	49.41	47.87	12.74	4.45	2.45	1.69	0.46	0.15	0.92
mesenchymal precursor cell - adipose, donor2	11748-123G2	208.87	56.90	51.08	12.91	4.00	2.54	2.36	0.36	0.73	0.73
mesenchymal precursor cell - adipose, donor3	11749-123G3	17.81	67.50	38.10	11.59	2.48	5.80	2.07	0.41	0.41	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	190.77	68.13	70.80	17.84	7.16	3.51	1.83	0.84	0.70	0.42
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	243.21	45.83	43.91	12.71	5.78	1.93	2.50	0.96	0.39	1.54
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	204.75	167.97	70.10	18.74	9.02	8.33	7.63	5.55	1.39	2.78
mesenchymal precursor cell - cardiac, donor1	11752-123G6	10.47	37.24	38.10	10.47	3.43	3.26	1.37	0.51	1.03	0.69
mesenchymal precursor cell - cardiac, donor2	11753-123G7	10.24	51.53	47.16	11.96	2.42	3.11	1.61	0.23	0.69	0.58
mesenchymal precursor cell - cardiac, donor3	11754-123G8	8.89	41.91	42.71	10.08	3.45	1.86	2.12	0.40	0.80	0.40
mesenchymal precursor cell - cardiac, donor4	11755-123G9	15.93	71.71	57.39	13.50	4.05	6.21	2.70	2.03	1.22	0.68
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	13.94	66.15	61.46	13.37	5.55	4.27	2.85	0.85	1.14	1.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	20.75	82.34	48.09	17.79	7.90	2.63	2.31	1.32	1.98	1.32
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	218.35	32.52	40.82	11.76	2.49	3.46	1.52	0.69	0.28	1.11
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	311.38	269.84	131.26	41.54	19.90	8.03	9.77	2.09	4.89	2.79
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	17.15	63.29	57.37	19.40	3.88	3.67	3.06	0.61	1.43	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	31.63	222.14	113.95	33.07	11.14	5.39	8.27	1.80	1.80	3.95
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	159.42	41.59	55.45	11.90	5.28	3.21	2.90	2.90	0.83	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	50.84	220.47	141.81	44.23	16.19	5.70	9.12	3.19	2.28	4.79
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	24.33	133.42	84.75	24.75	11.33	7.13	4.62	2.94	1.68	3.36
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	259.42	53.65	44.53	13.30	3.74	3.74	2.69	1.20	1.05	1.34
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	215.94	50.68	64.86	15.23	4.64	3.94	3.76	1.49	1.75	1.31
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	110.08	67.01	63.32	20.62	7.73	10.68	6.26	4.42	3.31	1.84
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	31.48	292.17	166.83	40.63	22.89	13.16	10.30	2.29	2.29	5.15
mesenchymal stem cell line:Hu5/E18	10568-108B1	55.15	136.41	72.84	29.05	2.95	8.84	4.21	0.84	0.42	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	91.33	35.16	16.44	8.22	5.02	1.83	0.46	0.00	0.91	2.28
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	154.49	41.69	33.25	5.88	4.60	2.05	1.53	0.51	0.26	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	166.74	44.24	35.34	8.64	3.14	1.83	2.36	0.26	0.26	1.05
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	203.03	85.03	49.91	25.26	4.93	1.85	2.46	0.31	1.23	1.54
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	154.39	39.07	30.60	7.53	3.53	1.41	1.18	0.24	0.47	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	158.74	34.18	21.32	8.46	1.69	1.35	1.02	0.00	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	168.19	94.31	49.51	18.47	4.72	2.75	3.93	0.79	1.18	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	144.11	65.80	36.61	15.29	5.10	2.32	4.17	0.00	0.46	0.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	144.91	193.21	144.91	0.00	0.00	0.00	48.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	179.68	64.61	40.38	11.54	3.46	2.88	1.73	0.00	0.58	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	154.61	60.24	34.13	11.16	3.12	1.34	2.23	0.45	0.89	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	169.93	58.17	38.46	12.26	3.36	1.68	1.20	0.48	1.20	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	111.47	24.20	11.73	15.40	2.93	0.73	0.00	0.00	0.73	1.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	156.08	53.71	36.25	11.41	3.69	2.01	2.69	0.34	0.34	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	142.05	71.23	31.11	16.78	3.68	1.64	0.41	0.00	0.41	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	151.63	39.09	28.78	12.89	3.44	2.58	2.15	0.00	1.72	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	65.63	49.22	13.67	5.47	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	428.69	113.63	51.65	10.33	10.33	15.49	5.16	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	111.40	60.41	38.00	15.91	4.55	2.92	3.57	0.00	0.97	1.30
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	161.50	39.28	23.28	8.73	1.45	1.45	1.45	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	109.81	61.30	34.12	16.53	8.00	1.60	3.20	0.00	0.00	1.60
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	170.10	80.96	24.53	9.81	4.09	4.09	2.45	0.00	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	132.16	71.14	38.87	18.66	7.00	3.11	3.50	0.00	0.78	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	216.17	29.38	18.89	8.39	8.39	4.20	2.10	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	87.43	63.58	22.85	21.86	2.98	6.95	0.99	0.00	1.99	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	348.01	95.34	57.21	9.53	14.30	4.77	0.00	0.00	4.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	139.35	44.47	24.90	9.49	3.56	0.59	4.74	0.00	1.78	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	135.25	37.77	31.68	7.31	3.66	4.87	2.44	0.00	1.22	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	81.16	81.16	0.00	0.00	0.00	0.00	27.05	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	124.78	47.50	20.27	8.87	3.80	0.63	1.27	0.00	1.27	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	112.44	45.18	21.04	11.38	2.76	1.38	2.76	0.00	0.34	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	238.56	53.73	51.58	10.75	8.60	2.15	2.15	0.00	0.00	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	431.11	75.84	31.93	15.97	3.99	0.00	3.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	595.79	58.55	48.21	17.22	3.44	6.89	3.44	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	226.96	64.38	48.49	17.93	4.07	4.07	3.26	0.00	0.41	1.63
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	228.80	46.87	36.54	17.48	2.38	3.18	3.97	0.00	1.59	2.38
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	310.68	60.13	34.19	20.04	6.48	2.95	2.95	0.00	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	138.71	48.63	33.35	12.16	3.43	0.94	1.25	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	427.74	76.19	40.10	16.04	2.67	1.34	2.67	2.67	4.01	2.67
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	351.25	125.36	68.59	26.02	8.28	5.91	5.91	0.00	7.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	852.58	233.69	133.54	64.20	23.11	7.70	15.41	0.00	2.57	7.70
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	291.19	135.61	92.93	42.68	16.52	2.07	5.51	1.38	4.82	4.82
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	434.94	150.42	111.33	41.56	10.39	6.43	6.43	0.00	1.98	2.47
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	848.98	207.48	173.83	62.80	10.09	4.49	4.49	0.00	1.12	10.09
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	647.51	183.82	128.48	49.61	17.81	5.72	10.81	0.00	2.54	3.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	292.16	77.37	49.57	35.46	7.66	4.84	4.03	0.00	1.21	2.42
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	1000.89	178.81	91.58	82.86	17.44	4.36	10.90	0.00	4.36	6.54
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	594.25	130.51	77.29	45.61	15.20	8.87	5.07	0.00	1.27	5.07
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	172.36	89.21	50.37	11.53	5.46	6.07	1.82	0.00	0.61	4.86
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	2196.22	357.00	189.80	112.97	22.59	13.56	9.04	4.52	4.52	9.04
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	761.90	239.69	174.62	75.78	22.24	8.24	10.71	1.65	2.47	2.47
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	130.56	11.11	8.93	8.14	1.19	0.60	0.00	1.59	0.00	0.60
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	146.67	44.46	34.40	12.66	4.22	2.27	1.95	1.30	0.32	1.30
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	573.49	160.94	99.83	49.91	14.26	5.09	3.06	1.02	5.09	3.06
mesodermal tumor cell line:HIRS-BM	10696-109G3	0.77	0.00	0.00	0.77	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	8.27	36.62	32.13	12.99	4.96	0.47	1.65	0.94	0.24	0.71
mesothelioma cell line:ACC-MESO-4	10494-107B8	15.29	93.60	74.37	32.67	9.50	3.48	2.78	0.70	1.16	0.93
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	354.71	461.55	217.95	85.47	34.19	21.37	21.37	0.00	12.82	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	184.23	414.39	195.33	90.21	23.94	19.83	18.80	15.52	10.48	7.30
mesothelioma cell line:Mero-25	10850-111F4	209.71	163.63	117.34	34.04	11.80	4.99	4.99	0.68	2.27	3.18
mesothelioma cell line:Mero-41	10851-111F5	18.34	247.65	143.02	46.69	16.14	6.60	7.33	1.47	2.44	3.67
mesothelioma cell line:Mero-48a	10852-111F6	20.59	315.54	238.92	62.00	22.14	12.40	10.85	3.54	4.65	4.87
mesothelioma cell line:Mero-82	10853-111F7	295.92	603.93	352.68	104.07	40.21	27.33	24.70	11.30	12.88	11.30
mesothelioma cell line:Mero-83	10854-111F8	16.68	579.60	397.98	98.90	45.79	30.47	21.62	10.38	9.87	11.58
mesothelioma cell line:Mero-84	10855-111F9	223.20	105.15	72.80	21.23	12.64	2.53	5.06	0.76	1.52	1.01
mesothelioma cell line:Mero-95	10856-111G1	17.60	157.35	120.71	31.47	14.08	7.04	6.21	2.48	4.55	2.07
mesothelioma cell line:NCI-H2052	10847-111F1	101.38	296.68	220.15	53.50	21.37	13.75	11.60	0.66	2.98	5.30
mesothelioma cell line:NCI-H226	10846-111E9	126.15	387.14	242.89	73.48	25.88	16.83	13.94	5.79	5.97	6.88
mesothelioma cell line:NCI-H2452	10848-111F2	158.01	159.21	122.82	30.24	10.76	5.98	5.64	3.25	3.59	3.07
mesothelioma cell line:NCI-H28	10845-111E8	53.18	303.07	227.24	60.82	23.92	17.05	8.14	5.60	4.33	4.83
mesothelioma cell line:No36	10857-111G2	180.39	127.87	89.38	25.12	9.13	6.85	8.81	11.09	4.57	1.63
mesothelioma cell line:ONE58	10858-111G3	13.55	131.41	73.43	32.51	10.30	4.61	5.15	1.63	1.90	1.35
migratory langerhans cells, donor1	11901-125F2	20.15	294.41	170.81	69.86	16.12	16.70	10.94	6.33	5.37	5.57
migratory langerhans cells, donor2	11902-125F3	9.16	79.25	42.25	26.01	3.30	3.42	3.30	5.25	1.95	1.83
migratory langerhans cells, donor3	11903-125F4	100.87	97.10	50.08	20.10	5.74	7.18	3.95	2.33	1.62	1.08
mixed mullerian tumor cell line:HTMMT	10689-109F5	75.74	136.47	88.15	37.87	12.08	8.81	6.53	7.51	3.59	1.96
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	27.55	40.27	31.15	14.20	2.54	2.76	0.64	1.27	0.64	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	16.36	49.53	27.18	16.36	2.07	2.53	2.07	0.92	0.92	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	24.17	81.25	69.08	22.07	8.94	7.99	5.52	1.14	0.38	1.90
myelodysplastic syndrome cell line:SKM-1	10772-110F7	26.43	122.52	87.22	29.20	10.90	6.10	5.54	1.29	1.29	1.66
myeloma cell line:PCM6	10474-106I6	13.05	57.13	41.11	10.48	3.56	1.98	3.36	2.37	0.20	0.59
myxofibrosarcoma cell line:MFH-ino	10600-108E6	8.12	97.40	44.64	28.92	6.09	1.01	0.51	0.00	1.52	1.01
myxofibrosarcoma cell line:NMFH-1	10684-109E9	22.95	122.00	81.20	31.58	1.77	4.90	4.12	0.00	1.37	1.77
nasal epithelial cells, donor1, tech_rep1	12226-129F3	78.67	9.58	7.91	3.45	0.78	0.00	0.33	0.00	0.00	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	64.42	7.72	4.56	3.60	0.44	0.00	0.07	0.22	0.07	0.15
nasal epithelial cells, donor2	12227-129F4	6.07	19.87	23.74	4.97	0.55	1.10	0.55	0.55	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	387.19	106.52	92.25	32.67	8.74	3.68	3.68	4.60	2.53	2.76
neuroblastoma cell line:NB-1	10539-107G8	37.04	128.53	107.95	30.68	12.72	3.55	7.11	3.55	1.31	1.68
neuroblastoma cell line:NBsusSR	10607-108F4	44.92	131.81	89.00	29.95	12.44	5.69	6.33	1.05	1.90	2.11
neuroblastoma cell line:NH-12	10555-107I6	71.37	358.35	268.53	75.84	35.03	19.01	12.67	3.91	11.18	4.85
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	85.64	404.23	278.27	102.72	39.14	39.38	14.00	5.69	13.76	6.17
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	32.15	134.78	94.87	45.77	11.56	11.56	5.07	6.97	6.18	3.33
neuroectodermal tumor cell line:TASK1	10774-110F9	36.83	133.03	98.82	30.99	9.86	7.04	6.44	1.61	1.21	2.42
neuroepithelioma cell line:SK-N-MC	10728-110A8	95.36	113.80	52.77	40.05	3.18	1.91	3.18	1.91	3.18	4.45
neurofibroma cell line:Hs 53.T	10729-110A9	10.11	24.49	14.91	6.39	1.60	2.13	0.80	0.27	1.06	1.06
neutrophil PMN, donor1	12133-128D9	0.00	0.00	14.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	53.12	0.00	13.28	0.00	0.00	0.00	0.00	0.00	13.28	0.00
neutrophil PMN, donor3	12141-128E8	9.47	9.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	15.73	132.76	126.33	30.44	13.87	4.06	5.92	1.69	1.01	0.85
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	21.61	14.41	11.21	10.41	0.80	0.00	0.00	1.60	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	25.97	42.64	35.27	13.79	3.53	3.53	2.24	2.24	0.64	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	226.50	67.53	48.61	16.55	6.57	3.15	2.63	0.26	1.84	0.26
nucleus accumbens, adult, pool1	10037-101F1	408.80	537.87	387.89	116.80	45.18	21.65	24.09	16.03	10.87	7.31
occipital cortex - adult, donor10196	10172-103C1	1003.41	519.22	471.83	261.67	45.33	28.85	20.60	115.38	35.03	14.42
occipital cortex, adult, donor10252	10163-103B1	575.91	1174.36	1066.47	513.65	104.39	119.15	58.23	190.00	152.43	24.96
occipital cortex, newborn, donor10223	10355-105E4	92.44	149.58	95.72	69.15	9.46	8.73	5.82	16.38	13.10	3.64
occipital lobe, adult, donor1	10076-102A4	45.40	239.57	165.57	82.39	33.06	53.53	19.42	1.31	9.71	3.41
occipital lobe, fetal, donor1	10073-102A1	37.76	314.10	181.51	110.71	22.74	43.77	17.59	15.45	16.31	6.87
occipital pole, adult, pool1	10036-101E9	378.75	219.42	164.54	46.60	18.21	8.75	9.38	4.49	4.57	3.86
olfactory region, adult	10195-103E6	78.90	1069.51	649.19	291.55	108.33	77.95	48.53	22.16	25.98	22.54
optic nerve, donor1	10277-104E7	306.16	412.22	152.08	254.13	28.01	8.00	20.01	42.02	30.02	10.01
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	32.24	90.90	90.10	18.11	11.73	3.42	4.10	0.80	0.57	1.59
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	28.03	91.50	72.40	19.51	6.73	2.20	2.47	1.24	1.79	0.27
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	63.33	165.77	118.19	32.68	16.76	6.26	8.47	0.00	1.69	2.88
oral squamous cell carcinoma cell line:SAS	10544-107H4	35.35	165.18	86.75	30.38	4.62	8.66	6.12	5.08	2.54	3.47
osteoclastoma cell line:Hs 706.T	10704-109H2	164.33	39.69	31.45	9.41	2.35	2.65	2.35	0.29	0.29	1.18
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	7.47	32.70	16.82	12.15	1.87	0.00	0.00	0.93	0.00	1.87
osteosarcoma cell line:HS-Os-1	10558-107I9	24.81	97.76	81.22	23.33	8.06	3.39	4.88	4.03	1.91	1.48
ovary, adult, pool1	10020-101D2	30.05	72.76	50.40	22.36	6.90	2.45	3.58	0.09	0.87	1.66
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	20.35	64.16	45.65	24.20	7.15	4.03	2.02	2.02	2.20	1.65
pancreas, adult, donor1	10049-101G4	102.53	187.19	141.10	32.92	14.11	9.41	15.05	6.58	1.88	5.64
pancreatic carcinoma cell line:NOR-P1	10698-109G5	403.37	263.32	163.53	69.60	24.60	16.77	14.82	11.46	8.95	4.75
papillary adenocarcinoma cell line:8505C	10437-106E5	59.45	531.67	367.79	87.22	49.23	22.32	22.15	0.34	4.43	6.64
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	25.33	59.44	49.84	17.55	4.47	3.31	1.99	0.83	0.66	1.82
paracentral gyrus, adult, pool1	10035-101E8	378.17	431.07	325.36	91.89	38.71	18.21	17.02	7.50	8.33	5.77
parietal cortex, adult, donor10258	10373-105G4	38.90	1167.80	786.12	271.58	65.33	72.67	48.44	21.29	34.50	40.37
parietal lobe - adult, donor10196	10171-103B9	476.83	890.64	621.66	210.67	63.01	81.82	40.44	28.21	31.98	20.69
parietal lobe, adult, donor10252	10157-103A4	385.65	1015.30	878.48	482.85	85.51	104.61	43.90	200.67	164.75	20.81
parietal lobe, adult, pool1	10034-101E7	282.07	370.28	295.99	83.71	35.07	17.10	14.63	9.96	6.70	6.17
parietal lobe, fetal, donor1	10072-101I9	68.86	993.11	726.41	344.29	77.59	103.77	30.06	2.91	24.25	10.67
parietal lobe, newborn, donor10223	10356-105E5	112.91	288.62	171.98	148.80	19.81	16.45	11.22	32.53	25.80	8.60
parotid gland, adult	10199-103F1	22.82	83.25	62.28	6.17	1.85	2.47	4.93	0.00	0.62	0.62
penis, adult	10200-103F2	136.96	403.91	258.35	122.46	39.21	26.86	15.04	20.95	15.04	8.06
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	27.70	67.68	49.46	21.01	5.02	4.65	2.97	9.85	15.06	2.05
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	288.33	235.15	185.32	52.45	21.27	11.51	14.42	3.79	3.35	4.37
pineal gland - adult, donor10196	10179-103C8	441.84	444.42	261.24	163.84	32.90	40.64	12.26	29.03	24.51	15.48
pineal gland, adult, donor10252	10160-103A7	118.44	1500.07	1034.00	419.29	120.81	88.83	48.56	110.15	39.09	23.10
pineal gland, adult, donor10258	10377-105G8	89.04	449.61	326.71	130.43	37.00	44.52	21.32	24.46	16.93	10.66
pituitary gland - adult, donor10196	10180-103C9	607.08	878.24	537.27	163.91	44.52	60.71	40.47	18.21	18.21	16.19
pituitary gland, adult, donor10252	10162-103A9	98.50	1012.13	768.74	227.76	74.01	47.95	43.26	26.06	27.62	15.64
pituitary gland, adult, donor10258	10378-105G9	142.16	1208.76	813.79	316.66	116.62	113.22	81.72	36.60	32.35	14.47
placenta, adult, pool1	10021-101D3	79.44	65.68	48.81	20.75	5.38	1.51	1.94	0.00	0.22	1.51
plasma cell leukemia cell line:ARH-77	10840-111E3	20.13	124.88	84.36	32.97	11.92	6.89	3.31	2.65	2.12	1.59
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	12.61	57.43	46.85	16.34	5.29	2.80	2.65	0.93	0.93	1.25
pons, adult, pool1	10033-101E6	321.72	419.06	325.42	97.17	36.49	15.66	17.47	10.50	7.49	6.20
postcentral gyrus, adult, pool1	10032-101E5	409.55	312.35	221.16	63.64	28.33	14.30	14.56	11.86	8.37	5.58
promyelocytes/myelocytes PMC, donor1	12132-128D8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	446.15	0.00	5.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	11.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	74.58	278.07	243.40	60.74	21.70	8.74	8.74	4.22	3.06	3.64
prostate cancer cell line:PC-3	10439-106E7	42.11	225.24	148.83	60.98	15.43	8.71	4.72	4.72	5.45	2.90
prostate, adult, pool1	10022-101D4	91.15	136.49	82.98	24.49	6.53	5.80	4.72	2.00	2.45	2.90
putamen, adult, donor10196	10176-103C5	1661.42	915.45	702.53	394.70	77.90	85.22	40.60	93.48	73.42	22.43
putamen, adult, donor10252	10152-102I8	660.76	296.07	225.48	298.03	25.49	0.00	11.76	9.80	5.88	3.92
putamen, adult, donor10258, tech_rep1	10372-105G3	81.96	826.16	386.85	253.53	25.13	25.13	16.39	14.21	10.93	16.39
putamen, adult, donor10258, tech_rep2	10372-105G3	126.85	1528.44	1293.59	424.75	112.83	71.28	70.79	12.81	25.85	24.40
putamen, newborn, donor10223	10365-105F5	92.96	296.87	191.16	149.18	16.49	11.24	10.50	11.99	8.25	3.75
rectal cancer cell line:TT1TKB	10469-106I1	41.02	43.93	53.53	27.35	4.36	1.45	1.75	4.36	4.95	1.45
rectum, fetal, donor1	10067-101I4	26.43	196.13	80.68	176.66	19.47	8.35	2.78	16.69	9.74	5.56
renal cell carcinoma cell line:OS-RC-2	10411-106B6	34.34	161.75	127.62	34.56	12.72	5.94	7.42	4.03	1.70	2.97
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	27.34	123.85	76.21	22.78	11.60	7.04	0.83	2.90	1.66	3.73
retina, adult, pool1	10030-101E3	215.70	305.55	242.83	68.09	25.74	18.09	19.28	16.00	6.86	5.57
retinoblastoma cell line:Y79	10475-106I7	5.20	286.04	228.11	70.15	20.78	11.43	10.39	4.16	2.60	2.60
rhabdomyosarcoma cell line:KYM-1	10787-110H4	25.57	194.75	150.37	56.93	16.72	0.25	11.93	5.29	4.67	2.83
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	33.74	261.52	214.84	65.80	23.34	12.65	6.47	4.22	2.81	2.25
sacrococcigeal teratoma cell line:HTST	10695-109G2	11.37	72.75	32.59	33.35	3.03	2.27	6.82	0.00	2.27	1.52
salivary acinar cells, donor1	11771-123I7	454.66	431.83	280.82	76.88	36.58	27.03	17.48	9.87	12.95	5.99
salivary acinar cells, donor2	11772-123I8	40.76	661.17	457.81	106.16	52.18	34.83	21.20	11.43	12.67	6.33
salivary acinar cells, donor3	11773-123I9	37.74	649.47	223.11	233.70	13.90	15.89	12.58	19.86	27.14	19.20
salivary gland, adult, pool1	10093-102C3	93.23	277.40	148.14	27.45	6.86	4.00	5.15	5.72	2.29	4.58
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	22.93	104.21	77.82	19.48	7.17	3.29	4.55	1.60	1.26	1.35
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	34.80	118.73	80.88	24.22	7.64	6.00	4.00	4.35	1.76	1.06
seminal vesicle, adult	10201-103F3	39.15	181.47	130.15	78.30	13.23	15.34	6.35	1.59	10.58	2.65
serous adenocarcinoma cell line:JHOS-2	10639-108I9	31.09	105.92	72.88	28.91	8.50	6.56	4.37	0.73	0.97	1.94
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	105.69	28.94	19.63	4.78	2.52	3.52	0.75	0.50	0.50	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	291.02	125.44	81.29	19.07	8.03	8.03	3.01	4.01	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	52.25	257.36	177.17	43.52	20.28	11.82	10.48	2.01	3.63	5.91
signet ring carcinoma cell line:Kato III	10436-106E4	29.95	171.43	139.49	32.16	11.49	4.31	5.53	0.44	1.11	1.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	22.06	104.51	84.77	25.16	8.13	3.23	2.45	1.55	1.55	3.23
skeletal muscle - soleus muscle, donor1	10282-104F3	3156.54	1623.67	794.46	624.21	90.09	65.26	58.87	4.26	29.08	43.27
skeletal muscle, adult, pool1	10023-101D5	366.89	93.67	77.60	42.70	7.32	2.52	5.28	0.12	0.60	1.68
skeletal muscle, fetal, donor1	10066-101I3	28.14	302.51	203.01	71.36	23.12	0.00	18.09	1.01	6.03	4.02
skin, adult, donor1	10074-102A2	0.00	176.42	169.63	27.14	6.79	0.00	6.79	6.79	6.79	13.57
skin, fetal, donor1	10065-101I2	83.95	118.04	77.64	36.61	7.57	25.25	4.42	1.26	5.05	1.89
small cell cervical cancer cell line:HCSC-1	10800-110I8	24.01	69.04	50.03	20.68	3.67	6.00	2.67	2.00	1.00	1.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	79.43	749.87	540.89	160.12	56.42	54.53	29.63	6.93	14.18	17.02
small cell lung carcinoma cell line:DMS 144	10841-111E4	225.32	99.07	65.34	8.29	0.39	7.32	2.51	2.51	2.31	0.96
small cell lung carcinoma cell line:LK-2	10541-107H1	28.35	202.08	157.41	46.32	16.48	5.44	6.10	1.65	3.30	3.63
small cell lung carcinoma cell line:NCI-H82	10842-111E5	21.39	339.71	235.64	73.35	26.06	24.93	10.94	7.56	13.67	3.22
small cell lung carcinoma cell line:WA-hT	10562-108A4	54.48	402.06	214.43	90.44	36.83	24.62	15.69	18.74	13.51	6.54
small intestine, adult, pool1	10024-101D6	243.66	174.51	133.78	51.48	16.72	6.45	6.57	3.70	2.63	3.70
small intestine, fetal, donor1	10064-101I1	35.38	614.98	572.72	143.00	81.57	52.09	28.26	38.08	19.16	11.06
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	102.58	317.49	173.36	108.22	25.65	1.03	11.80	3.59	5.13	3.59
smooth muscle, adult, pool1	10048-101G3	370.37	246.57	226.92	74.95	23.52	18.61	14.22	9.30	9.05	4.65
somatostatinoma cell line:QGP-1	10781-110G7	9.65	62.18	35.38	20.10	5.90	5.63	4.29	2.41	2.41	1.61
spinal cord - adult, donor10196	10181-103D1	720.33	514.79	469.82	321.17	50.93	30.05	14.91	68.59	51.85	10.09
spinal cord, adult, donor10252	10159-103A6	92.26	717.57	561.05	257.85	57.17	38.64	25.23	43.37	33.12	12.62
spinal cord, adult, donor10258	10369-105F9	20.75	830.16	308.54	271.88	29.06	52.58	23.52	18.68	15.22	24.21
spinal cord, fetal, donor1	10056-101H2	54.89	324.43	218.32	89.04	18.30	28.05	12.20	1.22	7.93	5.49
spinal cord, newborn, donor10223	10359-105E8	77.15	398.60	219.04	184.14	14.69	17.45	17.45	11.48	13.78	8.27
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	222.09	45.70	36.44	15.83	4.78	3.14	2.69	0.75	0.60	1.05
spleen, adult, pool1	10025-101D7	59.03	57.71	44.05	14.76	3.74	2.20	1.32	0.22	0.44	1.21
spleen, fetal, pool1	10044-101F8	86.53	46.72	34.09	9.77	3.42	1.91	1.83	2.07	0.79	0.40
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	30.74	205.68	247.19	60.14	27.22	11.08	11.28	3.83	3.42	5.90
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	26.58	134.05	87.91	36.84	8.16	3.99	3.61	2.09	2.09	2.85
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	446.95	483.29	345.61	105.19	41.93	32.50	19.22	6.64	8.04	11.53
squamous cell carcinoma cell line:T3M-5	10616-108G4	14.07	66.07	68.41	36.36	7.82	2.74	4.30	0.39	1.95	1.95
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	21.39	125.17	102.09	29.38	8.89	5.18	3.83	0.90	1.46	2.14
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	48.29	102.94	94.89	20.76	11.44	4.66	2.54	0.85	1.69	3.81
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	35.96	72.35	45.69	27.08	1.69	4.65	4.23	0.00	0.85	3.38
stomach, fetal, donor1	10062-101H8	11.75	119.61	86.51	57.67	2.14	6.41	8.54	2.14	5.34	1.07
submaxillary gland, adult	10202-103F4	41.59	165.21	102.54	46.71	14.24	6.84	6.27	0.57	1.14	1.14
substantia nigra - adult, donor10196	10178-103C7	33378.60	62632.37	45156.10	15196.76	4504.75	5590.24	4016.29	2062.42	1736.77	2279.51
substantia nigra, adult, donor10252	10158-103A5	186.10	382.59	309.69	173.85	28.87	40.92	17.03	51.51	48.40	9.55
substantia nigra, adult, donor10258	10371-105G2	16.03	862.77	278.28	198.62	23.28	46.55	21.21	5.17	10.35	27.41
substantia nigra, newborn, donor10223	10358-105E7	65.71	282.63	169.58	155.45	12.72	14.13	7.07	23.32	19.78	6.36
synovial sarcoma cell line:HS-SY-II	10441-106E9	109.13	191.44	194.88	62.82	15.82	12.61	9.17	8.71	4.36	5.27
temporal lobe, adult, pool1	10031-101E4	273.98	365.95	253.46	74.00	29.92	15.17	14.83	10.77	8.65	6.53
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	42.02	415.25	289.89	160.26	32.05	47.01	24.22	4.99	13.53	7.83
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	18.46	197.79	92.74	65.05	15.82	15.82	8.35	4.83	4.40	3.96
tenocyte, donor1	11763-123H8	25.48	156.75	101.59	28.63	15.71	5.59	4.19	0.00	2.09	2.79
tenocyte, donor2	11765-123I1	272.01	105.68	80.50	19.08	9.16	5.34	4.58	0.38	1.91	3.05
tenocyte, donor3	11768-123I4	19.65	134.18	80.06	26.69	11.12	6.30	3.34	0.00	1.85	2.97
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	44.53	244.74	153.81	46.23	11.73	14.96	9.69	19.55	8.50	3.57
teratocarcinoma cell line:NCR-G1	10798-110I6	50.87	161.55	117.15	39.15	12.33	10.33	8.94	20.19	4.78	3.85
teratocarcinoma cell line:PA-1	10807-111A6	17.98	108.48	82.76	24.80	8.21	6.20	5.89	2.63	1.70	2.48
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	28.18	112.98	94.19	32.63	8.25	5.71	5.20	0.89	2.29	1.27
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	57.86	218.58	167.15	57.10	17.40	15.13	7.56	4.16	7.19	3.40
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	8.83	109.28	108.08	35.55	1.20	6.43	3.93	1.31	2.51	1.74
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	89.57	336.78	260.56	79.80	34.20	18.89	11.40	3.58	7.17	5.54
testis, adult, pool1	10026-101D8	178.99	66.03	51.97	26.09	6.33	3.76	2.25	0.21	0.75	1.93
testis, adult, pool2	10096-102C6	659.04	1419.11	753.76	262.53	86.61	100.14	62.25	19.40	30.22	24.36
thalamus - adult, donor10196	10168-103B6	812.53	935.08	643.62	374.25	80.59	65.14	37.54	60.72	49.68	26.50
thalamus, adult, donor10252	10154-103A1	318.04	944.89	807.67	382.58	87.36	82.05	51.73	117.37	113.46	22.35
thalamus, adult, donor10258, tech_rep1	10370-105G1	27.71	1020.77	267.89	324.86	21.55	29.25	27.71	21.55	10.78	18.48
thalamus, adult, donor10258, tech_rep2	10370-105G1	209.81	1405.13	1034.58	364.46	115.45	100.79	79.05	53.85	48.58	29.31
thalamus, newborn, donor10223	10366-105F6	64.44	309.52	164.54	174.90	16.68	14.38	12.08	6.33	18.99	8.05
throat, adult	10209-103G2	43.44	125.83	76.40	25.22	14.98	8.24	6.24	0.00	1.75	2.25
throat, fetal, donor1	10061-101H7	28.03	162.71	128.28	60.03	18.59	17.67	8.84	0.30	5.18	3.05
thymic carcinoma cell line:Ty-82	10803-111A2	45.71	434.23	382.56	107.91	46.11	13.12	15.10	1.19	2.98	6.56
thymus, adult, pool1	10027-101D9	30.52	22.17	17.20	6.56	1.39	0.40	1.19	0.00	0.20	0.70
thymus, fetal, pool1	10043-101F7	55.90	61.72	46.03	13.72	3.43	1.66	3.43	1.77	1.35	0.52
thyroid carcinoma cell line:KHM-5M	10776-110G2	17.95	69.67	61.16	21.67	6.25	3.46	1.60	1.86	1.20	1.60
thyroid carcinoma cell line:TCO-1	10783-110G9	33.94	112.17	116.22	34.22	12.01	8.38	10.48	5.45	5.31	2.10
thyroid, adult, pool1	10028-101E1	134.00	61.21	44.32	20.06	4.01	1.59	2.24	0.00	0.56	0.75
thyroid, fetal, donor1	10060-101H6	59.32	549.47	317.19	232.55	47.72	60.12	20.30	51.15	35.07	14.24
tongue epidermis (fungiform papillae), donor1	10288-104F9	1810.81	797.62	431.15	403.43	30.80	43.11	33.88	67.75	43.11	15.40
tongue, adult	10203-103F5	64.66	198.62	198.62	61.40	19.30	5.81	6.51	0.47	2.79	3.95
tongue, fetal, donor1	10059-101H5	55.96	272.71	293.60	111.53	31.92	13.40	13.01	0.39	6.70	3.15
tonsil, adult, pool1	10047-101G2	97.97	92.46	65.31	19.43	7.01	3.41	3.81	2.10	2.40	1.30
trachea, adult, pool1	10029-101E2	123.60	78.36	49.57	22.00	5.81	3.52	3.44	1.47	1.31	1.55
trachea, fetal, donor1	10058-101H4	58.47	190.04	120.02	67.32	17.31	12.69	6.92	1.15	6.16	1.54
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	19.49	133.92	98.49	28.70	11.69	7.79	5.31	0.71	3.19	1.42
transitional-cell carcinoma cell line:5637	10418-106C4	22.59	61.20	50.46	10.94	5.37	2.03	2.13	1.52	1.22	1.11
transitional-cell carcinoma cell line:JMSU1	10492-107B6	39.80	136.16	115.01	34.00	12.85	4.86	4.07	5.17	4.39	2.35
tridermal teratoma cell line:HGRT	10694-109G1	0.00	91.32	49.47	24.73	0.00	1.90	3.81	0.00	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	25.82	160.16	122.49	35.13	13.21	10.75	11.00	8.13	4.49	2.88
umbilical cord, fetal, donor1	10057-101H3	329.67	310.89	202.39	81.37	33.38	16.69	4.17	14.61	0.00	2.09
uterus, adult, pool1	10100-102D1	69.96	218.23	115.17	29.52	8.70	7.51	5.46	4.95	3.07	3.41
uterus, fetal, donor1	10055-101H1	16.38	77.81	41.47	37.37	5.63	6.14	1.02	1.02	4.10	2.05
vagina, adult	10204-103F6	212.60	140.23	77.54	43.30	9.05	7.11	3.23	25.20	15.51	4.52
vein, adult	10191-103E2	20.17	94.26	60.28	28.50	7.01	4.60	2.41	0.22	0.66	1.97
xeroderma pigentosum b cell line:XPL 17	10563-108A5	25.10	233.92	154.35	47.27	19.49	12.28	12.82	8.01	10.41	5.87